Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 4.2.1.11 - phosphopyruvate hydratase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acidosis
Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation.
Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis.
Acidosis, Lactic
Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle.
Acquired Immunodeficiency Syndrome
Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies.
Enolase of Mycobacterium tuberculosis is a surface exposed plasminogen binding protein.
Acute Coronary Syndrome
Assessment of Silent Neuronal Injury Following Coronary Angiography and Intervention in Patients With Acute Coronary Syndrome.
Acute Febrile Encephalopathy
Serum neuron specific enolase is increased in pediatric acute encephalitis syndrome.
Acute Lung Injury
Gamma-enolase predicts lung damage in severe acute pancreatitis-induced acute lung injury.
Adamantinoma
Osteofibrous dysplasia and adamantinoma: correlation of proto-oncogene product and matrix protein expression.
Adenocarcinoma
A case of mixed ductal-endocrine carcinoma of the pancreas.
Adenoendocrine cell carcinoma of the gallbladder: report of a case.
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
Augmented expression of chromogranin A and serotonin in peri-malignant benign prostate epithelium as compared to adenocarcinoma.
Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis.
Carcinosarcoma of the liver: a case report and review of the literature.
Chemotherapy with Gemcitabine and Cisplatin for Advanced Ductal Adenocarcinoma of the Prostate: Clinical Courses of Two Patients.
Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma.
Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping.
Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Comparison of cytologic markers for automated lung cancer screening.
Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer.
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance.
ENO1 silencing impaires hypoxia-induced gemcitabine chemoresistance associated with redox modulation in pancreatic cancer cells.
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Expression of nse and pgp-9.5 in nonsmall-cell lung-cancers.
Gastric adenocarcinoma producing neuron-specific enolase.
Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics.
Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer.
Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor.
Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Immunohistochemical characterization of endocrine cells in experimental exocrine pancreatic cancer in the Syrian golden hamster.
Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.
Metastatic prostatic adenocarcinoma with neuroendocrine differentiation to meningioma.
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
NCAM: a surface marker for human small cell lung cancer cells.
Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
Neuron-specific enolase during chemotherapy of small cell lung cancer.
New cancer markers.
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report.
Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma.
Prostate cancer and neuroendocrine differentiation.
Recovery from Marie-Bamberger's syndrome and diabetes insipidus after removal of a lung adenocarcinoma with neuroendocrine features.
Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies.
Schwann cell differentiation of modified myoepithelial cells within adenoid cystic carcinomas and polymorphous low-grade adenocarcinomas: clinicopathologic assessment of immunohistochemical staining.
Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases.
Secretagogin is a new neuroendocrine marker in the human prostate.
Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion: morphological, immunohistochemical and clinical expressions.
Small cell undifferentiated ('neuroendocrine') carcinoma of the colon.
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease.
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
Two cases of small cell carcinoma of the prostate.
Ultrastructural and immunocytochemical definition of component neoplasms in an unusual gastro-oesophageal collision tumour.
[A case of small cell carcinoma of the prostate]
[Colon adenocarcinoma with neuroendocrine and squamous cell differentiation. A case report]
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases]
[Papillary and cystic tumor of the pancreas. Histological, immunohistochemical and flow cytometric study]
[Proteome analysis of autoantibodies in sera of patients with cancer]
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
Adenocarcinoma of Lung
Correlation analysis between serum neuron-specific enolase and the detection of gene mutations in lung adenocarcinoma.
Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells.
Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?
The potential significance of alpha-enolase (ENO1) in lung adenocarcinomas - A utility of the immunohistochemical expression in pathologic diagnosis.
[Proteome analysis of autoantibodies in sera of patients with cancer]
[Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma].
Adenocarcinoma, Papillary
Small cell carcinoma of the stomach: an immunohistochemical and electron microscopic study.
Adenoma
Anti-alpha-enolase antibodies in pituitary disease.
Determination of enolase isozymes in various adrenal gland tumours.
Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon.
Identification of proliferating human anterior pituitary adenoma cells in vitro.
Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.
Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas.
Myoepitheliomas and myoepithelial adenomas of salivary gland origin. Immunohistochemical evaluation of filament proteins, S-100 alpha and beta, glial fibrillary acidic proteins, neuron-specific enolase, and lactoferrin.
Neuroendocrine differentiation and nerves in human adrenal cortex and cortical lesions.
Neuroendocrine marker expression in thyroid epithelial tumors.
Pancreatic serous microcystic adenoma with extensive oncocytic change.
Paraganglioma in pituitary fossa.
Presence of neuron-specific enolase and somatostatin in human parathyroid tissues.
Small cell undifferentiated ('neuroendocrine') carcinoma of the colon.
Adenoma, Islet Cell
Glucagonoma in a jaguar (Panthera onca).
Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Adenoma, Oxyphilic
Autoimmune retinopathy and optic neuropathy associated with enolase-positive renal oncocytoma.
Pituitary oncocytoma presenting as Cushing's disease.
Renal oncocytoma in a cat with chronic renal failure.
Adenoma, Pleomorphic
S-100 protein and neuron specific enolase (NSE) immunoreactivity in pleomorphic adenomas of the salivary glands and its relationship to the composition of their extracellular matrix.
[Expression of epithelial and nervous-system-related antigens on pleomorphic adenoma of the salivary glands--an analysis of 20 cases]
Adrenocortical Carcinoma
Novel Germ Line Mutation p53-P177R in Adult Adrenocortical Carcinoma Producing Neuron-specific Enolase as a Possible Marker.
Adrenoleukodystrophy
Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics.
Alcohol Withdrawal Delirium
Delirium tremens: some clinico-chemical features. A study of alanine-aminotransferase, alcaline phosphatase, prothrombine and enolase.
Alzheimer Disease
An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor-alpha.
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia.
Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.
Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease.
Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Differential appearance of autoantibodies to human brain S100 protein, neuron specific enolase and myelin basic protein in psychiatric patients.
Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease.
Fungal Enolase, ?-Tubulin, and Chitin Are Detected in Brain Tissue from Alzheimer's Disease Patients.
Lack of beta-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations.
Multifunctional Roles of Enolase in Alzheimer Disease Brain: Beyond Altered Glucose Metabolism.
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance.
Serum levels of S100B and NSE proteins in Alzheimer's disease patients.
Serum neuron-specific enolase in senile dementia of the Alzheimer type.
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.
Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
Amnesia, Transient Global
Significance of serum neuron-specific enolase in transient global amnesia.
Amyloidosis
Proteomic analysis of inclusion body myositis.
Amyotrophic Lateral Sclerosis
CSF from amyotrophic lateral sclerosis patients applied to motor neurons in culture fails to alter neuron-specific enolase.
[Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis].
Anaplasia
An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.
Anemia
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
Anemia, Diamond-Blackfan
Normalization of red cell enolase level following allogeneic bone marrow transplantation in a child with Diamond-Blackfan anemia.
Anemia, Hemolytic
Chronic hemolytic anemia associated with erythrocyte enolase deficiency exacerbated by ingestion of nitrofurantoin.
[Enzymatic activity of glycolysis in the erythrocytes in the course of an experimental hemolytic anemia: phosphoglucomutase, aldolase and enolase activity.]
Anencephaly
Maternal serum neurone specific enolase in the diagnosis of anencephaly and other neural tube defects.
Neurone specific enolase in amniotic fluid: a potential marker of anencephaly.
Aneurysm, Dissecting
Serum Neuron-Specific Enolase Level as Predictor of Neurologic Outcome after Aortic Surgery.
Angiomyolipoma
Renal angiomyolipomas and HMB-45 reactivity.
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Antiphospholipid Syndrome
Serum neurone-specific enolase in the primary antiphospholipid syndrome: a new biochemical marker for cerebral vascular involvement?
Aortic Aneurysm, Thoracic
Serum Neuron-Specific Enolase Level as Predictor of Neurologic Outcome after Aortic Surgery.
Aortic Valve Stenosis
Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy.
Apnea
Release of erythropoietin and neuron-specific enolase after breath holding in competing free divers.
Appendicitis
Neuroendocrine apendicopathy in morphologically normal appendices of patients with diagnosis of acute appendicitis: Diagnostic study.
Apudoma
Presence of neuron-specific enolase and somatostatin in human parathyroid tissues.
Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
[Cutaneous apudoma. Apropos of a case and review of the literature]
Arthritis
Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian ?-enolase and arthritis in DR4-IE-transgenic mice.
Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model.
Arthritis, Experimental
Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model.
Arthritis, Juvenile
Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Arthritis, Reactive
Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library.
Arthritis, Rheumatoid
Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis.
Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis.
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study.
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN).
Citrullinated Aggrecan Epitopes as Targets of Auto-reactive CD4+ T cells in Patients with Rheumatoid Arthritis.
Decreased expression of alpha-enolase inhibits the proliferation of hypoxia-induced rheumatoid arthritis fibroblasts-like synoviocytes.
Evolutionarily conserved antigens in autoimmune disease: Implications for an infective aetiology.
Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis.
Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian ?-enolase and arthritis in DR4-IE-transgenic mice.
Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis.
Pathogenic role of antibodies to citrullinated proteins in rheumatoid arthritis.
Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
[Antibodies against alfa-enolase as an indication of inflammatory process in patients with celiac disease--preliminary results].
[Detection and analysis of serum level of anti-Candida enolase IgG antibody in patients with autoimmune diseases].
Ascariasis
Ascaris suum enolase is a potential vaccine candidate against ascariasis.
Aspergillosis
A novel monoclonal antibody against enolase antigen of Aspergillus fumigatus protects experimental aspergillosis in mice.
Aspergillosis, Allergic Bronchopulmonary
Mould allergens: Where do we stand with molecular allergy diagnostics?: Part 13 of the series Molecular Allergology.
Asthma
Analysis of Results of Specific IgE in 100 Atopic Dermatitis Patients with the Use of Multiplex Examination ALEX2-Allergy Explorer.
Identification of alpha-enolase as an autoantigen associated with severe asthma.
Increased IgG Antibody-Induced Cytotoxicity Against Airway Epithelial Cells in Patients with Nonallergic Asthma.
Isotype and IgG subclass distribution of autoantibody response to alpha-enolase protein in adult patients with severe asthma.
[Analysis of IgE reactivities of purified allergens from Candida albicans and Malassezia furfur among patients with atopic dermatitis]
Astrocytoma
An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.
Co-variation of free amino acids in human epileptogenic cortex.
Enolase activity and isoenzyme distribution in human brain regions and tumors.
Enolase isoenzyme distribution in the human brain and its tumours.
Neuron-specific gamma-enolase derived from human glioma.
Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.
[Immunocytochemistry of subependymal giant cell astrocytoma associated with tuberous sclerosis]
Ataxia
Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.
Atherosclerosis
Enolase is regulated by Liver X Receptors.
Atrial Fibrillation
Serum neuron-specific enolase, a marker of neuronal injury, increases after catheter ablation of atrial fibrillation.
Autoimmune Diseases
Alpha-enolase: a target of antibodies in infectious and autoimmune diseases.
Anti-alpha-enolase antibodies in pituitary disease.
Antibodies against Crandell Rees Feline Kidney (CRFK) Cell Line Antigens, alpha-Enolase, and Annexin A2 in Vaccinated and CRFK Hyperinoculated Cats.
Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae.
Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase.
Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders.
Treponema denticola enolase contributes to the production of antibodies against ENO1 but not to the progression of periodontitis.
[Detection and analysis of serum level of anti-Candida enolase IgG antibody in patients with autoimmune diseases].
[Enolase on the surface of prockaryotic and eukaryotic cells is a receptor for human plasminogen]
[Proteome analysis of autoantibodies in sera of patients with cancer]
Autoimmune Hypophysitis
Anti-alpha-enolase antibodies in pituitary disease.
Autoimmune phenomena involving the pituitary gland in children: New developing data about diagnosis and treatment.
Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase.
Pituitary autoantibodies in lymphocytic hypophysitis target both gamma- and alpha-Enolase - a link with pregnancy?
Avian Leukosis
Rhabdomyosarcoma of the pectoral muscles of a free-living European robin (Erithacus rubecula).
Bacterial Infections
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
Barrett Esophagus
Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping.
Blister
[Neuroprotective effect of surround needling combined with acupoint injection on acute herpetic neuralgia].
Bone Diseases
Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.
Bone Resorption
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
Brain Concussion
Brain Biomarkers in Children After Mild and Severe Traumatic Brain Injury.
One-year follow-up of mild traumatic brain injury: post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S-100B and neurone-specific enolase in acute phase.
One-year follow-up of patients with mild traumatic brain injury: occurrence of post-traumatic stress-related symptoms at follow-up and serum levels of cortisol, S-100B and neuron-specific enolase in acute phase.
Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial.
Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review.
S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls.
Serum Neuron-Specific Enolase Levels Associated with Connectivity Alterations in Anterior Default Mode Network after Mild Traumatic Brain Injury.
Brain Contusion
A novel rat model of blast-induced traumatic brain injury simulating different damage degree: implications for morphological, neurological, and biomarker changes.
Brain Death
Prolonged elevation of serum neuron-specific enolase in children after clinical diagnosis of brain death.
Brain Diseases
Association between Neuron-Specific Enolase Gene Polymorphism and Delayed Encephalopathy after Acute Carbon Monoxide Poisoning.
Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy.
Biomarkers in septic encephalopathy: a systematic review of clinical studies.
Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia.
Biomarkers S100B and Neuron-Specific Enolase Predict Outcome in Hypothermia-Treated Encephalopathic Newborns*.
Can we delineate brain injury in full-term neonates using serum biomarkers?
Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies.
Early manifestations of epileptic encephalopathy, brain atrophy, and elevation of serum neuron specific enolase in a boy with beta-propeller protein-associated neurodegeneration.
Effects of hypothermia on NSE and S-100 protein levels in CSF in neonates following hypoxic/ischaemic brain damage.
Experimental evidence for alpha enolase as one potential autoantigen in the pathogenesis of both autoimmune thyroiditis and its related encephalopathy.
High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy.
Neuroinvasion by human herpesvirus type 7 in a case of exanthem subitum with severe neurologic manifestations.
Neuron specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace.
Neuron-specific enolase in cerebrospinal fluid and plasma of patients with acute ischemic brain disease.
Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse.
Neuron-specific enolase in comatose children.
Neuron-specific enolase levels and neuroimaging in asphyxiated term newborns.
Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients.
Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.
Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy.
Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: A diagnostic validity.
Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures.
Serum S100? is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
Value of biochemical markers for outcome in term infants with asphyxia.
WDR45, one gene associated with multiple neurodevelopmental disorders.
[Autoimmune thyroid disease and brain]
[Changes in plamsa S-100beta and neuron-specific enolase in peri-operative period of orthotopic liver transplantation and its relationship with encephalopathy after operation.]
[Humoral link of autoimmune reactions to neuron-specific enolase in post-radiation encephalopathy patients]
[Reversible posterior leukoencephalopathy syndrome in Hashimoto's encephalopathy: a case report]
[Study of plasma neuron-specific enolase activity of patients with chronic pulmonary heart disease complicated by pulmonary encephalopathy]
[The determination in the blood of the enzyme neuron-specific enolase in children with acute encephalopathies: the prognostic value in neurological sequelae]
Brain Edema
Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
NEUROPROTECTIVE PROPERTIES OF A NEW INHIBITOR OF NA+/H+ EXCHANGER (COMPOUND RU-1355) ON THE MODEL OF FOCAL ISCHEMIA IN RATS.
Protective effect of topiramate on hypoxic-ischemic brain injury in neonatal rat.
Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: Critical care and extracorporeal membrane oxygenation management.
The neuron-specific enolase as a marker of brain destruction in a case of Reye's syndrome: related to the treatment of brain edema.
Brain Infarction
Herbal formula FBD extracts prevented brain injury and inflammation induced by cerebral ischemia-reperfusion.
Neuron-Specific Enolase and Matrix Metalloproteinase 9 Signal Perioperative Silent Brain Infarction During or After Transcatheter Aortic Valve Implantation.
Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction.
Brain Injuries
Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation.
Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis.
An experimental model of mass-type brain damage in the rat: Expression of brain damage based on neurospecific enolase and protein S100B.
Aortic valve replacement in a patient with a brain tumor.
Arterial blood pressure during targeted temperature management after out-of-hospital cardiac arrest and association with brain injury and long-term cognitive function.
Assessing brain injury after cardiac arrest, towards a quantitative approach.
Associations Between Impaired Cerebral Blood Flow Autoregulation, Cerebral Oxygenation, and Biomarkers of Brain Injury and Postoperative Cognitive Dysfunction in Elderly Patients After Major Noncardiac Surgery.
Associations between neural injury markers of intrauterine growth-restricted infants and neurodevelopment at 2 years of age.
Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model.
Biochemical changes in the injured brain.
Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia.
Brain Injury Biomarker Behavior in Spontaneous Intracerebral Hemorrhage.
Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore.
Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility.
Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
Changes in amplitude-integrated electroencephalography, neuron-specific enolase, and S100B in neonates with brain injury induced by neonatal hyperbilirubinemia and their significance.
Changes in NSE and S-100? during the perioperative period and effects on brain injury in infants with biliary atresia undergoing parent donor liver transplantation.
Clinical applications of biomarkers in pediatric traumatic brain injury.
Comparison of Cerebral Metabolism between Pig Ventricular Fibrillation and Asphyxial Cardiac Arrest Models.
Comparison of effects of propofol versus sevoflurane for patients undergoing cardiopulmonary bypass cardiac surgery.
Correlation among decreased regional cerebral oxygen saturation, blood levels of brain injury biomarkers, and cognitive disorder.
CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man.
Decreased S100B serum levels after treatment in bipolar patients in a manic phase.
Detection of brain injury by fatty acid-binding proteins.
Development of prognostic models for patients with traumatic brain injury: a systematic review.
Drug-induced therapeutic hypothermia after asphyxial cardiac arrest in Swine.
Effects of Different Target Temperatures on Angiogenesis and Neurogenesis Following Resuscitation in a Porcine Model After Cardiac Arrest.
Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
EVALUATION OF THE EFFECT OF ADEMOL ON THE DYNAMICS OF NEURON-SPECIFIC ENOLASE IN TRAUMATIC BRAIN INJURY IN RATS.
Evidence of an association between brain cellular injury and cognitive decline after non-cardiac surgery.
Hepatic Encephalopathy in Children With Acute Liver Failure: Utility of Serum Neuromarkers.
In diabetic ketoacidosis brain injury including cerebral oedema and infarction is caused by interleukin-1.
Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation.
Low?dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats.
Meta-analysis of neuron specific enolase in predicting pediatric brain injury outcomes.
Morphologic and Biochemical Characterization of Brain Injury in a Model of Controlled Blast Overpressure Exposure.
Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.
Neuron-specific enolase (NSE) improves clinical risk scores for prediction of neurological outcome and death in cardiac arrest patients: Results from a prospective trial.
Neuron-specific enolase as an effective immunohistochemical marker for injured axons after fatal brain injury.
Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse.
Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia.
Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation.
Neuron-specific enolase is increased after nonconvulsive status epilepticus.
Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring.
Neuron-specific enolase level as a predictor of neurological outcome in near-hanging patients: A retrospective multicenter study.
Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation.
Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus.
Neuroprotective effect of DUSP14 overexpression against isoflurane-induced inflammatory response, pyroptosis and cognitive impairment in aged rats through inhibiting the NLRP3 inflammasome.
Neuroprotective role of dexmedetomidine in epilepsy surgery: A preliminary study.
Normoxic re-oxygenation ameliorates end-organ injury after cardiopulmonary bypass.
Novel neuroprotective role of hydrogen sulfide in a rat model of stress brain injury.
Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs.
Predicting neurological outcome after cardiac arrest.
Propofol shows less negative effects on cognitive performances than dexmedetomidine in elderly intensive care unit patients.
Reduced Neuron-Specific Enolase Levels in Chronic Severe Traumatic Brain Injury.
Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury.
Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate.
S-100beta and neuron-specific enolase levels in carbon monoxide-related brain injury.
S100B and NSE serum levels in obstructive sleep apnea syndrome.
S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study.
Sepsis-associated encephalopathy and its differential diagnosis.
Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury?
Serum biochemical markers of brain injury.
Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury.
Serum Biomarkers of Regeneration and Plasticity are Associated with Functional Outcome in Pediatric Neurocritical Illness: An Exploratory Study.
Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.
Serum neuron-specific enolase in human status epilepticus.
Serum S100? is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.
The Diagnostic Value of Neuron-Specific Enolase in Children with Mild Blunt Trauma Requiring Cranial CT Scan.
The effect of initial serum neuron-specific enolase level on clinical outcome in acute carotid artery territory infarction.
The Neurological Morbidity of Carotid Revascularisation: Using Markers of Cellular Brain Injury to Compare CEA and CAS.
The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
The usefulness of neuron-specific enolase in cerebrospinal fluid to predict neurological prognosis in cardiac arrest survivors who underwent target temperature management: A prospective observational study.
Therapeutic hypothermia after cardiac arrest: outcome predictors.
Time profile of neuron specific enolase serum levels after experimental brain injury in rat.
Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
Twenty minutes of normothermic cardiac arrest in a pig model: the role of short-term hypothermia for neurological outcome.
Use of neuron-specific enolase to predict mild brain injury in motorcycle crash patients with maxillofacial fractures: A pilot study.
Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.
[Blood neuronal specific enolase in newborns with perinatal asphyxia]
[Cerebrospinal fluid as informative source of the brain]
[Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass]
[Comparison of brain injuries in rat cardiac arrest models induced by asphyxia and electrical stimulation].
[Differences in immunohistochemical findings in traumatic and hypoxic changes in the central nervous system]
[The evaluation neuropsychological development in preterm infants with hypoxic brain injury].
Brain Injuries, Traumatic
A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans.
A pilot trial of l-carnitine in patients with traumatic brain injury: Effects on biomarkers of injury.
A possible protective role of betain and omega-3 supplementation in traumatic brain injury.
Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers.
Biomarkers Associated with the Outcome of Traumatic Brain Injury Patients.
Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making.
Blood metallothionein, neuron specific enolase, and protein S100B in patients with traumatic brain injury.
Brain Biomarkers in Children After Mild and Severe Traumatic Brain Injury.
Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procalcitonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry.
Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury.
Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
Effect of carotid artery stenting on the release of S-100B and neurone-specific enolase.
Effect of erythropoietin administration on the expression of brain-derived neurotrophic factor, stromal cell-derived Factor-1, and neuron-specific enolase in traumatic brain injury: A literature review.
Effect of freezing-thawing process on neuron specific enolase concentration in severe traumatic brain injury sera samples.
Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.
Elevated Serum Protein S100B and Neuron Specific Enolase Values as Predictors of Early Neurological Outcome After Traumatic Brain Injury.
EVALUATION OF THE EFFECT OF ADEMOL ON THE DYNAMICS OF NEURON-SPECIFIC ENOLASE IN TRAUMATIC BRAIN INJURY IN RATS.
F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children.
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
Glial and neuronal serum markers after controlled cortical impact injury in the rat.
Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration.
Lactic acid, neuron-specific enolase, and blood-brain barrier index after a severe traumatic brain injury: a prospective study.
Meta-analysis of neuron specific enolase in predicting pediatric brain injury outcomes.
Multiple indicators model of long-term mortality in traumatic brain injury.
Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
Neuron-specific enolase serum levels after controlled cortical impact injury in the rat.
Neuron-specific-enolase is increased in plasma after hemorrhagic shock and after bilateral femur fracture without traumatic brain injury in the rat.
NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.
Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings.
Paper-Based Surface-Enhanced Raman Scattering Lateral Flow Strip for Detection of Neuron-Specific Enolase in Blood Plasma.
Prediction of Neurocognitive Outcome after Moderate-Severe Traumatic Brain Injury Using Serum Neuron-Specific Enolase and S100 biomarkers.
Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.
Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury.
Reduced Neuron-Specific Enolase Levels in Chronic Severe Traumatic Brain Injury.
Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury.
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury.
S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury.
Serial measurement of S100B and NSE in pediatric traumatic brain injury.
Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.
Serum Concentrations of Neuron-Specific Enolase in Dogs Following Traumatic Brain Injury.
Serum Glial Fibrillary Acidic Protein Is a Highly Specific Biomarker for Traumatic Brain Injury in Humans Compared With S-100B and Neuron-Specific Enolase.
Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury.
Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury.
Serum neuron-specific enolase is related to cerebellar connectivity - A resting-state fMRI pilot study.
Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
Serum S100? is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
Significance of serum neuron-specific enolase in patients with acute traumatic brain injury.
Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography.
The Diagnostic Value of Neuron-Specific Enolase in Children with Mild Blunt Trauma Requiring Cranial CT Scan.
The effect of doxycycline on neuron-specific enolase in patients with traumatic brain injury: a randomized controlled trial.
The effects of 7-nitroindazole on serum neuron-specific enolase and astroglia-derived protein (S100?) levels after traumatic brain injury.
The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis.
Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury.
Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
[Serum S-100B protein and neuron-specific enolase after traumatic brain injury]
Brain Ischemia
Beneficial effects of intravenous dexmedetomidine on cognitive function and cerebral injury following a carotid endarterectomy.
CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man.
Effect of Tempol on Cerebral Resuscitation Caused by Asphyxia-Induced Cardiac Arrest.
Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage.
Ferulic acid prevents the injury-induced decrease of ?-enolase expression in brain tissue and HT22 cells.
MR and cerebrospinal fluid enzymes as sensitive indicators of subclinical cerebral injury after open-heart valve replacement surgery.
Neuron-specific enolase in cerebrospinal fluid and plasma of patients with acute ischemic brain disease.
Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia.
Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid.
S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage.
Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia.
Surface modification of extracorporeal circuits: is there really an impact on cerebral performance after cardiopulmonary bypass?
[Effects of Electroacupuncture Intervention Combined with Gastrodin on Expression of Proteins Related to Proliferation-differentiation of Neural Stem Cells in Hippocampal CA 1 and CA 3 Regions in Focal Cerebral Ischemia Rats].
Brain Neoplasms
Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.
DNA sequences encoding enolase are remarkably conserved from yeast to mammals.
Electron-immunocytochemical localization of neuron-specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells.
Enolase activity and isoenzyme distribution in human brain regions and tumors.
Enolase distribution in human brain tumors, retinoblastomas and pituitary adenomas.
Enolase isoenzyme distribution in the human brain and its tumours.
Enolase isoenzymes in human cerebral metastasis.
Enolase isoenzymes in human gliomas.
Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.
Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection.
S-antigen and rod-opsin immunoreactions in midline brain neoplasms of transgenic mice: similarities to pineal cell tumors and certain medulloblastomas in man.
[Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)]
[Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis]
[Enzymes in cerebrospinal fluid (HK, TIM, GAPDH, PGK, enolase, PK, LDH, GPT, ChE) in normal samples, in brain neoplasms and other neurologic diseases]
[Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
[The value of neuron specific enolase (NSE) in patients with brain tumors]
Breast Diseases
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue.
Breast Neoplasms
Albumin possesses intrinsic enolase activity towards dihydrotestosterone which can differentiate benign from malignant breast tumors.
Arsenic, cadmium and neuron specific enolase (ENO2, ?-enolase) expression in breast cancer.
Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case.
Breast carcinomas with neuroendocrine differentiation.
C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Capillary column chromatography improves sample preparation for mass spectrometric analysis: complete characterization of human alpha-enolase from two-dimensional gels following in situ proteolytic digestion.
Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Glycolytic enzyme activities in breast cancer metastases.
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue.
Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer.
Hypoxia induces differential translation of enolase/MBP-1.
Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.
Immunocytochemical reactivity of breast cancer tissue with antibodies to neuron-specific enolase and an adenocarcinoma-associated glycolipid antigen.
Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
Immunohistochemical reactions of primary neuroendocrine breast cancer.
Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.
Localization of enolase in the subfractions of a breast cancer cell line.
Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Neuroendocrine differentiation in breast lesions.
Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations.
New cancer markers.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.
Primary small cell anaplastic carcinoma of the breast diagnosed by fine needle aspiration cytology: a case report.
Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients.
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation.
Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol.
Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.
Role of enolase-1 in response to hypoxia in breast cancer: Exploring the mechanisms of action.
Serum tumor marker levels at the development of intracranial metastasis in patients with lung or breast cancer.
STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization.
Synaptophysin in human breast carcinomas.
The c-erbB-2 protein in primary and metastatic breast carcinomas.
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.
[Assessment of a carcinogenic risk to the population of Bratsk]
Bronchitis, Chronic
Pulmonary endocrine cells in chronic bronchitis and emphysema.
Bronchopulmonary Sequestration
Extralobar pulmonary sequestration with elevated serum neuron-specific enolase: A case report and review of the literature.
Brucellosis
Enzymatic and biological characteristics of enolase in Brucella abortus A19.
Burkitt Lymphoma
Paravertebral Burkitt's Lymphoma in a Child: An Unusual Presentation.
Candidemia
Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia.
Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia.
Candidiasis
A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase.
Alcohol dehydrogenase of Candida albicans triggers differentiation of THP-1 cells into macrophages.
An oral vaccine against candidiasis generated by a yeast molecular display system.
Anti-enolase antibodies partially protective against systemic candidiasis in mice.
Detection of Candida enolase antibody in patients with candidiasis.
Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase.
Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics.
Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.
Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.
Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme.
Oral Immunization Against Candidiasis Using Lactobacillus casei Displaying Enolase 1 from Candida albicans.
Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: Analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms.
Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.
Candidiasis, Chronic Mucocutaneous
Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase.
Candidiasis, Invasive
Circulating candida enolase in invasive candidiasis.
Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis.
Diagnostic value of anti-Candida enolase antibodies.
Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis.
Fungal antigens expressed during invasive aspergillosis.
Generation and Characterization of Single Chain Variable Fragment against Alpha-Enolase of Candida albicans.
Kinetics of anti-mannan antibodies useful in confirming invasive candidiasis in immunocompromised patients.
Serum antibody signature directed against Candida albicans Hsp90 and enolase detects invasive candidiasis in non-neutropenic patients.
[Detection and analysis of serum level of anti-Candida enolase IgG antibody in patients with autoimmune diseases].
Carcinogenesis
Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells.
Elevated concentrations of gamma-enolase in renal cell tumors in rats: similarity to renal cell carcinoma in man.
Enolase isozymes in renal tubules and renal cell carcinoma.
Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients.
Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.
Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori.
The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity.
Three are better than one: plasminogen receptors as cancer theranostic targets.
Carcinoid Tumor
A comparison of paraganglioma, carcinoid tumor, and small-cell carcinoma of the larynx.
A foregut carcinoid tumor causing Zollinger-Ellison syndrome.
A study of the histopathogenesis of carcinoid tumors of the small intestine and appendix.
Aace/Ace disease state clinical review: diagnosis and management of midgut carcinoids.
Amine handling properties of human carcinoid tumour cells in tissue culture.
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
Antiproliferative effects of the Ca2+/calmodulin antagonist B859-35 and the Ca(2+)-channel blocker verapamil on human lung cancer cell lines.
Appendiceal carcinoids: correlation of histology and immunohistochemistry.
Atypical Thymic Carcinoid Associated with Cushing's Syndrome.
Bronchial carcinoids and phaeochromocytomas. A comparative study with special emphasis on S-100 protein, serotonin and neuron-specific enolase (NSE) immunoreactivity.
Carcinoid tumor of the Vater's papilla presenting with chronic pancreatitis--a case report--.
Carcinoid tumors of the thymus. An immunohistochemical study.
Carcinoid tumors--somatostatine in the diagnosis and therapy.
Coexisting undifferentiated thymic carcinoma and thymic carcinoid tumor.
Combined production of mucus, amines and peptides by goblet-cell carcinoids of the appendix and ileum.
Concomitant neuropeptide-producing endometrial carcinomas and ileal carcinoid tumors.
Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases.
Diagnosis of lung carcinoid with cutaneous hyperpigmentation eight years after bilateral adrenalectomy.
Differential immunohistochemical reactions of carcinoid tumors.
Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina.
Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects.
Gastrointestinal carcinoid tumours: histological, histochemical and immunohistochemical study.
Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: an analysis of 310 reported cases.
Immunocytochemical demonstration of cytokeratin in gastrointestinal carcinoids and their probable precursor cells.
Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Immunoexpression of the alpha subunit of a guanine nucleotide-binding protein (Go) in pulmonary neuroendocrine cells and neoplasms.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Immunohistology of gastrointestinal carcinoid tumors.
Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations.
Malignant tumors of the small intestine: a histopathologic study of 41 cases among 1,312 consecutive specimens of small intestine.
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Multidirectional carcinoma of the thymus with neuroendocrine and sarcomatoid components and carcinoid syndrome.
Multiple ileal carcinoids and appendiceal endocrine carcinoma in association with Meckel's diverticulum. A histochemical and immunohistochemical study.
Multiple pulmonary neoplasia positive for thyroglobulin.
Neuron-specific enolase in mucosal endocrine cells and carcinoid tumours of the small intestine: a comparative study with neuron-specific enolase immunocytochemistry and silver stains.
Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
Ossifying gastric carcinoid tumor containing bone morphogenetic protein, osteopontin and osteonectin.
Pathologic observations of the duodenum in 615 consecutive duodenal specimens in a single Japanese hospital: II. malignant lesions.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors?
Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report.
Primary renal carcinoid.
Primary tumours of the thymus in the rat.
Rectal adenocarcinoid with lymph node metastasis.
Secretagogin is a novel marker for neuroendocrine differentiation.
Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours.
Spontaneous gastric carcinoid tumors in the striped field mouse (Apodemus agrarius).
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Subepithelial neuroendocrine cells and carcinoid tumours of the human small intestine and appendix. A comparative immunohistochemical study with regard to serotonin, neuron-specific enolase and S-100 protein reactivity.
Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo.
Thymic carcinoid tumor with Cushing's syndrome. Report of a case with electron microscopic and immunoperoxidase studies for neuron-specific enolase and corticotropin.
Usefulness of chromogranin A, neuron-specific enolase and 5-hydroxyindolacetic acid measurements in patients with malignant carcinoids.
[A case of small cell carcinoma of the urinary bladder]
[Biochemical parameters in the comprehensive diagnosis of lung cancer]
[Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin]
[Multiple duodenal and ampullary carcinoids and von Recklinghausen's neurofibromatosis]
[Primary carcinoid tumor of the kidney. Apropos of a case with immunohistochemical study]
[Renal neuroendocrine tumor (carcinoid) : a case report].
Carcinoma
201Tl/67Ga uptake ratio in small cell carcinoma of the lung: with special reference to serum neuron-specific enolase and prognosis.
A comparison of paraganglioma, carcinoid tumor, and small-cell carcinoma of the larynx.
A point-of-care testing system with Love-wave sensor and immunogold staining enhancement for early detection of lung cancer.
A ureteral small cell carcinoma mixed with malignant mesodermal and ectodermal elements: a clinicopathological, morphological and immunohistochemical study.
Adenoendocrine cell carcinoma of the gallbladder: report of a case.
Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China.
Aldolase C in neuroendocrine tumors: an immunohistochemical study.
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers.
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Antigenic phenotype of lung carcinomas: usual spectrum of distribution of thyroid transcription factor-1, cytokeratin 7, cytokeratin 20, and neuron specific enolase - basic immunohistochemical study of 21 cases.
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters.
Argyrophilic, 'carcinoid-like' prostatic carcinoma. An immunocytochemical study.
ASO Author Reflections: Neuron-Specific Enolase as a Valuable Biomarker for Patients with Merkel Cell Carcinoma in the Era of Immunotherapy.
Assessment of serum CYFRA 21-1 in lung cancer.
Association of folate deficiency and selected tumor marker concentrations in long-term hexavalent chromium exposed population.
Atypical enolase isoenzyme in serum: a macroenolase formed from the alpha gamma-hybrid form.
Basal cell carcinoma with progression to metastatic neuroendocrine carcinoma.
Canine Clitoral Carcinoma: A Clinical, Cytologic, Histopathologic, Immunohistochemical, and Ultrastructural Study.
Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas.
Chemiluminescence enzyme immunoassay using magnetic nanoparticles for detection of neuron specific enolase in human serum.
Choroid plexus tumours--an immunohistochemical analysis with review of literature.
Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature.
Clear cell carcinoma of salivary glands: immunohistochemical evaluation of clear tumor cells.
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
Clinical Management of Small-Cell Carcinoma of the Urinary Tract: A 10-Year Single-Center's Experience.
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.
Clinicopathological characteristics of head and neck Merkel cell carcinomas.
Coexisting undifferentiated thymic carcinoma and thymic carcinoid tumor.
Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Comparative proteomic analysis of esophageal squamous cell carcinoma.
Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
Comparison of cytologic markers for automated lung cancer screening.
Composite neuroendocrine and adenocarcinoma of the common bile duct associated with Clonorchis sinensis: a case report.
Creatine kinase B subunit as a biomarker for small cell carcinoma of the lung: comparison with gamma-enolase.
Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases.
CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology.
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
CYFRA 21-1. A new marker in lung cancer.
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung.
Desmin and neural marker expression in mesothelial cells and mesotheliomas.
Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients.
Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis.
Differential expression of the human alpha-enolase gene in oral epithelium and squamous cell carcinoma.
Discovery of stage-related proteins in esophageal squamous cell carcinoma using proteomic analysis.
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.
Early clinical diagnosis of synchronous multiple primary lung cancer.
Ectopic ACTH syndrome associated with anorectal carcinoma. Report of a case and review of the literature.
Efficacy of thoracoscopic anatomical segmentectomy for small pulmonary nodules.
Electrochemical Immunosensors for Sensitive Detection of Neuron-Specific Enolase Based on Small-Size Trimetallic Au@Pd^Pt Nanocubes Functionalized on Ultrathin MnO2 Nanosheets as Signal Labels.
Electron microscopy of Merkel cell carcinoma from formalin-fixed tissue.
Elevated concentrations of gamma-enolase in renal cell tumors in rats: similarity to renal cell carcinoma in man.
Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy.
Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
Endocrine profile in gastric carcinomas. An immunohistochemical study.
Enolase isoenzymes as tumour markers.
Enolase isozymes in renal tubules and renal cell carcinoma.
Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio.
Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.
Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens.
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Evaluation of Cyfra 21-1 as a marker for lung cancer.
Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Evaluation of gamma-enolase as a tumor marker for lung cancer.
Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Evaluation of laboratory data by conventional statistics and by three types of neural networks.
Evaluation of neuroendocrine markers in renal cell carcinoma.
Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation.
Expression of cytokeratin and neuron-specific enolase in small cell carcinomas of the lung.
Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung.
Expression of nse and pgp-9.5 in nonsmall-cell lung-cancers.
Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China.
Extrapulmonary small-cell carcinoma of the liver.
Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid?
Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.
Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue.
Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: an analysis of 310 reported cases.
Hemangioblastoma arising in the skin.
Hepatobiliary neuroendocrine carcinoma in cats: a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases.
High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Histogenesis of renal cell carcinoma and renal oncocytoma. An immunohistochemical study.
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
How to express tumor markers in bronchoalveolar lavage.
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.
Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis.
Hyperplastic gastric polyposis, hypergastrinaemia and colorectal neoplasia: a description of four cases.
Identification of potential serum biomarkers for simultaneously classifying lung adenocarcinoma, squamous cell carcinoma and small cell carcinoma.
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor.
Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Immunoexpression of the alpha subunit of a guanine nucleotide-binding protein (Go) in pulmonary neuroendocrine cells and neoplasms.
Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Immunohistochemical investigation of vimentin, neuron-specific enolase, alpha 1-antichymotrypsin and alpha 1-antitrypsin in adenoid cystic carcinoma of the salivary gland.
Immunohistochemical Profile of Urothelial and Small Cell Carcinomas of the Bladder.
Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Impact of chronic kidney disease on serum tumor markers concentrations.
Improved screen-printed carbon electrode for multiplexed label-free amperometric immuniosensor: Addressing its conductivity and reproducibility challenges.
Increased plasma concentrations of tumour markers in the absence of neoplasia.
Isoenzyme pattern of enolase in the diagnosis of neuroendocrine bronchopulmonary tumors.
Laparotomy Cryoablation in Rabbit VX2 Pancreatic Carcinoma.
Large cell carcinoma of the lung. Ultrastructural and immunohistochemical features.
Malignant jugulotympanic paraganglioma in a dog.
Mapping of antigenic sites in human neuron-specific enolase by expression subcloning.
Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
Mediastinal lymph node metastasis of renal cell carcinoma: A case report.
Merkel cell carcinoma of the eyelid and periocular tissues.
Merkel cell carcinoma.
Merkel cell carcinoma: a report of three cases with neurone-specific enolase activity.
Merkel cell tumor in a trichilemmal cyst: collision or association?
Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene.
Metastatic subcutaneous sarcoma and abdominal carcinoma in a peach-faced lovebird (Agapornis roseicollis).
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Motilin-producing liver and bone metastases evidenced 14 years after resection of a rectal polyp.
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Nervous system-specific enolase in serum as a marker for neuroblastoma.
Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component.
Neuroendocrine carcinoma arising in an ovarian mucinous cystadenoma.
Neuroendocrine carcinoma of the parotid gland: a report of two cases with ultrastructural and immunohistochemical studies.
Neuroendocrine cells in the prostatic carcinomas after neoadjuvant hormonal therapy.
Neuroendocrine differentiation and nerves in human adrenal cortex and cortical lesions.
Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas.
Neuroendocrine differentiation in prostatic carcinoma.
Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Neuroendocrine marker expression in thyroid epithelial tumors.
Neuroendocrine small cell carcinoma of the uterine cervix showing polypoid growth and complicated by pregnancy.
Neuroendocrine tumor, well differentiated, of the breast: a relatively high-grade case in the histological subtype.
Neurofilament immunoreactivity in Merkel-cell tumors: a differentiating feature from small-cell carcinoma.
Neuron specific enolase expression in carcinoma of the lung.
Neuron specific enolase in human small cell carcinoma cultures.
Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.
Neuron-specific enolase as a marker for neuroblastoma and small-cell carcinoma of the lung.
Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
Neuron-specific enolase during chemotherapy of small cell lung cancer.
Neuron-specific enolase expression and neuroendocrine differentiation in carcinomas of the breast.
Neuron-specific enolase immunoreactivity in small-cell carcinoma of the uterine cervix.
Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung.
Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.
New cancer markers.
New Horny Layer Marker Proteins for Evaluating Skin Condition in Atopic Dermatitis.
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Overexpression of enolase 2 is associated with worsened prognosis and increased glycikolysis in papillary renal cell carcinoma.
Pagetoid Merkel cell carcinoma: epidermal origin of the tumor.
Palliative treatment efficacy of glucose inhibition combined with chemotherapy for non-small cell lung cancer with widespread bone and brain metastases: A case report.
Performance characteristics of seven neuron-specific enolase assays.
Peripheral primitive neuroectodermal tumor of the chest wall of a 69-year-old man.
Pheochromocytoma of the urinary bladder. Report of 2 cases with ultrastructural and immunohistochemical analyses.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.
Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Potential lung carcinogenicity induced by chronic exposure to PM2.5 in the rat.
Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
pp60c-src activation in human colon carcinoma.
Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
Preparation and characterization of monoclonal antibodies to human neuron-specific enolase.
Primary Combined Neuroendocrine and Squamous Cell Carcinoma of the Maxillary Sinus: Report of a Case with Immunohistochemical and Molecular Characterization.
Primary composite tumour with bipartite differentiation of the esophagus.
Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
Primary undifferentiated small cell carcinoma (Merkel cell carcinoma) in a patient after heart transplantation--case report.
Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.
Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.
Prognostic value of serum tumor markers in patients with lung cancer.
Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients.
Prostatic carcinoma: a multivariate analysis of prognostic factors.
Protein Expression Profile using Two-Dimensional Gel Analysis in Squamous Cervical Cancer Patients.
Pulmonary large cell carcinoma expressing neuroendocrine markers: the morphological, biological, and neuroendocrine features of their cell lines and surgical cases.
Purification of the plasmin receptor from human carcinoma cells and comparison to alpha-enolase.
Quantification of serum HBXAP DNA in lung cancer patients by quantitative fluorescent polymerase chain reaction.
Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer.
Rare pediatric adrenocortical carcinoma with oncocytic change: a cytologic dilemma.
Reevaluaton of the usefulness of systematic bone scanning in initial staging and follow-up of small cell lung carcinoma, taking into account the serum levels of neuron-specific enolase.
Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China.
Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
Right Lung Consolidation Combined Elevated Serum Neuron Specific Enolase Misdiagnosed as Lung Carcinoma Ultimately Confirmed Pulmonary Cryptococcosis by CT-guided Percutaneous Lung Biopsy: a Case Report and Literature Review.
Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies.
S100 protein positive human breast carcinomas: an immunohistochemical study.
Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response.
Serum levels of five tumor markers for lung cancer in patients with chronic renal failure.
Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Serum markers change for intraocular metastasis in renal cell carcinoma.
Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Serum neuron-specific enolase in "non-functioning" islet-cell carcinoma.
Serum neuron-specific enolase levels in patients with small cell carcinoma of the uterine cervix.
Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet cell carcinoma.
Serum tumour markers in patients with chronic kidney disease.
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma.
Simultaneous flow cytometric detection of nuclear DNA and tumor-associated antigens in lung cancers.
Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients.
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome.
Small cell carcinoma of the brain without extracranial involvement by serial CT, MRI and PET.
Small cell carcinoma of the prostate treated with amrubicin.
Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
Small cell carcinoma of the renal pelvis: a clinicopathological, morphological and immunohistochemical study of 2 cases.
Small cell carcinoma of the stomach: an immunohistochemical and electron microscopic study.
Small cell carcinoma of the uterine cervix.
Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma.
Small cell undifferentiated ('neuroendocrine') carcinoma of the colon.
Small-cell neuroendocrine carcinoma of the ampulla of Vater.
Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma.
Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.
Synovial sarcoma of the hypopharynx in an 11-year-old boy: treatment by partial supraglottic laryngopharyngectomy.
The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
The diagnostic value of neuron-specific enolase and carcino-embryonic antigen analyses in patients with carcinoma of the lung.
The distribution of S-100 protein in hyperplastic and neoplastic prostatic epithelium.
The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung.
The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types.
The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma.
Thymic carcinomas: histopathological varieties and immunohistochemical study.
Tissue and Blood Biomarkers in Lung Cancer: A Review.
Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways.
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
Tripartite differentiation in a carcinoma of the duodenum.
Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in human renal cell carcinoma.
Tumor markers in patients with chronic renal failure.
Tumor markers in patients with lung cancer.
Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?
Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
Type I collagen metabolites as tumor markers in patients with lung carcinoma.
Ultrastructural and immunocytochemical definition of component neoplasms in an unusual gastro-oesophageal collision tumour.
Unusual Case of a Caruncular Oncocytoma.
Unusual histologic types of high-grade prostatic intraepithelial neoplasia.
Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Utility of tumour markers in the diagnosis of neoplastic pleural effusion.
UVA1-induced decrease in dermal neuron-specific enolase (NSE) in acrosclerosis.
Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
Value of serum marker HE4 in pulmonary carcinoma diagnosis.
Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma.
[A case of small cell carcinoma of the prostate]
[A case of small cell carcinoma of the urinary bladder]
[A clinical evaluation of the versatility of various tumor markers in diagnosing the primary carcinoma of the lung]
[A rare case of primary adenoendocrine cell carcinoma of lower bile duct with anomalous creatine kinase isoenzyme and extremely high serum level of neuron specific enolase]
[Antigenic expression in human choroid plexus carcinoma: report of 2 cases]
[Application of serum tumor markers and support vector machine in the diagnosis of oral squamous cell carcinoma]
[Biochemical parameters in the comprehensive diagnosis of lung cancer]
[Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung]
[Clinical Significance of Tumor Marker Detection in Patients ?with Advanced Squamous Cell Carcimoma of the Lung].
[Clinical Utility of Serum Tumor Markers in Lung Cancer.]
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[CYFRA 21-1: a new marker of epidermoid cancer of the bronchi. Comparison with 3 other markers]
[Determination of tumor markers NSE and CEA in patients with various lung diseases, especially carcinomas]
[Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]
[Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung]
[Expression of CD56, as a potential diagnostic marker, in small cell carcinoma]
[Expression of endocrine-paracrine cells in prostatic carcinoma]
[Gamma-enolase (gamma-eno)]
[Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase]
[Immunohistochemical study of renal cell carcinoma by anti neuron specific enolase (NSE) antibody]
[Immunophenotypic characterization of cutaneous neuroendocrine carcinoma derived from Merkel cells]
[In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?]
[Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer]
[Neuroendocrine larynx cancer of the small cell (oat cell) type. Morphologic and immunohistochemical findings and their significance for therapy]
[Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma]
[Neuron-specific enolase: a new marker for small-cell pulmonary carcinoma]
[Neuron-specific serum enolase in patients with non-tumor pathologies]
[Pathologic diagnoses of core needle biopsies of the mediastinum]
[Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study]
[Prognostic value of pre-therapeutic levels of carcino-embryonic antigen in primary bronchial carcinoma]
[Radioimmunometric assay of neuron specific enolase in aqueous humor and serum in patients with retinoblastoma]
[Risk of endocrine activation in interventions of paragangliomas in the head-neck area]
[Serum gamma-enolase as a marker for renal cell carcinoma]
[Serum neuron-specific enolase in small cell bronchial cancers]
[The association of neuro-endocrine carcinoma of the skin and Bowen's disease. Review of the literature apropos of 4 cases]
[The use of tumoral markers in clinical practice]
[The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma]
[Treatment monitoring of patients with small cell lung cancer by determining levels of serum neuron specific enolase]
[Tumor markers in lung cancer]
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
[Tumour markers in chronic kidney disease.]
[Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung]
[Value of neuron specific enolase levels and squamous cell carcinoma antigen in bronchial lavage fluid in patients with lung cancer]
Carcinoma, Acinar Cell
Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor.
Carcinoma, Adenoid Cystic
Immunohistochemical investigation of vimentin, neuron-specific enolase, alpha 1-antichymotrypsin and alpha 1-antitrypsin in adenoid cystic carcinoma of the salivary gland.
Carcinoma, Adenosquamous
Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Carcinoma, Basal Cell
Basal cell carcinoma with progression to metastatic neuroendocrine carcinoma.
Carcinoma, Bronchogenic
Circulating arginine-vasopressin, calcitonin, carcinoembryonic antigen, neuron-specific enolase, and beta-2 microglobulin fluctuations during combined modality induction therapy for small-cell bronchogenic carcinoma. Association of postchemotherapy AVP surge with high tumor response rate and durable remission.
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide.
Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma. A prospective study in an unselected series.
Recurrent Syncope Associated with Lung Cancer.
Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?
[Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin]
[Diagnostic usefulness of the determination of serum neuron-specific enolase in small cell bronchial carcinoma]
[Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma]
[Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma]
[Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study]
[Prognostic value of serum neurospecific enolase in small cell bronchial carcinoma]
[Significance of neuron-specific enolase (NSE) in the diagnosis of bronchial carcinomas and neuroendocrine tumors]
[The role of determining the levels of bombesin and gamma-enolase in differential diagnosis of bronchogenic carcinoma of the lung]
Carcinoma, Ductal
Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Carcinoma, Embryonal
Glutamate receptor-mediated currents and toxicity in embryonal carcinoma cells.
Carcinoma, Hepatocellular
Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
Carcinosarcoma of the liver: a case report and review of the literature.
Differential expression of laminin receptors in human hepatocellular carcinoma.
Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients.
Exosome-derived ENO1 regulates integrin ?6?4 expression and promotes hepatocellular carcinoma growth and metastasis.
Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid?
Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase.
Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells.
Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis.
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
[Role of enolase 1 in hepatocellular carcinoma and possible mechanism].
Carcinoma, Intraductal, Noninfiltrating
C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ.
Carcinoma, Islet Cell
Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet cell carcinoma.
Carcinoma, Large Cell
Comparison of cytologic markers for automated lung cancer screening.
Evaluation of gamma-enolase as a tumor marker for lung cancer.
Expression of nse and pgp-9.5 in nonsmall-cell lung-cancers.
Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
Carcinoma, Medullary
An immunohistochemical study in thyroid cancer.
Neuroendocrine marker expression in thyroid epithelial tumors.
S-100 protein and neuron-specific enolase in parathyroid glands and C-cells of the thyroid.
[Histopathological and immunohistochemical studies on medullary thyroid carcinoma]
[Neuron specific enolase (ESA) as a marker of medullary carcinoma of the thyroid gland]
Carcinoma, Merkel Cell
ASO Author Reflections: Neuron-Specific Enolase as a Valuable Biomarker for Patients with Merkel Cell Carcinoma in the Era of Immunotherapy.
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Feline cutaneous neuroendocrine carcinoma (Merkel cell tumour): clinical and pathological findings.
Merkel cell carcinoma of the eyelid and periocular tissues.
Merkel cell carcinoma within follicular cysts: report of two cases.
Merkel cell carcinoma.
Merkel cell carcinoma: a report of three cases with neurone-specific enolase activity.
Merkel cell tumor in a trichilemmal cyst: collision or association?
Pagetoid Merkel cell carcinoma: epidermal origin of the tumor.
Primary undifferentiated small cell carcinoma (Merkel cell carcinoma) in a patient after heart transplantation--case report.
The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
Carcinoma, Neuroendocrine
A case of mixed adenoneuroendocrine carcinoma of the pancreas: Immunohistochemical analysis for histogenesis.
Anaplastic small cell (oat cell) carcinoma of the tonsils: report of two cases.
Basal cell carcinoma with progression to metastatic neuroendocrine carcinoma.
Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers.
Carcinosarcoma of the liver: a case report and review of the literature.
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolization.
Hepatobiliary neuroendocrine carcinoma in cats: a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases.
Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Neuroendocrine breast cancer.
Neuroendocrine carcinoma of the skin: an immunohistochemical study of tumor markers and neuroendocrine products.
Neuroendocrine carcinoma of the stomach with extensive somatostatin immunoreactivity.
New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma.
Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia.
Primary Combined Neuroendocrine and Squamous Cell Carcinoma of the Maxillary Sinus: Report of a Case with Immunohistochemical and Molecular Characterization.
Primary neuroendocrine (Merkel cell?) carcinoma of the skin. II. An immunocytochemical study of 21 cases.
Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.
Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases.
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease.
Carcinoma, Non-Small-Cell Lung
A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Biomarkers along the continuum of care in lung cancer.
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
Clinical implications for pro-GRP in small cell lung cancer. A single center experience.
Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer.
Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Correlation analysis between serum neuron-specific enolase and the detection of gene mutations in lung adenocarcinoma.
Cut-off levels of NSE to differentiate SCLC from NSCLC.
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer.
Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer.
Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments.
Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.
Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
Interconversion of biological characteristics of small cell lung cancer depending on culture conditions.
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study.
Neuron specific enolase and prognosis of non-small cell lung cancer: A systematic review and meta-analysis.
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer.
p19(ras) Represses proliferation of non-small cell lung cancer possibly through interaction with Neuron-Specific Enolase (NSE).
Performance characteristics of seven neuron-specific enolase assays.
Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer.
Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer.
Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China.
Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
Serum neuron specific enolase level as a prognostic factor in non-small cell lung cancer.
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.
The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Value of serum neuron-specific enolase in nonsmall cell lung cancer.
WITHDRAWN: Dynamic Observation of Postoperative Infection and Neuron-specific Enolase Levels in Serum in Patients with Non-small Cell Lung Cancer According to Positron Emission Tomography-Computed Tomography.
[Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer]
[Clinical significance of serum neuron-specific enolase in non-small cell lung cancer]
[Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]
[ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer]
[Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer]
[Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
[Study on the specific expressions of p53, bcl-2 and c-myc in non-small cell lung cancer with neuroendocrine differentiation.]
Carcinoma, Ovarian Epithelial
New cancer markers.
Carcinoma, Papillary
Neuroendocrine marker expression in thyroid epithelial tumors.
Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis.
Carcinoma, Renal Cell
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature.
Elevated concentrations of gamma-enolase in renal cell tumors in rats: similarity to renal cell carcinoma in man.
Enolase isozymes in renal tubules and renal cell carcinoma.
Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Evaluation of neuroendocrine markers in renal cell carcinoma.
Hemangioblastoma arising in the skin.
Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
Overexpression of enolase 2 is associated with worsened prognosis and increased glycikolysis in papillary renal cell carcinoma.
Rare pediatric adrenocortical carcinoma with oncocytic change: a cytologic dilemma.
Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
Serum markers change for intraocular metastasis in renal cell carcinoma.
Tumor markers in human renal cell carcinoma.
Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma.
Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
[Immunohistochemical study of renal cell carcinoma by anti neuron specific enolase (NSE) antibody]
[Serum gamma-enolase as a marker for renal cell carcinoma]
Carcinoma, Small Cell
201Tl/67Ga uptake ratio in small cell carcinoma of the lung: with special reference to serum neuron-specific enolase and prognosis.
A ureteral small cell carcinoma mixed with malignant mesodermal and ectodermal elements: a clinicopathological, morphological and immunohistochemical study.
Aldolase C in neuroendocrine tumors: an immunohistochemical study.
Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas.
Comparison of cytologic markers for automated lung cancer screening.
Composite neuroendocrine and adenocarcinoma of the common bile duct associated with Clonorchis sinensis: a case report.
Creatine kinase B subunit as a biomarker for small cell carcinoma of the lung: comparison with gamma-enolase.
Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases.
Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.
Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens.
Evaluation of gamma-enolase as a tumor marker for lung cancer.
Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
Expression of cytokeratin and neuron-specific enolase in small cell carcinomas of the lung.
Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
Immunoexpression of the alpha subunit of a guanine nucleotide-binding protein (Go) in pulmonary neuroendocrine cells and neoplasms.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Immunohistochemical Profile of Urothelial and Small Cell Carcinomas of the Bladder.
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Neuroendocrine small cell carcinoma of the uterine cervix showing polypoid growth and complicated by pregnancy.
Neuron specific enolase in human small cell carcinoma cultures.
Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung.
Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.
New cancer markers.
Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Preparation and characterization of monoclonal antibodies to human neuron-specific enolase.
Primary composite tumour with bipartite differentiation of the esophagus.
Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
Serum neuron-specific enolase levels in patients with small cell carcinoma of the uterine cervix.
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome.
Small cell carcinoma of the brain without extracranial involvement by serial CT, MRI and PET.
Small cell carcinoma of the prostate treated with amrubicin.
Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
Small cell carcinoma of the renal pelvis: a clinicopathological, morphological and immunohistochemical study of 2 cases.
Small cell carcinoma of the stomach: an immunohistochemical and electron microscopic study.
Small cell carcinoma of the uterine cervix.
Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Tumor markers in patients with lung cancer.
Ultrastructural and immunocytochemical definition of component neoplasms in an unusual gastro-oesophageal collision tumour.
Unusual histologic types of high-grade prostatic intraepithelial neoplasia.
[A case of small cell carcinoma of the prostate]
[A case of small cell carcinoma of the urinary bladder]
[Biochemical parameters in the comprehensive diagnosis of lung cancer]
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[Expression of CD56, as a potential diagnostic marker, in small cell carcinoma]
[Gamma-enolase (gamma-eno)]
[Pathologic diagnoses of core needle biopsies of the mediastinum]
[Risk of endocrine activation in interventions of paragangliomas in the head-neck area]
[Serum neuron-specific enolase in small cell bronchial cancers]
Carcinoma, Squamous Cell
A point-of-care testing system with Love-wave sensor and immunogold staining enhancement for early detection of lung cancer.
Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China.
Assessment of serum CYFRA 21-1 in lung cancer.
Association of folate deficiency and selected tumor marker concentrations in long-term hexavalent chromium exposed population.
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.
Comparative proteomic analysis of esophageal squamous cell carcinoma.
Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
Comparison of cytologic markers for automated lung cancer screening.
CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology.
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
CYFRA 21-1. A new marker in lung cancer.
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung.
Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients.
Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis.
Differential expression of the human alpha-enolase gene in oral epithelium and squamous cell carcinoma.
Discovery of stage-related proteins in esophageal squamous cell carcinoma using proteomic analysis.
Early clinical diagnosis of synchronous multiple primary lung cancer.
Efficacy of thoracoscopic anatomical segmentectomy for small pulmonary nodules.
Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy.
Enolase isoenzymes as tumour markers.
Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.
Evaluation of Cyfra 21-1 as a marker for lung cancer.
Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
Expression of nse and pgp-9.5 in nonsmall-cell lung-cancers.
Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.
How to express tumor markers in bronchoalveolar lavage.
Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis.
Identification of potential serum biomarkers for simultaneously classifying lung adenocarcinoma, squamous cell carcinoma and small cell carcinoma.
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Impact of chronic kidney disease on serum tumor markers concentrations.
Improved screen-printed carbon electrode for multiplexed label-free amperometric immuniosensor: Addressing its conductivity and reproducibility challenges.
Increased plasma concentrations of tumour markers in the absence of neoplasia.
Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Neuron-specific enolase during chemotherapy of small cell lung cancer.
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
New Horny Layer Marker Proteins for Evaluating Skin Condition in Atopic Dermatitis.
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
Potential lung carcinogenicity induced by chronic exposure to PM2.5 in the rat.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
Primary Combined Neuroendocrine and Squamous Cell Carcinoma of the Maxillary Sinus: Report of a Case with Immunohistochemical and Molecular Characterization.
Primary composite tumour with bipartite differentiation of the esophagus.
Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.
Prognostic value of serum tumor markers in patients with lung cancer.
Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients.
Protein Expression Profile using Two-Dimensional Gel Analysis in Squamous Cervical Cancer Patients.
Quantification of serum HBXAP DNA in lung cancer patients by quantitative fluorescent polymerase chain reaction.
Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer.
Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China.
Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response.
Serum levels of five tumor markers for lung cancer in patients with chronic renal failure.
Serum tumour markers in patients with chronic kidney disease.
Simultaneous flow cytometric detection of nuclear DNA and tumor-associated antigens in lung cancers.
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.
The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung.
The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.
The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
Tissue and Blood Biomarkers in Lung Cancer: A Review.
Tripartite differentiation in a carcinoma of the duodenum.
Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in patients with chronic renal failure.
Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?
Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
Type I collagen metabolites as tumor markers in patients with lung carcinoma.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Utility of tumour markers in the diagnosis of neoplastic pleural effusion.
[Clinical Utility of Serum Tumor Markers in Lung Cancer.]
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[CYFRA 21-1: a new marker of epidermoid cancer of the bronchi. Comparison with 3 other markers]
[Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]
[In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?]
[Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer]
[Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma]
[Prognostic value of pre-therapeutic levels of carcino-embryonic antigen in primary bronchial carcinoma]
[Tumor markers in lung cancer]
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
[Tumour markers in chronic kidney disease.]
[Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma].
[Value of neuron specific enolase levels and squamous cell carcinoma antigen in bronchial lavage fluid in patients with lung cancer]
Carcinoma, Transitional Cell
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
Cardiomegaly
Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy.
Differential expression of alpha-enolase in the normal and pathological cardiac growth.
Cardiomyopathies
A rare case of sudden death due to hypotension during Cesarean section in a woman suffering from pheochromocytoma and neurofibromatosis.
Cardiovascular Diseases
Serum beta-enolase in acute myocardial infarction.
Carotid Stenosis
Silent stroke and cognitive decline in asymptomatic carotid stenosis revascularization.
Cataract
Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.
Electrophoretic determination of aqueous and serum neuron-specific enolase in the diagnosis of retinoblastoma.
Immunohistochemical analysis of lens cells on formation of different types of age-related cataract in humans.
[Electrophoretic determination of aqueous and serum neuron-specific enolase (NSE) in the diagnosis of retinoblastoma]
[Immunohistochemical analysis of the lens cells during development of the various types of age-associated cataract in man]
[Morphological basis of ocular desympathetization as a new method for experimental cataract modeling].
Celiac Disease
Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.
Anti-GM1 ganglioside antibodies, neuron specific enolase and interleukin 10 concentrations as potential markers of autonomic nervous system impairment in celiac disease - preliminary findings.
Identification of new celiac disease autoantigens using proteomic analysis.
Central Nervous System Diseases
Childhood leukemia: cerebrospinal fluid enolase isoenzymes in central nervous system infiltration.
[A clinical study on neuron-specific enolase activities in cerebrospinal fluid of neonates]
[Central nervous system disorders in myotonic dystrophy--with special reference to neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme levels in CSF]
[Central nervous system disorders in newborn infants and spinal fluid neuron-specific enolase]
Central Nervous System Infections
[A case of congenital toxoplasmosis confirmed by detection of Toxoplasma gondii in placenta]
Cerebellar Ataxia
A prognostic value of neuron-specific enolase in cerebrospinal fluid of acute cerebellar ataxia.
Increased enolase activity in erythrocytes in a family with cerebellar ataxia.
[A case of acute cerebellar ataxia associated with serum anti-NH2 terminal of alpha-enolase (NAE) antibody]
Cerebral Hemorrhage
Correlation of serum ferritin levels with neurological function-related indices and cognitive dysfunction in patients with cerebral hemorrhage.
Effects of Xingnaojing on serum high-sensitivity C-reactive protein and neuron-specific enolase in patients with acute cerebral hemorrhage: A protocol of systematic review and meta-analysis.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
[Effect of panax notoginseng saponins on serum neuronal specific enolase and rehabilitation in patients with cerebral hemorrhage]
[Intracerebral hemorrhage and neuron-specific enolase in premature and full-term infants--a clinical study]
[Measurement of serum neuron-specific enolase levels after subarachnoid hemorrhage and intracerebral hemorrhage]
Cerebral Infarction
Cerebrospinal fluid enolase in stroke.
Cerebrospinal fluid levels of superoxide dismutases in neurological diseases detected by sensitive enzyme immunoassays.
Clinical and laboratory factors related to acute isolated vertigo or dizziness and cerebral infarction.
Correlation between serum level of neuron-specific enolase and long-term functional outcome after acute cerebral infarction: prospective study.
Elevated Serum Levels of NSE and S-100? Correlate with Increased Risk of Acute Cerebral Infarction in Asian Populations.
Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid.
Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction.
Silent cerebral infarction after percutaneous coronary intervention of chronic total occlusions (CTO) and non-CTOs.
[Changes of plasma cross-linked D-dimer and neuron-specific enolase in patients with cerebral infarction]
[Changes of serum Neuron specific enolase, Protein S-100 and myelin basic protein levels in patients with cerebral infarction.]
[Effect of Shuxuetong injection on neuron-specific enolase of serum and recovery of function in patients with acute cerebral infarction].
[Superoxide dismutase in cerebrospinal fluid in patients with neurological diseases]
Cerebral Palsy
[Changes and clinical significance of serum NSE and MBP levels in children with cerebral palsy at high altitude during comprehensive rehabilitation].
Cerebrovascular Disorders
Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases.
Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit.
Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients.
Chagas Disease
In silico approach for the identification of immunological properties of enolase from Trypanosoma cruzi and its possible usefulness as vaccine in Chagas disease.
In silico repositioning of etidronate as a potential inhibitor of the Trypanosoma cruzi enolase.
Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.
Chlamydia Infections
The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.
Cholangiocarcinoma
Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.
Cholangitis, Sclerosing
Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.
[Antibodies against alfa-enolase as an indication of inflammatory process in patients with celiac disease--preliminary results].
Chondroblastoma
Cytokeratin expression in chondroblastomas.
Chondrosarcoma
A ureteral small cell carcinoma mixed with malignant mesodermal and ectodermal elements: a clinicopathological, morphological and immunohistochemical study.
Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation.
Chondrosarcoma, Mesenchymal
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Chordoma
Chordoma: cytologic and immunocytochemical study of four cases.
Immunohistochemical distinction of classic and chondroid chordomas.
Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma.
S-100 protein and neuron specific enolase (NSE) expression by chordomas in relation to the composition of their stromal mucosubstances.
Clonorchiasis
Immune response induced by oral delivery of Bacillus subtilis spores expressing enolase of Clonorchis sinensis in grass carps (Ctenopharyngodon idellus).
Oral delivery of Bacillus subtilis spore expressing enolase of Clonorchis sinensis in rat model: induce systemic and local mucosal immune responses and has no side effect on liver function.
Coccidiosis
Effect of Acetamizuril on enolase in second-generation merozoites of Eimeria tenella.
Colitis
Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.
Evaluation of a latex agglutination test for diagnosis of Clostridium difficile-associated colitis.
Myenteric neuronal loss in rats with experimental colitis: Role of tissue transglutaminase-induced apoptosis.
Colitis, Ulcerative
Anti-alpha-enolase antibodies in patients with inflammatory bowel disease.
Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis.
Colonic Neoplasms
Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements.
Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
Prognostic Value of Enolase Gene Family in Colon Cancer.
Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells.
The Effect of Artificial Neural Network Model Combined with Six Tumor Markers in Auxiliary Diagnosis of Lung Cancer.
Colorectal Neoplasms
Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
Correlation between chromogranin A, neuron-specific enolase and synaptophysin expression, and some clinico-pathological features of colorectal cancer.
Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.
Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer.
Neuroendocrine differentiation in colorectal carcinomas.
Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.
Regulation of N-myristoyltransferase by novel inhibitor proteins.
Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma.
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer.
Upregulation of ? enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.
[Clinical significance of serum neuron specific enolase (NSE) levels in patients with gastric and colorectal cancer]
Coma
Arterial blood pressure during targeted temperature management after out-of-hospital cardiac arrest and association with brain injury and long-term cognitive function.
Bench-to-bedside review: brain dysfunction in critically ill patients - the intensive care unit and beyond.
Bispectral index predicts deaths within 2 weeks in coma patients, a better predictor than serum neuron-specific enolase or S100 protein.
Blood metallothionein, neuron specific enolase, and protein S100B in patients with traumatic brain injury.
Combining brain computed tomography and serum neuron specific enolase improves the prognostic performance compared to either alone in comatose cardiac arrest survivors treated with therapeutic hypothermia.
Contemporary approach to neurologic prognostication of coma after cardiac arrest.
Diagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study.
Early EEG correlates of neuronal injury after brain anoxia.
Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.
Effect of nursing mode under the seamless connection between operating room and ward on severe traumatic brain injury patients in coma.
Effects of sequential nutritional support on nutritional status and expression of regulatory T lymphocyte in patients with early severe traumatic brain injury.
Efficacy of Citicoline as a Neuroprotector in children with post cardiac arrest: a randomized controlled clinical trial.
F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children.
In-depth characterization of a long-term, resuscitated model of acute subdural hematoma-induced brain injury.
Neuron specific enolase and Glasgow motor score remain useful tools for assessing neurological prognosis after out-of-hospital cardiac arrest treated with therapeutic hypothermia.
Neuron-specific enolase as a marker of neuronal lesions during various comas in man.
Neuron-specific enolase concentrations for the prediction of poor prognosis of comatose patients after out-of-hospital cardiac arrest: an observational cohort study.
Neuron-specific enolase in comatose children.
Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage.
Neuroprognostication after cardiac arrest in the light of targeted temperature management.
Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Prediction of poor outcome within the first 3 days of postanoxic coma.
Predictive Value and Correlation of Neuron-Specific Enolase for Prognosis in Patients with Coma: A Systematic Review and Meta-Analysis.
Prognostic roles of sleep electroencephalography pattern and circadian rhythm biomarkers in the recovery of consciousness in patients with coma: a prospective cohort study.
Risk Factors for Poor Outcome in Hypertensive Intraventricular Haemorrhage Treated by External Ventricular Drainage with Intraventricular Fibrinolysis.
Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Serum lactate as a predictor of neurologic outcome in emergency department patients with acute carbon monoxide poisoning.
Serum levels of neurofilament light chain, neuron-specific enolase and S100 calcium-binding protein B during acute bacterial meningitis: a prospective cohort study.
Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury.
Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors.
Serum neuron-specific enolase as early predictor of outcome after cardiac arrest.
Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort study.
Serum neuron-specific enolase in human status epilepticus.
Serum Neuron-Specific Enolase Levels from the Same Patients Differ Between Laboratories: Assessment of a Prospective Post-cardiac Arrest Cohort.
Serum neuron-specific enolase predicting neurological outcomes post-cardiac arrest: a review of the literature.
Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study.
Serum NSE and S100B protein levels for evaluating the impaired consciousness in patients with acute carbon monoxide poisoning.
Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier.
The neuron specific enolase (NSE) ratio offers benefits over absolute value thresholds in post-cardiac arrest coma prognosis.
The structural determination of phosphosulfolactate synthase from Methanococcus jannaschii at 1.7-A resolution: an enolase that is not an enolase.
Trauma scores and neuron-specific enolase, cytokine and C-reactive protein levels as predictors of mortality in patients with blunt head trauma.
[Clinical effect of electroacupuncture at Baihui and Shuigou points in treatment of brain injury in patients with sepsis-associated encephalopathy].
[Clinical efficacy of restrictive fluid management in patients with severe traumatic brain injury].
[Comparison of the accuracy of predicting prognosis of brain function in patients after cardiopulmonary cerebral resuscitation with two kinds of electroencephalogram techniques combined with neuron-specific enolase].
[The determination in the blood of the enzyme neuron-specific enolase in children with acute encephalopathies: the prognostic value in neurological sequelae]
Congenital Abnormalities
[Diagnosis of early phase diffuse axonal injury using immunohistochemical methods]
[Immunohistochemical methods in the differential diagnosis of primary traumatic and subsequent secondary cerebral changes]
Connective Tissue Diseases
Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders.
Coronary Disease
Serum S-100? and NSE levels after off-pump versus on-pump coronary artery bypass graft surgery.
COVID-19
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury.
Craniocerebral Trauma
Biofluid biomarkers of traumatic brain injury.
Comparison of serial S-100 and NSE serum measurements after severe head injury.
Correlation of computed tomography findings and serum brain damage markers following severe head injury.
Diagnosis of traumatical and hypoxial changes of the CNS--immunohistochemical study.
Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury.
Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage.
Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value.
Neuron-specific enolase as a marker of in vitro neuronal damage. Part I: Assessment of neuron-specific enolase as a quantitative and specific marker of neuronal damage.
Neuron-specific enolase as a marker of neuronal lesions during various comas in man.
Neuron-specific enolase as an aid to outcome prediction in head injury.
Olfactory mucosa of patients with olfactory disturbance following head trauma.
Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial.
Prognostic value of serum neuron-specific enolase levels after head injury.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
S-100B and neuron specific enolase in outcome prediction of severe head injury.
Serum markers of brain damage and outcome prediction in patients after severe head injury.
Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study.
Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluid.
The Diagnostic Value of Neuron-Specific Enolase in Children with Mild Blunt Trauma Requiring Cranial CT Scan.
The prognostic value of neuron-specific enolase in head trauma patients.
Trauma scores and neuron-specific enolase, cytokine and C-reactive protein levels as predictors of mortality in patients with blunt head trauma.
[Diagnostic value of s-100 protein and neuron-specific enolase as serum markers for cerebral deficiency after general anesthesia. Study in patient with hip or knee replacement]
[Differences in immunohistochemical findings in traumatic and hypoxic changes in the central nervous system]
[Effects of propofol and isoflurane on serum neuron-specific enolase level in surgical patients with acute craniocerebral trauma: a comparative study]
[Neuron-specific enolase and craniocerebral injuries]
[Significance of serum neuron-specific enolase levels after head injury]
Creutzfeldt-Jakob Syndrome
14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Brain in human nutrition and variant Creutzfeldt-Jakob disease risk (vCJD): detection of brain in retail liver sausages using cholesterol and neuron specific enolase (NSE) as markers.
Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies.
Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.
Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.
Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease.
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
Early elevation of cerebrospinal fluid neuron-specific enolase in Creutzfeldt-Jakob disease.
Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease.
High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease.
Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease.
Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
[Cerebrospinal fluid neuron-specific enolase as a useful indicator for the early diagnosis of Creutzfeldt-Jakob disease]
[Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid]
[Diffuse reduced uptake in 99m-Tc-HM-PAO SPECT and high level of neuron-specific enolase in cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease]
[Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid]
Crohn Disease
Association of Serum Neuron-Specific Enolase and C-Reactive Protein With Disease Location and Endoscopic Inflammation Degree in Patients With Crohn's Disease.
Cryoglobulinemia
Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia.
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
Cryptococcosis
Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia.
Right Lung Consolidation Combined Elevated Serum Neuron Specific Enolase Misdiagnosed as Lung Carcinoma Ultimately Confirmed Pulmonary Cryptococcosis by CT-guided Percutaneous Lung Biopsy: a Case Report and Literature Review.
Cushing Syndrome
Determination of enolase isozymes in various adrenal gland tumours.
Thymic carcinoid tumor with Cushing's syndrome. Report of a case with electron microscopic and immunoperoxidase studies for neuron-specific enolase and corticotropin.
Cystadenocarcinoma
Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
Cystadenoma
[Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases]
Cysticercosis
A novel enolase from Taenia solium metacestodes and its evaluation as an immunodiagnostic antigen for porcine cysticercosis.
Cystitis, Interstitial
Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis.
Cysts
Actin, RhoA, and Rab11 participation during encystment in Entamoeba invadens.
An immunohistochemical study of the presence and distribution of neuronal and glial markers in simple testicular cysts in the ostrich (Struthio camelus).
Cerebral neurocytoma without ganglion cell differentiation.
Clonorchis sinensis enolase: Identification and biochemical characterization of a glycolytic enzyme from excretory/secretory products.
Colloid cyst of the third ventricle. A comparative immunohistochemical study of neuraxis cysts and choroid plexus epithelium.
Congenital cystic eye.
Entamoeba invadens, encystation process and enolase.
Insights into the Giardia intestinalis enolase and human plasminogen interaction.
Naegleria fowleri: enolase is expressed during cyst differentiation.
Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Neuron-specific enolase in patients with neurocysticercosis.
The structure of bradyzoite-specific enolase from Toxoplasma gondii reveals insights into its dual cytoplasmic and nuclear functions.
Ultrasonographical and morphological examination of subependymal cystic lesions in maturely born infants.
[Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis]
Decompression Sickness
Neuron-specific enolase and S100B protein levels in recreational scuba divers with neurological decompression sickness.
Dehydration
A continuous assay for l-talarate/galactarate dehydratase using circular dichroism.
alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis.
Catalytic metal ion binding in enolase: the crystal structure of an enolase-Mn2+-phosphonoacetohydroxamate complex at 2.4-A resolution.
Crystal structure of enolase indicates that enolase and pyruvate kinase evolved from a common ancestor.
Evolution of enzymatic activities in the enolase superfamily: identification of the general acid catalyst in the active site of D-glucarate dehydratase from Escherichia coli.
Evolution of enzymatic activity in the enolase superfamily: functional studies of the promiscuous o-succinylbenzoate synthase from Amycolatopsis.
Evolution of enzymatic activity in the enolase superfamily: structural and mutagenic studies of the mechanism of the reaction catalyzed by o-succinylbenzoate synthase from Escherichia coli.
Expression, purification, and biological characterization of Anaplasma phagocytophilum enolase.
Identification and functional characterization of alpha-enolase from Taenia pisiformis metacestode.
In vitro reconstitution and characterisation of the oxidative D-xylose pathway for production of organic acids and alcohols.
Magnesium ion requirements for yeast enolase activity.
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.
Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution.
Production of bioactive conjugated linoleic acid by the multifunctional enolase from Lactobacillus plantarum.
Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic.
Reverse protonation is the key to general acid-base catalysis in enolase.
Structure and catalytic properties of an engineered heterodimer of enolase composed of one active and one inactive subunit.
Structures of asymmetric complexes of human neuron specific enolase with resolved substrate and product and an analogous complex with two inhibitors indicate subunit interaction and inhibitor cooperativity.
Vibrio parahaemolyticus enolase is an adhesion-related factor that binds plasminogen and functions as a protective antigen.
Delirium
A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
A Systematic Literature Review of Cerebrospinal Fluid Biomarkers in Delirium.
Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis.
Brain-derived neurotrophic factor and neuron-specific enolase, but not S100?, levels are associated to the occurrence of delirium in intensive care unit patients.
Cerebrospinal fluid in long-lasting delirium compared with Alzheimer's dementia.
Incidence, risk factors, and clinical implications of post-operative delirium in lung transplant recipients.
Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value.
Neuroprotective effect of bispectral index-guided fast-track anesthesia using sevoflurane combined with dexmedetomidine for intracranial aneurysm embolization.
Therapeutic Effect of Perioperative Mild Hypothermia on Postoperative Neurological Outcomes in Patients with Acute Stanford Type A Aortic Dissection.
[Effects of Scalp Acupuncture on Serum NSE and S-100? Concentrations and Postoperative Cogni- tive Function of Elderly Patients Undergoing Hip Replacement].
[Predictive value of procalcitonin in intensive care unit delirium].
[Research on the mechanism of delirium based on related serum biomarkers of the delirium].
Dementia
Cerebrospinal fluid in long-lasting delirium compared with Alzheimer's dementia.
Cerebrospinal fluid levels of alpha-synuclein, amyloid ?, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.
Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease.
Determination of glial fibrillary acidic protein, S100, myelin basic protein and neuron specific enolase in cerebrospinal fluid from patients suffering from dementia.
Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease.
Neural tissue hypersensitivity in psychiatric disorders with immunologic features.
Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?
Neuron-specific enolase in patients with acute ischemic stroke and related dementia.
Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia.
Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
[Neuro-specific enolase in acute ischemic stroke and related dementia patients]
Dementia, Multi-Infarct
Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.
Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Dementia, Vascular
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia.
Serum somatostatin and neuron-specific enolase might be biochemical markers of vascular dementia in the early stage.
Demyelinating Diseases
Biochemical markers of damage of the central nervous system in multiple sclerosis.
Cerebrospinal fluid levels of S-100b protein and neuron-specific enolase in chronic inflammatory demyelinating polyneuropathy.
Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.
Dengue
Immunochemical and single molecule force spectroscopy studies of specific interaction between the laminin binding protein and the West Nile virus surface glycoprotein E domain II.
Dental Caries
Oral therapeutic vaccination with Streptococcus sobrinus recombinant enolase confers protection against dental caries in rats.
rEnolase maternal immunization confers caries protection on offspring.
Dermatitis, Atopic
Enolase-1 expression in the stratum corneum is elevated with parakeratosis of atopic dermatitis and disrupts the cellular tight junction barrier in keratinocytes.
[Analysis of IgE reactivities of purified allergens from Candida albicans and Malassezia furfur among patients with atopic dermatitis]
Dermatitis, Exfoliative
Rare paraneoplastic erythroderma associated with ectopic neuron-specific enolase deposition in basal cells.
Dermatomyositis
Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Dermoid Cyst
N-myc gene amplification and neuron specific enolase production in immature teratomas.
Desmoplastic Small Round Cell Tumor
[Unusual intra-abdominal tumor]
Diabetes Mellitus
Effect of photobiomodulation on serum neuron specific enolase (NSE) among patients with diabetic peripheral neuropathy - A pilot study.
Immunoreactivity of neuron-specific enolase (NSE) in human pancreas in health and type 1 diabetes mellitus.
Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus.
[A clinical study in serum levels of neuron-specific enolase (NSE) in diabetes mellitus. Special reference to types of diabetes and neuropathy]
[The levels of endothelin, neuron-specific enolase, and their autoantibodies in the serum and tear fluid of patients with type 2 diabetes mellitus]
Diabetes Mellitus, Type 1
Immunoreactivity of neuron-specific enolase (NSE) in human pancreas in health and type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
[The levels of endothelin, neuron-specific enolase, and their autoantibodies in the serum and tear fluid of patients with type 2 diabetes mellitus]
Diabetic Cardiomyopathies
Oxidative and nitrative modifications of alpha-enolase in cardiac proteins from diabetic rats.
Diabetic Ketoacidosis
Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis.
The Study of Serum Neuron-Specific Enolase and S100 calcium-binding protein B in Pediatric Diabetic Ketoacidosis
Diabetic Nephropathies
Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy.
Diabetic Neuropathies
Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus.
Diabetic Retinopathy
Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy.
High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy.
Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema.
[The levels of endothelin, neuron-specific enolase, and their autoantibodies in the serum and tear fluid of patients with type 2 diabetes mellitus]
Diffuse Axonal Injury
Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury.
The Serum Changes of Neuron-Specific Enolase and Intercellular Adhesion Molecule-1 in Patients With Diffuse Axonal Injury Following Progesterone Administration: A Randomized Clinical Trial.
Disseminated Intravascular Coagulation
Serial disseminated intravascular coagulation score with neuron specific enolase predicts the mortality of cardiac arrest-a pilot study.
Drug Resistant Epilepsy
Efficacy and safety of sodium valproate plus lamotrigine in children with refractory epilepsy.
[Epileptogenesis of acute encephalitis and acute encephalopathy: epilepsy with its onset in the acute phase and without a latent period]
Dry Eye Syndromes
Identification of Tear Fluid Biomarkers in Dry Eye Syndrome Using iTRAQ Quantitative Proteomics.
Dysgerminoma
A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase.
Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma.
Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin level.
Pediatric ovarian dysgerminoma with highly elevated serum neuron-specific enolase.
Dyspnea
Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.
Echinococcosis
Fructose-bisphosphate aldolase and enolase from Echinococcus granulosus: Genes, expression patterns and protein interactions of two potential moonlighting proteins.
Ehrlichiosis
Alpha Enolase 1 Ubiquitination and Degradation Mediated by Ehrlichia chaffeensis TRP120 Disrupts Glycolytic Flux and Promotes Infection.
Empyema, Pleural
[Pyothorax associated lymphoma with increased neuron-specific enolase level in serum and pleural effusion: a case report]
Encephalitis
Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.
Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Immunochemical and single molecule force spectroscopy studies of specific interaction between the laminin binding protein and the West Nile virus surface glycoprotein E domain II.
Neuron-specific enolase in comatose children.
Serum neuron specific enolase is increased in pediatric acute encephalitis syndrome.
Serum time course of two brain-specific proteins, alpha(1) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease.
The identification of a sequence related to apicomplexan enolase from Sarcocystis neurona.
[Neuron-specific enolase activity in rubella encephalitis]
[Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of patients with encephalitis and meningitis]
[Reversible posterior leukoencephalopathy syndrome in Hashimoto's encephalopathy: a case report]
[Value and limitations of the study of gamma-enolase in cerebrospinal fluid as evidence of neuronal degeneration]
Encephalitis, Tick-Borne
Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.
Evaluation of NSE and S100B in patients with tick-borne encephalitis.
Force-induced globule-coil transition in laminin binding protein and its role for viral-cell membrane fusion.
Encephalitis, Viral
[Serum levels of ferritin and neuron-specific enolase in children with hand-foot-mouth disease complicated by acute viral encephalitis].
Encephalomyelitis
Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
Encephalomyelitis, Autoimmune, Experimental
Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
Endodermal Sinus Tumor
Clinical use of tumor markers in childhood malignancies.
Endometrial Neoplasms
Concomitant neuropeptide-producing endometrial carcinomas and ileal carcinoid tumors.
Enolase-1 is a therapeutic target in endometrial carcinoma.
Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells.
Endometriosis
Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis.
Evaluation of elevated urinary enolase I levels in patients with endometriosis.
Neuroendocrine cells in eutopic endometrium of women with endometriosis.
The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis.
Enterocolitis
Structural and functional changes of neuronal and glial components of the feline enteric nervous system in cats with chronic inflammatory and non-inflammatory diseases of the gastrointestinal tract.
Eosinophilia
Pulmonary infiltration with eosinophilia and increased serum levels of squamous cell carcinoma-related antigen and neuron specific enolase.
Ependymoma
Atypical central neurocytoma: report of a case.
Cauda equina tumor with ependymal and paraganglionic differentiation.
Enolase isoenzyme distribution in the human brain and its tumours.
Immunohistochemical demonstration of keratin in canine neuroepithelioma.
Epilepsies, Partial
Excitotoxicity. Experimental correlates to human epilepsy.
Epilepsy
A Meta-Analysis of Neuron-Specific Enolase Levels in Cerebrospinal Fluid and Serum in Children With Epilepsy.
Cerebrospinal fluid neuron specific enolase, interleukin-1? and erythropoietin concentrations in children after seizures.
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy.
CSF neuron-specific enolase after methohexital activation during electrocorticography.
Effect of add-on melatonin on seizure outcome, neuronal damage, oxidative stress, and quality of life in generalized epilepsy with generalized onset motor seizures in adults: A randomized controlled trial.
Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial.
Elevated Blood-Based Brain Biomarker Levels in Patients with Epileptic Seizures: A Systematic Review and Meta-analysis.
Elevated S100B and Neuron Specific Enolase Levels in Patients with Migraine-without Aura: Evidence for Neurodegeneration?
Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: A video-EEG study.
Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Neuroprotective role of dexmedetomidine in epilepsy surgery: A preliminary study.
Serum neuron specific enolase: a marker for neuronal dysfunction in children with continuous EEG epileptiform activity.
Serum neuron-specific enolase in children with febrile seizures: time profile and prognostic implications.
Serum Visinin-Like Protein 1 Is a Better Biomarker Than Neuron-Specific Enolase for Seizure-Induced Neuronal Injury: A Prospective and Observational Study.
Sodium valproate combined with levetiracetam in pediatric epilepsy and its influence on NSE, IL-6, hs-CRP and electroencephalogram improvement.
[Effect of Ilepcimide Combined Western Drugs on Serum Level of Neuron Specific Enolase in Treating Epilepsy Children Patients].
Epilepsy, Temporal Lobe
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy.
Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: A video-EEG study.
Neuroprotective role of dexmedetomidine in epilepsy surgery: A preliminary study.
Erythema
[Glucagonoma: case report and literature review]
Esophageal Achalasia
Distribution of peptide-containing nerve fibres in achalasia of the oesophagus.
Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
Esophageal Neoplasms
Enolase 1 differentially contributes to cell transformation in lung cancer but not in esophageal cancer.
Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
The Effect of Artificial Neural Network Model Combined with Six Tumor Markers in Auxiliary Diagnosis of Lung Cancer.
Essential Hypertension
Increased serum S-100B and neuron specific enolase - Potential markers of early nervous system involvement in essential hypertension.
Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension.
Esthesioneuroblastoma, Olfactory
Esthesioneuroblastoma masquerading as extramedullary plasmacytoma.
Exanthema
[NSE-positive lymphoblastic lymphoma in a boy with cutaneous involvement, giant splenomegaly, and hyper-gamma globulinemia]
Eye Diseases
Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus.
Favism
[New acquisitions on the subject of the bio-enzymology of ictero-hemoglobinuric favism. Note I. The enolase, fructokinase and phosphofructokinase activity of the erythrocytes.]
Fibroma
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Immunohistochemical expression of neural tissue markers (neuron-specific enolase, glial fibrillary acidic protein, S100 protein) in ameloblastic fibrodentinoma: a comparative study with ameloblastic fibroma.
Fibromyalgia
Serum levels of neuron-specific enolase in patients with fibromyalgia syndrome: Correlation with cognitive functions, quality of life and psychological state.
Fibrosarcoma
An investigation of beta enolase as a histological marker of rhabdomyosarcoma.
Assignment of the gene for enolase to mouse chromosome 4 using somatic cell hybrids.
Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.
Disodium Cromolyn and Anti-podoplanin Antibodies Strongly Inhibit Growth of BHK 21/C13-derived Fibrosarcoma in a Chick Embryo Chorioallantoic Membrane Model.
Inhibition of experimental metastasis of human fibrosarcoma cells by anti-recombinant 37-kDa laminin binding protein antibody.
Metastatic subcutaneous sarcoma and abdominal carcinoma in a peach-faced lovebird (Agapornis roseicollis).
Food Hypersensitivity
Proteome mining for novel IgE-binding proteins from the German cockroach (Blattella germanica) and allergen profiling of patients.
Frontotemporal Lobar Degeneration
Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
fructose-bisphosphate aldolase deficiency
Tarui disease and distal glycogenoses: clinical and genetic update.
Ganglioglioma
Immunohistochemical expression of tyrosine kinase (Trk) receptor proteins in mature neuronal cell tumors of the central nervous system.
Rapid growth of an optic nerve ganglioglioma in a patient with neurofibromatosis 1.
Ganglioneuroblastoma
Determination of three enolase isozymes and S-100 protein in various tumors in children.
Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Localization of neuron-specific (gamma gamma) enolase in proliferating (supportive and neoplastic) Schwann cells. An immunohisto- and electron-immunocyto-chemical study of ganglioneuroblastoma and schwannomas.
Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor.
Neuron-specific enolase in relation to differentiation in human neuroblastoma.
Thoracic paravertebral ganglioneuroma with high immunohistochemical expression of TrkA.
Ganglioneuroma
Determination of three enolase isozymes and S-100 protein in various tumors in children.
Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Ganglioneuroma of parapharyngeal region.
Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Neuron-specific enolase in relation to differentiation in human neuroblastoma.
Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Thoracic paravertebral ganglioneuroma with high immunohistochemical expression of TrkA.
Gastrinoma
Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks.
Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.
Gastroenteritis
Detection and diagnostic value of serum NSE and S100B protein levels in patients with seizures associated with mild gastroenteritis: A retrospective observational study.
Gastrointestinal Stromal Tumors
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Histopathological features and clinical course of the gastrointestinal stromal tumors.
Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen's disease.
Genetic Diseases, Inborn
Overexpression of enolase 2 is associated with worsened prognosis and increased glycikolysis in papillary renal cell carcinoma.
Germinoma
Composite germ cell tumor and B-cell non-Hodgkin's lymphoma arising in the sella turcica.
Negative neuron-specific enolase immunostain in intracranial germinomas: a finding against the existence of a tumor of pineal parenchymal-cell origin with histological features of germinoma?
Pituitary and systemic autoimmunity in a case of intrasellar germinoma.
Giant Cell Tumors
Central neuronal tumors in childhood: relationship to dysplasia.
[Immunohistochemical study of subependymal giant cell tumor associated with tuberous sclerosis]
Giardiasis
Polymeric immunoglobulin receptor in intestinal immune defense against the lumen-dwelling protozoan parasite Giardia.
Glaucoma
Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo.
Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients.
Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients.
Electrophoretic determination of aqueous and serum neuron-specific enolase in the diagnosis of retinoblastoma.
Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients.
[Electrophoretic determination of aqueous and serum neuron-specific enolase (NSE) in the diagnosis of retinoblastoma]
Glaucoma, Open-Angle
[The levels of neuron specific enolase and autoantibodies to it in lacrimal and intraocular fluids in patients with open-angle glaucoma (preliminary report)].
Glioblastoma
Biomarker discovery: a proteomic approach for brain cancer profiling.
Enolase activity and isoenzyme distribution in human brain regions and tumors.
Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.
Neuron-specific gamma-enolase derived from human glioma.
Neuronal and glial proteins in medulloblastomas. II. Heterotransplantation of human medulloblastoma.
Passenger deletions generate therapeutic vulnerabilities in cancer.
Pediatric glioblastoma with giant cells and "supratentorial" primitive neuroectodermal component - case report and review of the literature.
Proteomic Analysis on Anti-Proliferative and Apoptosis Effects of Curcumin Analog, 1,5-bis(4-Hydroxy-3-Methyoxyphenyl)-1,4-Pentadiene-3-One-Treated Human Glioblastoma and Neuroblastoma Cells.
Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.
[Risk of endocrine activation in interventions of paragangliomas in the head-neck area]
Glioma
14-3-2 protein in rat primary and transplanted gliomas and neurinomas and in clonal cell lines.
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.
Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1.
Butyrate-induced increase in neuron-specific enolase and ornithine decarboxylase in anaplastic glioma cells.
Contrary effect of lactic acid on expression of neuron-specific enolase and glial fibrillary acidic protein in human glioma cells.
Correction: Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.
Electron-immunocytochemical localization of neuron-specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells.
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase.
Enolase isoenzymes in human cerebral metastasis.
Enolase isoenzymes in human gliomas.
Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.
Glioma cell populations grouped by different cell type markers drive brain tumor growth.
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell.
Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.
Immunoradiometric and immunohistochemical demonstration of neuron-specific enolase in experimental rat gliomas.
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma.
Neuron-specific gamma-enolase derived from human glioma.
Phosphorylation of pyruvate kinase and glycolytic metabolism in three human glioma cell lines.
Regulation of neuron-specific enolase in NG108-15 hybrid cells and C6BU-1 glioma cells.
Routine immunohistochemical characterization of short term in vitro explants from human intracranial tumours.
Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study.
Glomerulonephritis, Membranous
Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN).
Glomus Tumor
Glomus tumours. An immunohistochemical study.
Glucagonoma
Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Duodeno-pancreatic neuroendocrine tumours.
[Glucagonoma: case report and literature review]
Glucose Intolerance
[Glucagonoma: case report and literature review]
Glycogen Storage Disease
Metabolic and drug-induced muscle disorders.
Tarui disease and distal glycogenoses: clinical and genetic update.
Goiter
[Effects of excessive iodine on activity of enolase in hippocampus of developing mice]
Gout
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine.
Granular Cell Tumor
Alveolar soft part sarcoma, granular cell tumor, and paraganglioma. An immunohistochemical comparative study.
Benign Tumors of the Esophagus: A Histopathologic Study of 49 Cases among 931 Consecutive Esophageal Biopsies.
Coexistence of granular cell tumor with squamous cell carcinoma on the tongue: a case report.
Congenital epulis.
Gingival granular cell myoblastoma in newborns. Report of two cases.
Granular cell tumor of the urethra.
Granular cell tumor of the urinary bladder.
Granular cell tumors: evidence for heterogeneous tumor cell differentiation. An immunocytochemical study.
Histologic and immunohistochemical studies of granular cell tumors in seven dogs, three cats, one horse, and one bird.
Immunohistochemical observation of S-100 protein and neuron specific enolase in the tumour cells of granular cell tumour.
Immunohistochemical staining of granular cell tumour for neurone specific enolase: evidence in support of a neural origin.
Immunohistochemical study of granular cell tumours. Demonstration of neurone specific enolase, S 100 protein, laminin and alpha-1-antichymotrypsin.
Oral granular cell tumours: a histological and immunocytochemical study.
Pediatric Granular Cell Tumor of the Breast: A Case Report and Review of the Literature.
[Benign and malignant granular cell tumors. An immunohistochemical classification of tumor cells]
Granuloma
Exploring the interaction between Mycobacterium tuberculosisEnolase and human plasminogen using computational methods and experimental techniques.
Expression of neuron-specific enolase immunoreactivity by cutaneous and extracutaneous Langerhans-cell histiocytoses ("X").
Granulosa Cell Tumor
Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Guillain-Barre Syndrome
Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome.
[Cerebrospinal fluid neuron-specific enolase (NSE) and S-100b protein in Guillain-Barré syndrome--their relations to prognosis]
Hamartoma
Lipomatous differentiation in ependymomas: a report of three cases and comparison with similar changes reported in other central nervous system neoplasms of neuroectodermal origin.
Hand, Foot and Mouth Disease
[Value of serum S100B protein and neuron-specific enolase levels in predicting the severity of hand, foot and mouth disease].
Head and Neck Neoplasms
Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.
Hearing Loss
[Relationship between brainstem auditory evoked potential and serum neuron-specific enolase in neonates with asphyxia]
Heart Arrest
Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection.
Change in neuron specific enolase levels in out-of-hospital cardiopulmonary arrest survivors as a simple and useful tool to predict neurological prognosis.
Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation.
Circulating microRNAs after cardiac arrest.
Combination of neuron-specific enolase measurement and initial neurological examination for the prediction of neurological outcomes after cardiac arrest.
Combining brain computed tomography and serum neuron specific enolase improves the prognostic performance compared to either alone in comatose cardiac arrest survivors treated with therapeutic hypothermia.
Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest.
Cost-effectiveness analysis of multimodal prognostication in cardiac arrest with EEG monitoring.
CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man.
Drug-induced therapeutic hypothermia after asphyxial cardiac arrest in Swine.
Early prediction of long-term cognitive impairment after cardiac arrest.
Effect of carotid artery stenting on the release of S-100B and neurone-specific enolase.
Glycated Hemoglobin is Associated with Glycemic Control and 6-Month Neurologic Outcome in Cardiac Arrest Survivors Undergoing Therapeutic Hypothermia.
Hypothermia after cardiac arrest does not affect serum levels of neuron-specific enolase and protein S-100b.
Hypoxic-Ischemic Encephalopathy Evaluated by Brain Autopsy and Neuroprognostication After Cardiac Arrest.
Impact of low and high partial pressure of carbon dioxide on neuron-specific enolase derived from serum and cerebrospinal fluid in patients who underwent targeted temperature management after out-of-hospital cardiac arrest: A retrospective study.
Increased cerebral endothelium-dependent vasodilation in rats in the post-cardiac arrest period.
Invasive versus noninvasive cooling after in- and out-of-hospital cardiac arrest.
Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients.
Molecular markers of brain damage--clinical and ethical implications with particular focus on cardiac arrest.
Neural tissue-related proteins (NSE, G0 alpha, 28-kDa calbindin-D, S100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest.
Neurological outcome after cardiac arrest: a prospective study of the predictive ability of prognostic biomarkers neuron-specific enolase, glial fibrillary acidic protein, S-100B, and procalcitonin.
Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis.
Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation.
Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia.
Neuron-specific enolase (NSE) improves clinical risk scores for prediction of neurological outcome and death in cardiac arrest patients: Results from a prospective trial.
Neuron-specific enolase and neuroimaging for prognostication after cardiac arrest treated with targeted temperature management.
Neuron-specific enolase and S-100B are associated with neurologic outcome after pediatric cardiac arrest.
Neuron-specific enolase and S-100b in prolonged targeted temperature management after cardiac arrest: A randomised study.
Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33°C and 36°C.
Neuron-specific enolase concentrations for the prediction of poor prognosis of comatose patients after out-of-hospital cardiac arrest: an observational cohort study.
Neuron-specific enolase correlates with other prognostic markers after cardiac arrest.
Neuron-specific enolase kinetics: an additional tool for neurological prognostication after cardiac arrest.
Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients.
Optimizing neurologic prognosis after cardiac arrest.
Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Prediction of delayed neuropsychiatric sequelae after carbon monoxide poisoning via serial determination of serum neuron-specific enolase levels.
Prognostic Abilities of Serial Neuron-Specific Enolase and Lactate and their Combination in Cardiac Arrest Survivors During Targeted Temperature Management.
Prognostic value of serum biomarkers of cerebral injury in classifying neurological outcome after paediatric resuscitation.
Prolonged elevation of serum neuron-specific enolase in children after clinical diagnosis of brain death.
Recover of peripheral nerve function after prolong hypothermic cardiac arrest in a porcine model with extra corporeal life support.
S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review.
S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment.
Serial measurement of neuron specific enolase improves prognostication in cardiac arrest patients treated with hypothermia: a prospective study.
Serum neuron specific enolase - impact of storage and measuring method.
Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.
Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors.
Serum neuron-specific enolase as early predictor of outcome after cardiac arrest.
Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study.
Serum neuron-specific enolase is related to cerebellar connectivity - A resting-state fMRI pilot study.
Targeting low-normal or high-normal mean arterial pressure after cardiac arrest and resuscitation: a randomised pilot trial.
Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial.
The neuron specific enolase (NSE) ratio offers benefits over absolute value thresholds in post-cardiac arrest coma prognosis.
The usefulness of neuron-specific enolase in cerebrospinal fluid to predict neurological prognosis in cardiac arrest survivors who underwent target temperature management: A prospective observational study.
The value of neuron-specific enolase in prognostication after cardiac arrest.
Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest.
Usefulness of early plasma S-100B protein and Neuron-Specific Enolase measurements to identify cerebrovascular etiology of out-of-hospital cardiac arrest.
Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC.
[Biomarkers after resuscitation : Relevance in daily clinical practice for prognosis estimation and definition of therapeutic goals].
[Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest]
[Serum neuron-specific enolase as a prognostic marker after a cardiac arrest].
Heart Block
Antibody reactivity to alpha-enolase in mothers of children with congenital heart block.
Heart Defects, Congenital
Serum Neuronal Biomarkers in Neonates With Congenital Heart Disease Undergoing Cardiac Surgery.
Heart Diseases
Co-purification of arrestin like proteins with alpha-enolase from bovine myocardial tissues and the possible role in heart diseases as an autoantigen.
Heart Failure
Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.
Hemangioblastoma
Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study.
Imaging diagnosis-magnetic resonance imaging features of a cerebral hemangioblastoma in a dog.
Immunohistochemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma.
Immunohistologic analysis of neuron-specific enolase and neuropeptides in stromal cells of cerebellar hemangioblastomas.
Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas.
Sporadic Hemangioblastoma of the Kidney: a rare renal tumor.
Sporadic hemangioblastoma of the kidney: an underrecognized pseudomalignant tumor?
[Hippel-Lindau syndrome: morphology and immunohistochemistry of tumors related to this syndrome]
Hemangioma
Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas.
Hemangiosarcoma
Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas.
[Hemangiosarcoma of the liver with unusual expression of neuron-specific enolase (NSE)]
Hematuria
Determination of urine neuron-specific enolase levels in neuroblastoma patients.
Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma.
Hemorrhagic Stroke
Hemoglobin metabolism by-products are associated with an inflammatory response in patients with hemorrhagic stroke.
Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. An enzymatic test for predicting outcome?
Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.
Hemosiderosis
Extrarenal rhabdoid sarcoma.
Hepatic Encephalopathy
Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate.
Serum levels of astroglial S100-beta and neuron-specific enolase in hepatic encephalopathy patients.
Hepatitis
Extrarenal rhabdoid sarcoma.
Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis.
In situ distribution of enolase isozymes in chronic liver disease.
Hepatitis B
Alpha-enolase regulates hepatitis B virus replication through suppression of the interferon signalling pathway.
Patterns of antigen expression in hepatoblastoma and hepatocellular carcinoma in childhood.
Hepatitis C
Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis.
Hepatitis, Autoimmune
Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.
Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis.
Hepatitis, Chronic
Extrarenal rhabdoid sarcoma.
In situ distribution of enolase isozymes in chronic liver disease.
Hepatoblastoma
Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation.
Hepatomegaly
Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma.
Hereditary Sensory and Autonomic Neuropathies
Two malignant peripheral primitive neuroepithelial tumor cell lines established from consecutive samples of one patient: characterization and cytogenetic analysis.
Herpes Simplex
Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.
Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter.
Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters.
Transduction of foreign regulatory sequences by a replication-defective herpes simplex virus type 1: the rat neuron-specific enolase promoter.
[Reversible posterior leukoencephalopathy syndrome in Hashimoto's encephalopathy: a case report]
[Value and limitations of the study of gamma-enolase in cerebrospinal fluid as evidence of neuronal degeneration]
Herpes Zoster
Identification of alpha-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex.
Hirschsprung Disease
An immunohistochemical study of the enteric neural plexi in Hirschsprung's disease.
Development profile of neuron-specific enolase in human gut and its implications in Hirschsprung's disease.
Diagnostic roles of calretinin in hirschsprung disease: A comparison to neuron-specific enolase.
Immunohistochemical study of neuron specific enolase and S-100 protein in Hirschsprung's disease.
Immunoperoxidase stains of ganglion cells and abnormal mucosal nerve proliferations in Hirschsprung's disease.
Neuron-specific enolase and Hirschsprung's disease.
Neuron-specific enolase as an immunohistochemical tool for the diagnosis of Hirschsprung's disease.
The innervation and neuroendocrine cell population of the appendix in total colonic aganglionosis.
Usefulness of immunocytochemical demonstration of neuron-specific enolase in the diagnosis of Hirschsprung's disease.
Histiocytoma, Benign Fibrous
[A benign neuroendocrine tumor of the lung: study on the origin of the so-called sclerosing hemangioma of the lung]
Histiocytoma, Malignant Fibrous
Malignant fibrous histiocytoma masquerading as germ cell tumor by producing beta-human chorionic gonadotropin and neuron-specific enolase.
Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases.
Histiocytosis
Expression of neuron-specific enolase immunoreactivity by cutaneous and extracutaneous Langerhans-cell histiocytoses ("X").
Neuron-specific enolase is a marker of cutaneous Langerhans' cell histiocytosis ("X")-a comparative study with S100 protein.
Histiocytosis, Langerhans-Cell
Expression of neuron-specific enolase immunoreactivity by cutaneous and extracutaneous Langerhans-cell histiocytoses ("X").
Hodgkin Disease
Expression of enolases in T cell tumors and Hodgkin's disease.
For which cancer types can neuron-specific enolase be clinically helpful in Turkish patients?
Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Huntington Disease
Brain levels of neuron-specific and nonneuronal enolase in Huntington's disease.
Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease.
Production of transgenic miniature pigs by pronuclear microinjection.
Hydrocephalus
Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis.
[Changes in cerebrospinal fluid neuron-specific enolase (NSE), S 100 protein and creatine kinase BB (CK-BB) levels in newborn infants with post hemorrhagic hydrocephalus]
Hyperaldosteronism
Determination of enolase isozymes in various adrenal gland tumours.
Hyperbilirubinemia, Neonatal
Changes in amplitude-integrated electroencephalography, neuron-specific enolase, and S100B in neonates with brain injury induced by neonatal hyperbilirubinemia and their significance.
Hypercalcemia
Combined Hepatocellular Carcinoma and Neuroendocrine Carcinoma with Ectopic Secretion of Parathyroid Hormone: A Case Report and Review of the Literature.
Hypercalcemia in prostate cancer with positive neuron-specific enolase stain.
Increased level of immunoreactive neuron-specific enolase in thyroid C cells from dogs and guinea pigs after chronic hypercalcemia.
Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Hyperglycemia
Hyperglycemia Decreases the Expression of ATP Synthase ? Subunit and Enolase 2 in Glomerular Epithelial Cells.
Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis.
Hyperlipidemias
New solid-phase enzyme immunoassay of neuron-specific enolase in serum: effect of storage temperature, lipemia, icterus, and hemolysis.
Hyperoxaluria
Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion.
Hypersensitivity
Characterization of enolase allergen from Rhodotorula mucilaginosa.
Characterization of IgE-binding epitopes on Candida albicans enolase.
Diagnostic value of Alt a 1, fungal enolase and manganese-dependent superoxide dismutase in the component-resolved diagnosis of allergy to pleosporaceae.
Enolases are highly conserved fungal allergens.
Evidence for the presence of immunoglobulin E antibodies specific to the cell wall phosphomannoproteins of Candida albicans in patients with allergies.
Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.
IgE reactivity to fish allergens from Pacific cod (Gadus macrocephalus) in atopic dogs.
Inhalant allergies to fungi: reactions to bakers' yeast (Saccharomyces cerevisiae) and identification of bakers' yeast enolase as an important allergen.
Molecular study of hypersensitivity to spores in adults and children from Castile & Leon.
Serum IgE cross-reactivity between fish and chicken meats in dogs.
Skin prick test response to enzyme enolase of the baker's yeast (Saccharomyces cerevisiae) in diagnosis of respiratory allergy.
[Blood levels of CA-50, CA-19.9, CA-125, enolase, CA-15.3 and carcinoembryonic antigen in non-cancerous bronchopulmonary pathology]
Hypertension
Effects of circadian rhythm disorder on the hippocampus of SHR and WKY rats.
Incidence and Clinical Outcome of Patients with Hypertensive Acute Ischemic Stroke: An Update from Tertiary Care Center of Central India.
The impact of body mass index on patient survival after therapeutic hypothermia after resuscitation.
Hypertension, Pulmonary
Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase.
Hypertrophy, Left Ventricular
Differential expression of alpha-enolase in the normal and pathological cardiac growth.
Hyphema
Electrophoretic determination of aqueous and serum neuron-specific enolase in the diagnosis of retinoblastoma.
[Electrophoretic determination of aqueous and serum neuron-specific enolase (NSE) in the diagnosis of retinoblastoma]
Hypoglycemia
Association between Achievement of Estimated Average Glucose Level and 6-Month Neurologic Outcome in Comatose Cardiac Arrest Survivors: A Propensity Score-Matched Analysis.
Glucose dysregulation and neurological injury biomarkers in critically ill children.
[Clinical value of serum neuroglobin in evaluating hypoglycemic brain injury in neonates].
Hyponatremia
Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
Hypopituitarism
Pituitary autoantibodies in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Pituitary autoimmunity in patients with Sheehan's syndrome.
Hypothyroidism
[A case of acute cerebellar ataxia associated with serum anti-NH2 terminal of alpha-enolase (NAE) antibody]
[Neuron specific enolase as a measure of the efficacy of mexidol in patients with neurologic complications of primary hypothyroidism].
Hypoxia, Brain
Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study.
Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning.
Enzyme immunoassay of NSE and GFAP as the criterion of dynamic evaluation of the rat blood-brain barrier in perinatal hypoxic ischemic injury of the CNS.
Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase.
Serum neuron-specific enolase as early predictor of outcome after cardiac arrest.
Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest.
[Early evaluation of neurological prognosis and therapy after cardiopulmonary resuscitation : Current opportunities and clinical implications.]
Hypoxia-Ischemia, Brain
A correction formula for neuron-specific enolase measurement in hemolyzed neonatal serum samples.
Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia.
Early prediction of neurological outcome after cardiopulmonary resuscitation: a multimodal approach combining neurobiochemical and electrophysiological investigations may provide high prognostic certainty in patients after cardiac arrest.
Hydrogen water reduces NSE, IL-6, and TNF-? levels in hypoxic-ischemic encephalopathy.
Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy.
Neuron-specific enolase in cerebrospinal fluid as a biomarker of brain damage in infants with hypoxic-ischemic encephalopathy.
Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse.
Neuron-specific enolase levels and neuroimaging in asphyxiated term newborns.
Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients.
Optimized Clustering Algorithm for Comparative Analysis of Different Prenatal Corticosteroid Neurological Deficits in Premature Infants through Magnetic Reasoning Imaging (MRI).
Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia.
Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns.
Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings.
[Biomarkers after resuscitation : Relevance in daily clinical practice for prognosis estimation and definition of therapeutic goals].
[Changes of electroencephalographic background patterns and serum neuron specific enolase levels in neonates with hypoxic-ischemic encephalopathy.]
[Effects of erythropoietin on serum NSE and S-100B levels in neonates with hypoxic-ischemic encephalopathy].
[Efficacy and safety of selective brain hypothermia therapy on neonatal hypoxic-ischemic encephalopathy].
Infarction, Middle Cerebral Artery
Selective accumulation of monoclonal antibodies against neurospecific enolase in brain tissue of rats with middle cerebral artery occlusion.
[Usefulness of determining the level of neuron-specific enolase (NSE) in the cerebrospinal fluid as a biochemical indicator of the extent of cerebral ischemic stroke. Experimental study of the rat model of stroke]
Infections
14-3-3 and enolase abundances in the CSF of Prion diseased rats.
A hypothetical model of crossing Bombyx mori nucleopolyhedrovirus through its host midgut physical barrier.
A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections.
A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase.
A T4SS Effector Targets Host Cell Alpha-Enolase Contributing to Brucella abortus Intracellular Lifestyle.
Alpha Enolase 1 Ubiquitination and Degradation Mediated by Ehrlichia chaffeensis TRP120 Disrupts Glycolytic Flux and Promotes Infection.
Als3-mediated attachment of enolase on the surface of Candida albicans cells regulates their interactions with host proteins.
An octamer of enolase from Streptococcus suis.
Analysis and identification of tyrosine phosphorylated proteins in hemocytes of Litopenaeus vannamei infected with WSSV.
Ascaris suum: RNAi mediated silencing of enolase gene expression in infective larvae.
Assessment of the diagnostic efficacy of enolase as an indication of active infection of Schistosoma japonicum.
Changes in the contents of metabolites and enzyme activities in rice plants responding to Rhizoctonia solani Kuhn infection: activation of glycolysis and connection to phenylpropanoid pathway.
Clostridium difficile cytotoxin B in adults with diarrhea: a comparison of patients treated or not treated with antibiotics prior to infection.
Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital.
Comparative proteomic analysis reveals different responses in porcine lymph nodes to virulent and attenuated homologous African swine fever virus strains.
Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma.
Detection of candidal antigens in autoimmune polyglandular syndrome type I.
Diagnostic value of serum neutrophil gelatinase-associated lipocalin, interleukin-6 and anti-citrullinated alpha-enolase peptide 1 for lower respiratory tract infections.
Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.
Effect of infectious bursal disease virus infection on energy metabolism in embryonic chicken livers.
Effect of ions and inhibitors on the catalytic activity and structural stability of S. aureus enolase.
Effects of diclazuril on the expression of enolase in second-generation merozoites of Eimeria tenella.
Enolase and dipeptidyl peptidase IV protein sub-unit vaccines are not protective against a lethal Streptococcus suis serotype 2 challenge in a mouse model of infection.
Epitopes of Immunoreactive Proteins of Streptococcus Agalactiae: Enolase, Inosine 5'-Monophosphate Dehydrogenase and Molecular Chaperone GroEL.
Exploring the interaction between Mycobacterium tuberculosisEnolase and human plasminogen using computational methods and experimental techniques.
Fasciola hepatica surface tegument: glycoproteins at the interface of parasite and host.
Featured Species-Specific Loops Are Found in the Crystal Structure of Mhp Eno, a Cell Surface Adhesin From Mycoplasma hyopneumoniae.
Gene expression of Paracoccidioides virulence factors after interaction with macrophages and fibroblasts.
Genetic organization and mRNA expression of enolase genes of Candida albicans.
Hydrophobic proteins secreted into the apoplast may contribute to resistance against Phytophthora infestans in potato.
Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2.
Identification and characterization of an immunogenic antigen, enolase 2, among excretory/secretory antigens (ESA) of Toxoplasma gondii.
Identification of bacterial protein markers and enolase as a plant response protein in the infection of Olea europaea subsp. europaea by Pseudomonas savastanoi pv. savastanoi
Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Immunization with recombinant enolase of Sporothrix spp. (rSsEno) confers effective protection against sporotrichosis in mice.
Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2.
Intravenous granulocyte colony-stimulating factor increases the release of tumour necrosis factor and interleukin-1beta into the cerebrospinal fluid, but does not inhibit the growth of Streptococcus pneumoniae in experimental meningitis.
iTRAQ-based proteomic profile analysis of ISKNV-infected CPB cells with emphasizing on glucose metabolism, apoptosis and autophagy pathways.
Lactobacillus crispatus and its enolase and glutamine synthetase influence interactions between Neisseria gonorrhoeae and human epithelial cells.
Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme.
Molecular docking of alpha-enolase to elucidate the promising candidates against Streptococcus pneumoniae infection.
Molecular mimicry between neurons and an intracerebral pathogen induces a CD8 T cell-mediated autoimmune disease.
Mycoplasma synoviae enolase is a plasminogen/fibronectin binding protein.
Neuroinvasion by human herpesvirus type 7 in a case of exanthem subitum with severe neurologic manifestations.
Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.
Octameric structure of Staphylococcus aureus enolase in complex with phosphoenolpyruvate.
Paenibacillus larvae enolase as a virulence factor in honeybee larvae infection.
Prevalent distribution and conservation of Streptococcus suis Lmb protein and its protective capacity against the Chinese highly virulent strain infection.
Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.
Proteomic analysis of fungal host factors differentially expressed by Fusarium graminearum infected with Fusarium graminearum virus-DK21.
Proteomic analysis reveals differentially abundant proteins probably involved in the virulence of amastigote and promastigote forms of Leishmania infantum.
Proteomics identification of novel fibrinogen-binding proteins of Streptococcus suis contributing to antiphagocytosis.
Proteomics Profiling of Chikungunya-Infected Aedes albopictus C6/36 Cells Reveal Important Mosquito Cell Factors in Virus Replication.
Proteomics unravels new candidate genes for Meloidogyne resistance in wild Arachis.
Purification of native enolase from medically important Candida species.
Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.
SILAC and LC-MS/MS identification of Streptococcus equi ssp. zooepidemicus proteins that contribute to mouse brain microvascular endothelial cell infection.
Steinernema glaseri surface enolase: Molecular cloning, biological characterization, and role in host immune suppression.
Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface.
Surface-expressed enolase contributes to the pathogenesis of clinical isolate SSU of Aeromonas hydrophila.
The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples.
The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumoniae to epithelial and endothelial cells.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
WITHDRAWN: Dynamic Observation of Postoperative Infection and Neuron-specific Enolase Levels in Serum in Patients with Non-small Cell Lung Cancer According to Positron Emission Tomography-Computed Tomography.
[A case of congenital toxoplasmosis confirmed by detection of Toxoplasma gondii in placenta]
[Metabolic aspects of hepatic tissue in infection of the mouse from EDP virus. I. Phosphoglucomutase, aldolase and enolase activity.]
Infertility
Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure.
Infertility, Male
Disruption of a Spermatogenic Cell-Specific Mouse Enolase 4 (Eno4) Gene Causes Sperm Structural Defects and Male Infertility.
Inflammatory Bowel Diseases
Anti-alpha-enolase antibodies in patients with inflammatory bowel disease.
Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).
Influenza, Human
Experimental validation of influenza A virus matrix protein (M1) interaction with host cellular alpha enolase and pyruvate kinase.
Infratentorial Neoplasms
"Polyphenotypic" tumors in the central nervous system: problems in nosology and classification.
Insulin Resistance
Effects of Isolated Impaired Fasting Glucose on Brain Injury During Cardiac Surgery Under Cardiopulmonary Bypass.
Insulinoma
Are Biochemical Markers of Neuroendocrine Tumors Coreleased With Insulin Following Local Calcium Stimulation in Patients With Insulinomas?
Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks.
Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Neuropeptide Y secretion from a human insulinoma.
Intellectual Disability
Neural tissue hypersensitivity in psychiatric disorders with immunologic features.
WDR45, one gene associated with multiple neurodevelopmental disorders.
Intervertebral Disc Displacement
Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.
Intestinal Volvulus
Identification of proteins expressing differences among isolates of Meloidogyne spp. (Nematoda: Meloidogynidae) by nano-liquid chromatography coupled to ion-trap mass spectrometry.
Immunohistological studies on neoplasms of female and male Onchocerca volvulus: filarial origin and absence of Wolbachia from tumor cells.
Molecular cloning of an alpha-enolase from the human filarial parasite Onchocerca volvulus that binds human plasminogen.
Intracranial Aneurysm
Serum neuron-specific enolase levels after subarachnoid hemorrhage.
Intracranial Hemorrhages
Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage.
Invasive Pulmonary Aspergillosis
Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia.
Iron Deficiencies
Iron deficiency in children at the time of initial neuroblastoma diagnosis.
Ischemic Attack, Transient
Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events.
Ischemic Stroke
A cross-sectional study to assess the association between major depression and inflammatory markers in patients with acute ischemic stroke.
Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke.
Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke.
Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients.
CXCR7+ and CXCR4+ stem cells and neuron specific enolase in acute ischemic stroke patients.
Effects of Kudiezi Injection on Serum Inflammatory Biomarkers in Patients with Acute Cerebral Infarction.
Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke.
Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.
Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Neuron-specific enolase and blood sugar level in ischemic stroke patients.
Neuron-specific enolase and S 100B protein as predictors of outcome in ischaemic stroke.
Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.
Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review.
Neuron-specific enolase in patients with acute ischemic stroke and related dementia.
Neuron-specific enolase is correlated with lesion topology, relative infarct volume and outcome of symptomatic NAIS.
Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke.
Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion Injury.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients.
Prognostic Value of Investigating Neuron-Specific Enolase in Patients with Ischemic Stroke.
Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit.
Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke.
Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke.
S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.
Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients.
Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis.
Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events.
The second elevation of neuron-specific enolase peak after ischemic stroke is associated with hemorrhagic transformation.
[Markers of inflammation, autoantibodies to neurospecific antigens and outcome in patients with acute ischemic stroke]
[Neuro-specific enolase in acute ischemic stroke and related dementia patients]
[Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke]
[Usefulness of determining the level of neuron-specific enolase (NSE) in the cerebrospinal fluid as a biochemical indicator of the extent of cerebral ischemic stroke. Experimental study of the rat model of stroke]
Keratoconus
Molecular changes in selected epithelial proteins in human keratoconus corneas compared to normal corneas.
Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study.
Kernicterus
Neuroprotective Effect of ?-3 Polyunsaturated Fatty Acids on Bilirubin Encephalopathy In Vitro and In Vivo.
Ketosis
Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis.
Kidney Calculi
Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion.
In vitro evidence of the promoting effect of testosterone in kidney stone disease: A proteomics approach and functional validation.
Kidney Failure, Chronic
Minimum Alveolar Concentration-Awake of Sevoflurane Is Decreased in Patients With End-Stage Renal Disease.
Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease.
Tumor markers in patients with chronic renal failure.
Upregulation of Inflammatory Mediators in End-Stage Renal Disease as Measured Using Biochip Array Technology.
Leiomyoma
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation.
Compensatory alterations in energy homeostasis characterized in uterine tumors from hereditary leiomyomatosis and renal cell cancer.
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Gastric submucosal tumours of neurogenic origin with neuroaxonal and Schwann cell elements.
Leiomyosarcoma
A rare tumor in the adrenal region: neuron-specific enolase (NSE)-producing leiomyosarcoma in an elderly hypertensive patient.
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation.
Creatine kinase BB and neuron-specific gamma-enolase are enhanced in leiomyosarcoma.
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Gastric submucosal tumours of neurogenic origin with neuroaxonal and Schwann cell elements.
LEIOMYOSARCOMA OF THE COLON.
Neuron-specific enolase-producing leiomyosarcoma of the mesentery.
Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry.
[A neuron-specific enolase (NSE) positive leiomyosarcoma]
Leishmaniasis
Enolase as a plasminogen binding protein in Leishmania mexicana.
Membrane orientation of laminin binding protein.
Leishmaniasis, Visceral
Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice.
Leptospirosis
Leptospira interrogans enolase is secreted extracellularly and interacts with plasminogen.
Leukemia
Childhood leukemia: cerebrospinal fluid enolase isoenzymes in central nervous system infiltration.
Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study.
Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
No Evidence of Antibodies against GAD65 and Other Specific Antigens in Children with Autism.
Primitive neuroectodermal tumor/Ewing sarcoma of the retina.
Successful Radical Pneumonectomy for a Primitive Neuroendodermal Tumor in the Lung: A Case Report and Review of the Literature.
Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer cell lines.
[Mediastinal germ-cell tumor associated with AML (M7)--the syndrome of mediastinal germ-cell tumors associated with hematologic neoplasia?]
Leukemia-Lymphoma, Adult T-Cell
Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Leukocytosis
Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis.
Leukoencephalopathies
Sepsis-associated encephalopathy and its differential diagnosis.
Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC.
Leukomalacia, Periventricular
Amniotic fluid neuron-specific enolase: a role in predicting neonatal neurologic injury?
Reference values of amniotic fluid neuron-specific enolase.
Liposarcoma
Small round cell neoplasms: can electron microscopy and immunohistochemical studies accurately classify them?
Liver Abscess, Amebic
Cloning and characterization of Entamoeba histolytica antigens recognized by human secretory IgA antibodies.
Liver Cirrhosis
Liver cirrhosis and serum neuron-specific enolase.
Serum levels of astroglial S100-beta and neuron-specific enolase in hepatic encephalopathy patients.
Using Immunoproteomics to Identify Alpha-enolase as an Autoantigen in Liver Fibrosis.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Liver Cirrhosis, Biliary
Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis.
Liver Diseases
Blood cell superoxide dismutase and enolase activities as markers of alcoholic and nonalcoholic liver diseases.
In situ distribution of enolase isozymes in chronic liver disease.
Neuron-specific enolase concentrations in serum in benign liver diseases.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Liver Failure, Acute
S-100b and neuron-specific enolase in patients with fulminant hepatic failure.
Liver Neoplasms
'Neuroendocrine' differentiation in primary neoplasms of the liver.
?-enolase is highly expressed in liver cancer and promotes cancer cell invasion and metastasis.
Lung Diseases
A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Evaluation of laboratory data by conventional statistics and by three types of neural networks.
Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseases.
Multifunctional neuron-specific enolase: its role in lung diseases.
Neuron-specific enolase in non-neoplastic lung diseases, a marker of hypoxemia?
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury.
New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1.
Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Serum neuron specific enolase levels correlate with patient prognosis for advanced lung cancer.
Serum neuron-specific enolase in various pathological conditions.
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Systematic review and meta-analysis of the efficacy of serum neuron-specific enolase for early small cell lung cancer screening.
The diagnostic and prognostic value of ProGRP in lung cancer.
Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin.
Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Value of serum neuron-specific enolase in nonsmall cell lung cancer.
[Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer]
[Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer]
[Significance of neuron-specific enolase (NSE) in the diagnosis of bronchial carcinomas and neuroendocrine tumors]
[The clinical value of vascular endothelial growth factor in patients with small cell lung cancer.]
[Tumor markers in the diagnosis of lung cancer]
Lung Diseases, Interstitial
Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis.
Anti-fibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis.
Lung Injury
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury.
Lung Neoplasms
A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.
A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
A ureteral small cell carcinoma mixed with malignant mesodermal and ectodermal elements: a clinicopathological, morphological and immunohistochemical study.
A wireless point-of-care testing system for the detection of neuron-specific enolase with microfluidic paper-based analytical devices.
Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China.
Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer.
Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
An Experimental Platform for Characterizing Cancer Biomarkers with Capabilities in Noninvasive and Continuous Screening.
Antiproliferative and antioxidant potential of beta-ionone against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice.
Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.
Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement.
Assessment of serum CYFRA 21-1 in lung cancer.
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide.
Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels.
Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Biomarkers along the continuum of care in lung cancer.
Biomarkers for the lung cancer diagnosis and their advances in proteomics.
Biomarkers in the lung cancer diagnosis: a clinical perspective.
Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients.
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis.
Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
Clinical implications for pro-GRP in small cell lung cancer. A single center experience.
Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer.
Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer.
Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.
Combination assay of lung cancer associated serum markers using surface-enhanced Raman spectroscopy.
Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
Comparison of cytologic markers for automated lung cancer screening.
Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer.
Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.
Correction of the NSE concentration in hemolyzed serum samples improves its diagnostic accuracy in small-cell lung cancer.
Correlation analysis between serum neuron-specific enolase and the detection of gene mutations in lung adenocarcinoma.
Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer.
Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer.
Cut-off levels of NSE to differentiate SCLC from NSCLC.
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer.
Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy.
Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer.
Determination of serum neuron-specific enolase by differential immunocapture.
Determination of the best prognostic value of serum tumor markers in patients with suspected lung cancer in an Iranian population.
Development of a prediction model with serum tumor markers to assess tumor metastasis in lung cancer.
Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients.
Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Diagnostic value of NSE factor combined with ultrasound hemodynamic indexes in cervical lymph node metastasis of lung cancer.
Diagnostic value of the combined detection of CEA, NSE and IL-18 for lung cancer and their relationship with apoptosis gene Bcl-2.
Differences in initial NSE levels in malignant and benign diseases of the thoracic wall.
Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells.
Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.
Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.
Do neuron-specific enolase levels discriminate between small-cell lung cancer and mediastinal tumors?
Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis.
Dual Immunomagnetic Nanobeads-Based Lateral Flow Test Strip for Simultaneous Quantitative Detection of Carcinoembryonic Antigen and Neuron Specific Enolase.
Dual Molecularly Imprinted Polymer-Based Plasmonic Immunosandwich Assay for the Specific and Sensitive Detection of Protein Biomarkers.
Dual-signal electrochemiluminescence immunosensor for Neuron-specific enolase detection based on "dual-potential" emitter Ru(bpy)32+ functionalized zinc-based metal-organic frameworks.
Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.
Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments.
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide.
Enolase 1 differentially contributes to cell transformation in lung cancer but not in esophageal cancer.
Enolase isoenzymes as tumour markers.
Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.
Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio.
Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Establishment and evaluation of a radioimmunoassay for neuron-specific enolase. A marker for small cell lung cancer.
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
Evaluation of biological characteristics of lung cancer by the human 28 kDa vitamin D-dependent calcium binding protein, calbindin-D28k.
Evaluation of Cyfra 21-1 as a marker for lung cancer.
Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Evaluation of gamma-enolase as a tumor marker for lung cancer.
Evaluation of histochemical anthracyclin binding as potential prognostic parameter in small cell lung cancer.
Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
Exploration and analysis of the value of tumor-marker joint detection in the pathological type of lung cancer.
Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells.
Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
Expression patterns and clinical significances of ENO2 in lung cancer: an analysis based on Oncomine database.
Facilitating serum determination of neuron specific enolase at clinically relevant levels by coupling on-line molecularly imprinted solid-phase extraction to LC-MS/MS.
Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
For which cancer types can neuron-specific enolase be clinically helpful in Turkish patients?
Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer.
Generation and characterization of anti-alpha-enolase single-chain antibodies in chicken.
High Sensitive Immunoelectrochemical Measurement of Lung Cancer Tumor Marker ProGRP Based on TiO?-Au Nanocomposite.
High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays.
Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report.
History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.
How to integrate serum tumor markers into clinical oncologic practice.
Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small cell lung cancer: clinical evaluation and biological hypothesis.
Immunoassay of three enolase isozymes in human serum and in blood cells.
Immunocapture and LC-MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum.
Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers.
Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Immunodetection of neuron-specific enolase and keratin in cytological preparations as an aid in the differential diagnosis of lung cancer.
Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles.
Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Improvement of enzyme-linked immunosorbent assay for the multicolor detection of biomarkers.
Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.
Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer.
Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.
Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer.
Interconversion of biological characteristics of small cell lung cancer depending on culture conditions.
Isoenzyme pattern of enolase and creatine kinase in small cell lung cancer patients.
Isoenzyme pattern of enolase in the diagnosis of neuroendocrine bronchopulmonary tumors.
Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines.
Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells.
Label-free electrochemical immunoassay for neuron specific enolase based on 3D macroporous reduced graphene oxide/polyaniline film.
Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer.
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer.
Microwave induced alteration in the neuron specific enolase gene expression.
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Multiple tumour markers for diagnosis, management and follow-up of potentially resectable lung cancer.
Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS.
NCAM: a surface marker for human small cell lung cancer cells.
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.
Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes.
Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study.
Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.
Neuron specific enolase and prognosis of non-small cell lung cancer: A systematic review and meta-analysis.
Neuron specific enolase expression in carcinoma of the lung.
Neuron specific enolase in human small cell carcinoma cultures.
Neuron specific enolase in small cell lung cancer. Clinical and biochemical evaluation.
Neuron specific enolase promotes tumor metastasis by activating the Wnt/?-catenin pathway in small cell lung cancer.
Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer.
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.
Neuron-specific enolase (NSE) in bronchial washings: a better diagnostic marker for small cell lung cancer.
Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
Neuron-specific enolase and lung cancer.
Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.
Neuron-specific enolase as a guide to the treatment of small cell lung cancer.
Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
Neuron-specific enolase concentrations in serum in benign liver diseases.
Neuron-specific enolase during chemotherapy of small cell lung cancer.
Neuron-specific enolase in the diagnosis and therapy monitoring of lung cancer: a comparison with CEA, TPA, ferritin and calcitonin.
Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report.
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer.
Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.
Neuron-specific enolase.
Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Neurone-specific enolase and liver metastasis in small cell lung cancer.
Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis.
New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1.
Novel electrochemical catalysis as signal amplified strategy for label-free detection of neuron-specific enolase.
Novel gold-decorated polyaniline derivatives as redox-active species for simultaneous detection of three biomarkers of lung cancer.
Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer.
Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
On-Chip Spyhole Nanoelectrospray Ionization Mass Spectrometry for Sensitive Biomarker Detection in Small Volumes.
On-line duplex molecularly imprinted solid-phase extraction for analysis of low-abundant biomarkers in human serum by liquid chromatography-tandem mass spectrometry.
p19(ras) Represses proliferation of non-small cell lung cancer possibly through interaction with Neuron-Specific Enolase (NSE).
Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib.
Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
Predictive factors in radiotherapy for non-small cell lung cancer: present status.
Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer.
Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer.
Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations.
Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer.
Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis.
Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer.
Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
Prognostic value of serum tumor markers in patients with lung cancer.
ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma.
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation.
Pyothorax-associated lymphoma: a review of 106 cases.
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
Radioimmunoassay development for human neuron-specific enolase: with some clinical results in lung cancers and neuroblastoma.
Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?
Recent advances in biosensor for detection of lung cancer biomarkers.
Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China.
Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative review.
Risk factors for nicotine dependence in Chinese patients with lung cancer.
Serum antibodies to retinal antigens in lung cancer and sarcoidosis.
Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung.
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
Serum neuron specific enolase level as a prognostic factor in non-small cell lung cancer.
Serum neuron specific enolase levels correlate with patient prognosis for advanced lung cancer.
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis.
Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.
Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening.
Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
Significance of tumor markers in lung cancer.
Simultaneous detection of two lung cancer biomarkers using dual-color fluorescence quantum dots.
Sputum carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 levels in lung cancer diagnosis.
Systematic review and meta-analysis of the efficacy of serum neuron-specific enolase for early small cell lung cancer screening.
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy.
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis.
The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage.
The combination of pretreatment prognostic nutritional index and neuron-specific enolase enhances prognosis predicting value of small cell lung cancer.
The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.
The diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma.
The Effect of Artificial Neural Network Model Combined with Six Tumor Markers in Auxiliary Diagnosis of Lung Cancer.
The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
The prognostic influence of serum neuron specific enolase in small cell lung cancer.
The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.
The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
The value of tumour markers in lung cancer.
Therapy for small cell and non-small cell lung cancer.
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Tissue and Blood Biomarkers in Lung Cancer: A Review.
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Ultrasensitive electrochemical detection of neuron-specific enolase based on spiny core-shell Au/CuxO@CeO2 nanocubes.
Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.
Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Value of Growth/Differentiation Factor 15 in Diagnosis and the Evaluation of Chemotherapeutic Response in Lung Cancer.
Value of serum neuron-specific enolase in nonsmall cell lung cancer.
WITHDRAWN: Dynamic Observation of Postoperative Infection and Neuron-specific Enolase Levels in Serum in Patients with Non-small Cell Lung Cancer According to Positron Emission Tomography-Computed Tomography.
[A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer]
[Assessment of the informative value of neuron-specific enolase determined by the immunoenzyme method]
[Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer]
[Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer]
[Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer]
[Clinical evaluation of serum NSE and CEA in primary lung cancer patients]
[Clinical significance of detection of serum values of neuron specific enolase before and after treatment for small cell lung cancer].
[Clinical significance of ProGRP31-98 in patients with small-cell lung cancer]
[Clinical significance of serum neuron-specific enolase in non-small cell lung cancer]
[Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer]
[Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer]
[Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer]
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum]
[Determination of carcinoembryonic antigen in lung cancer using an immunoenzyme assay]
[Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]
[Determining the level of the tumor marker--neuron-specific enolase in patients with neoplastic and non-neoplastic diseases]
[Diagnositic values of combined determination of carbohydrate antigen and tissue polypeptide antigen and neuron-specific enolase and carcinoembryonic antigen in the malignant pleural effusion.]
[Diagnostic and prognostic values of serum CA125, NSE, CT levels in patients with lung cancer.]
[Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer]
[Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
[Diagnostic value of ProGRP and NSE for small cell lung cancer: a meta-analysis].
[ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
[Evaluation of gamma-enolase as a tumor marker for lung cancer]
[Level of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of small cell lung cancer patients: correlation with performance status, disease extent and prognosis]
[Localization of enolase in the cancer nest of digestive organs]
[Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer]
[Monoclonal antibodies to neuron-specific enolase in phenotyping lung cancer]
[Neuroendocrine differentiation as a survival prognostic factor in advanced non-small cell lung cancer]
[Neuron specific enolase gene silencing suppresses proliferation and promotes apoptosis of lung cancer cells in vitro].
[Neuron specific enolase in small cell lung cancer]
[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer]
[Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study]
[Neuron-specific enolase: a new marker for small-cell pulmonary carcinoma]
[Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study]
[Prognostic value of neuron enolase levels in serum of patients with lung neoplasms]
[Proteome analysis of autoantibodies in sera of patients with cancer]
[Recent progress in the biology of small cell bronchial carcinoma]
[Relation between serum neuron-specific enolase and CEA levels in the patients with lung cancer]
[Relation between the level of TPS, NSE, CEA and beta2-mG in the serum and the biological behavior of small cell lung cancer]
[Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer]
[Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]
[Serum neuron-specific enolase (NSE) in patients with primary lung cancer]
[Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)]
[Serum neuron-specific enolase as a marker of lung cancers]
[Serum neuron-specific enolase in patients with lung cancer]
[Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels]
[Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]
[Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
[Study on the specific expressions of p53, bcl-2 and c-myc in non-small cell lung cancer with neuroendocrine differentiation.]
[Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion.]
[The changes in serum neuron-specific enolase in patients with small cell lung cancer]
[The prognostic value of serum neuron specific enolase detection in small cell lung cancer]
[The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma]
[The value of determining neuron specific enolase for diagnosis of complete remission during treatment of small cell lung cancer]
[Treatment monitoring of patients with small cell lung cancer by determining levels of serum neuron specific enolase]
[Tumor markers in bronchus cancer]
[Tumor markers in lung cancer]
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
[Tumor markers in the diagnosis of lung cancer]
[Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma]
[Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms]
[Usefulness of monitoring levels of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of patients with small cell lung cancer for evaluating treatment outcome]
[Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma].
[Value of neuron specific enolase levels and squamous cell carcinoma antigen in bronchial lavage fluid in patients with lung cancer]
Lupus Erythematosus, Discoid
Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus.
Lupus Erythematosus, Systemic
Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis.
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN).
Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
[Detection and analysis of serum level of anti-Candida enolase IgG antibody in patients with autoimmune diseases].
Luteoma
A case report of an uncommon sex-cord stromal tumor consisted of luteal and sertoli cells in a spayed bitch.
Lyme Disease
A surface enolase participates in Borrelia burgdorferi-plasminogen interaction and contributes to pathogen survival within feeding ticks.
Serum time course of two brain-specific proteins, alpha(1) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease.
The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles.
Lymphatic Metastasis
A case of cervical metastases from temporal bone carcinoid.
Clinical utility of endoscopic ultrasound-guided fine-needle aspiration in mixed adenoneuroendocrine carcinoma with signet-ring cells of the pancreas: a case report and review of the literature.
Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.
Diagnostic value of NSE factor combined with ultrasound hemodynamic indexes in cervical lymph node metastasis of lung cancer.
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer.
Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies.
The c-erbB-2 protein in primary and metastatic breast carcinomas.
Lymphohistiocytosis, Hemophagocytic
Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation?
Lymphoma
B cell stimulatory effects of alpha-enolase that is differentially expressed in NZB mouse B cells.
Carcinoma of the nasopharynx. Histopathological examination with supplementary immunohistochemistry.
Cytomorphology and immunohistochemistry of extrarenal rhabdoid tumor: a case report with review of literature.
Demonstration of lymphoid antigens in decalcified bone marrow trephines.
Diagnostic immunohistochemistry of canine round cell tumors.
Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL).
Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens.
Expression of enolases in B cell tumors.
Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma.
Merkel cell carcinoma: important aspects of diagnosis and management.
Monoclonal antibody MB2: a potential marker for Ewing's sarcoma and primitive neuroectodermal tumor.
Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Neuron-specific enolase and malignant lymphomas (23 cases).
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China.
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
[Increased neuron-specific enolase levels in patients with long-standing pyothorax-associated lymphoma]
[Primary malignant T-cell-rich B-cell lymphoma of the central nervous system: a case report]
[Pyothorax associated lymphoma with increased neuron-specific enolase level in serum and pleural effusion: a case report]
[Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma]
Lymphoma, B-Cell
A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.
B cell stimulatory effects of alpha-enolase that is differentially expressed in NZB mouse B cells.
Composite germ cell tumor and B-cell non-Hodgkin's lymphoma arising in the sella turcica.
Expression of enolases in B cell tumors.
Intestinal clear cell sarcoma with melanocytic differentiation and EWS [corrected] rearrangement: report of a case.
Paeoniflorin attenuates hippocampal damage in a rat model of vascular dementia.
Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Lymphoma, B-Cell, Marginal Zone
Novel autoantibodies in Sjögren's syndrome: A comprehensive review.
Lymphoma, Follicular
Expression of enolases in B cell tumors.
Lymphoma, Large B-Cell, Diffuse
Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma.
Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Macular Degeneration
Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.
Malaria
Application of yeast enolase as antigen for immunodiagnosis of malaria.
Biliverdin targets enolase and eukaryotic initiation factor 2 (eIF2?) to reduce the growth of intraerythrocytic development of the malaria parasite Plasmodium falciparum.
Differential susceptibility of Plasmodium falciparum versus yeast and mammalian enolases to dissociation into active monomers.
Effect of deletion of a plant like pentapeptide insert on kinetic, structural and immunological properties of enolase from Plasmodium falciparum.
Immunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles.
Molecular characterisation of the enolase gene from the human malaria parasite Plasmodium falciparum. Evidence for ancestry within a photosynthetic lineage.
Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization.
Protective Properties and Surface Localization of Plasmodium falciparum Enolase.
Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
Sub-cellular localization and post-translational modifications of the Plasmodium yoelii enolase suggest moonlighting functions.
Surface-expressed enolases of Plasmodium and other pathogens.
Malnutrition
Maternal undernutrition induces the expression of hypoxia-related genes in the fetal brain.
The metabolic flow rate through the phosphopyruvate hydratase and glucose phosphate isomerase steps of glycolysis in normal rat liver, in cirrhosis, and in quantitative undernutrition.
Mania
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects.
Massive Hepatic Necrosis
Neuron-specific enolase as a marker of neuronal lesions during various comas in man.
Measles
Noncanonical Transmission of a Measles Virus Vaccine Strain from Neurons to Astrocytes.
Medulloblastoma
A clinical case of presumed cerebellar medulloblastoma in a Japanese Black calf with increased neuron-specific enolase in cerebrospinal fluid.
An immunohistochemical study on the distribution of glial fibrillary acidic protein, S-100 protein, neuron-specific enolase, and neurofilament in medulloblastomas.
Differentiation in medulloblastomas and other primitive neuroectodermal tumours.
Differentiation in medulloblastomas: immunohistochemical study of twenty-one cases.
Enolase isoenzyme distribution in the human brain and its tumours.
Histogenesis and cell lineage analysis of medulloblastomas.
Immunohistochemical Profiling and Telomerase Activity of a Canine Medulloblastoma.
Medulloblastomas in childhood: histological factors influencing patients' outcome.
Neuron-specific enolase and neurofilament protein as markers of differentiation in medulloblastoma.
Neuron-specific enolase as a marker for medulloblastoma.
Neuron-specific gamma-enolase derived from human glioma.
Neuronal and glial proteins in medulloblastomas. I. Immunohistochemical study.
Neuronal and glial proteins in medulloblastomas. II. Heterotransplantation of human medulloblastoma.
Pathology of midline brain tumors. Immunocytochemical tumor markers and classificatory aspects.
Melanoma
A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
A melanoma cell surface laminin binding protein with apparent Mr 90,000.
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
Balloon cell melanoma in three dogs: a histopathological, immunohistochemical and ultrastructural study.
Clinical significance of serum S100 in metastatic malignant melanoma.
Congenital cutaneous melanoma in a dog.
Cutaneous malignant melanomas in 57 cats: identification of (amelanotic) signet-ring and balloon cell types and verification of their origin by immunohistochemistry, electron microscopy, and in situ hybridization.
Desmoplastic malignant melanoma of the gingiva: case report and review of the literature.
Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.
Enolase isoenzymes in uveal melanomas--a possible parameter of malignancy.
Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells.
Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
Gamma-enolase activity in choroidal melanoma.
Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside binding lectin.
Immature Chondroid Choristoma: Clinicopathologic, Immunohistochemical, and Molecular Study of an Unusual Benign Skin Tumor.
Immunohistochemical characterization of experimental Greene melanoma.
Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
Immunohistochemical staining techniques of intraocular tumors.
Immunohistochemical study of malignant melanoma.
Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Intestinal clear cell sarcoma with melanocytic differentiation and EWS [corrected] rearrangement: report of a case.
Malignant melanoma of the eyelid in a red squirrel (Sciurus vulgaris orientis).
Malignant melanoma simulating schwannian differentiation.
Malignant rhabdoid skin tumor: an uncommon primary skin neoplasm. Ultrastructural and immunohistochemical analysis.
Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
Melanotic neuroectodermal tumor of the epididymis in infancy: case report and review of the literature.
Melanotic neuroectodermal tumour as a predominant component of an immature testicular teratoma. Case report with immunohistochemical investigations.
Metastatic Melanomas in Young Broiler Chickens (Gallus gallus domesticus).
Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
Neuron-specific enolase as a tumor marker in metastatic melanoma.
Neuron-specific enolase as serum marker for malignant melanoma.
Neuron-specific enolase.
Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma.
Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma.
Neurotropic melanoma of the face invading the maxillary nerve.
Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
Prognosis of conjunctival melanomas in relation to histopathological features.
Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE.
Renal cell carcinoma with rhabdoid features.
Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases.
Routine immunohistochemical characterization of short term in vitro explants from human intracranial tumours.
S-100 and NSE as serum markers in melanoma.
Serological markers for melanoma.
Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.
The evaluation of putative tumor markers for malignant melanoma.
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.
The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.
Transcription factor e3 protein-positive perivascular epithelioid cell tumor of the appendix presenting as acute appendicitis: a case report and review of the literature.
Usefulness of neuron-specific enolase as a serum marker of metastatic melanoma.
[Laboratory markers of melanoma progression]
[Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma]
[Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma]
Melanoma, Amelanotic
Diagnostic immunohistochemistry of canine round cell tumors.
Melanoma, Experimental
Laminin and 67 kD laminin binding protein in mouse B16 melanoma cells and 3T3 fibroblast spheroids.
Melanosis
Melanosis coli--histochemical and immunohistochemical comparison of the pigments of melanosis coli and Dubin-Johnson syndrome.
Meningeal Carcinomatosis
Tumor markers in patients with lung cancer.
Meningioma
Enolase activity and isoenzyme distribution in human brain regions and tumors.
Enolase isoenzyme distribution in the human brain and its tumours.
Histologic and immunohistochemical studies of granular cell tumors in seven dogs, three cats, one horse, and one bird.
Human meningioma and neuron-specific enolase expression.
Immunohistochemical profile of meningiomas and their histological subtypes.
Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas.
Metastatic prostatic adenocarcinoma with neuroendocrine differentiation to meningioma.
Phenotypic change of human cultured meningioma cells.
Routine immunohistochemical characterization of short term in vitro explants from human intracranial tumours.
The expression of S-100 protein and neuron-specific enolase in meningiomas.
[Immunohistochemical demonstration of neuron-specific enolase in meningiomas and in normal meningocytes]
Meningitis
Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis.
Enolase of Streptococcus Suis Serotype 2 Enhances Blood-Brain Barrier Permeability by Inducing IL-8 Release.
Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2.
Inhibition of glutamine synthetase in rabbit pneumococcal meningitis is associated with neuronal apoptosis in the dentate gyrus.
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis.
Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant.
[Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of patients with encephalitis and meningitis]
[The markers of damage of neurons and glia in cerebrospinal liquor under meningitis in children.]
Meningitis, Aseptic
Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant.
Meningitis, Bacterial
Cerebrospinal fluid levels of superoxide dismutases in neurological diseases detected by sensitive enzyme immunoassays.
Neuron-Specific Enolase Is Correlated to Compromised Cerebral Metabolism in Patients Suffering from Acute Bacterial Meningitis; An Observational Cohort Study.
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis.
Serum levels of neurofilament light chain, neuron-specific enolase and S100 calcium-binding protein B during acute bacterial meningitis: a prospective cohort study.
The fluctuations of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome.
[Superoxide dismutase in cerebrospinal fluid in patients with neurological diseases]
Meningitis, Pneumococcal
Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis.
Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
Meningitis, Viral
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis.
Meningoencephalitis
[Evaluation of cerebrospinal fluid and plasma neuron-specific enolase (NSE) concentration in patients with purulent, bacterial meningoencephalitis]
Mesothelioma
Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomas.
Mesothelioma, Malignant
Desmin and neural marker expression in mesothelial cells and mesotheliomas.
Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomas.
Metabolic Syndrome
Metabolic syndrome and its components with neuron-specific enolase: a cross-sectional study in large health check-up population in China.
Microphthalmos
Immunohistochemical Characteristics of Normal Canine Eyes.
Migraine Disorders
Elevated S100B and Neuron Specific Enolase Levels in Patients with Migraine-without Aura: Evidence for Neurodegeneration?
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
S100B and neuron-specific enolase levels in episodic and chronic migraine.
Serum concentrations of neuron-specific enolase in pediatric migraine.
Mitochondrial Encephalomyopathies
Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.
Mixed Connective Tissue Disease
Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Mongolian Spot
Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Mouth Diseases
[Value of serum S100B protein and neuron-specific enolase levels in predicting the severity of hand, foot and mouth disease].
Mucocutaneous Lymph Node Syndrome
Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant.
Multiple Endocrine Neoplasia
Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Multiple Myeloma
Correction: Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.
Expression of neuron-specific enolase in multiple myeloma and implications for clinical diagnosis and treatment.
Neuron-specific enolase expression in multiple myeloma.
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.
[Neuron specific enolase producing multiple myeloma]
[Neuron specific enolase-producing IgD multiple myeloma with high serum amylase activity]
Multiple Sclerosis
Biochemical markers of damage of the central nervous system in multiple sclerosis.
Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis.
Enolase autoantibodies and retinal function in multiple sclerosis patients.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Multiple Sclerosis, Chronic Progressive
Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
Muscular Atrophy
Proteomic and bioinformatic analysis of differentially expressed proteins in denervated skeletal muscle.
Muscular Diseases
Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis.
Serum enolase: a non-destructive biomarker of white skeletal myopathy during pancreas disease (PD) in Atlantic salmon Salmo salar L.
[Intestinal dysmotility-pseudo-obstruction]
Muscular Dystrophies
Content and synthesis of glycolytic enzymes and creatine kinase in skeletal muscles and normal and dystrophic chickens.
Serum carbonic anhydrase III in progressive muscular dystrophy.
Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
Muscular Dystrophy, Duchenne
Alpha-enolase plasminogen receptor in myogenesis.
Serum carbonic anhydrase III in progressive muscular dystrophy.
Total and immunologically reacting muscle enolase in blood serum of Duchenne muscular dystrophy patients and carriers.
Myasthenia Gravis
Myoid cells in the human thymus and thymoma revealed by three different immunohistochemical markers for striated muscle.
Mycoses
Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.
The glycolytic enzyme enolase represents a plasminogen-binding protein on the surface of a wide variety of medically important fungal species.
Myelitis, Transverse
Inflammatory transverse myelitis: evolving concepts.
Myocardial Infarction
Immunological determination of muscle-type enolase in the serum as a diagnostic test for myocardial infarction.
Serum beta-enolase in acute myocardial infarction.
Serum enolase and pyruvate kinase activities in the diagnosis of myocardial infarction.
[High creatine kinase MB concentration and activity in patients with rhabdomyosarcoma]
Myoclonus
Added value of somato-sensory evoked potentials amplitude for prognostication after cardiac arrest.
Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.
Electroencephalography Predicts Poor and Good Outcomes After Cardiac Arrest: A Two-Center Study.
Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation.
Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Prognosis After Cardiac Arrest and Hypothermia: A New Paradigm.
Sedation Confounds Outcome Prediction in Cardiac Arrest Survivors Treated with Hypothermia.
[Juvenile onset Creutzfeldt-Jakob disease with the history of neurosurgical operation]
[Predicting prognosis in post-anoxic coma]
Myoepithelioma
Myoepitheliomas and myoepithelial adenomas of salivary gland origin. Immunohistochemical evaluation of filament proteins, S-100 alpha and beta, glial fibrillary acidic proteins, neuron-specific enolase, and lactoferrin.
Myotonic Dystrophy
Serum carbonic anhydrase III in myotonic dystrophy.
[Central nervous system disorders in myotonic dystrophy--with special reference to neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme levels in CSF]
Myxoma
Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution.
Immunohistochemical investigation in odontogenic myxoma.
Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex.
[A case of cardiac myxoma with multiple brain hemorrhage]
Nasopharyngeal Neoplasms
[The expressions of alpha-enolase in the nasopharyngeal cancer tissue].
Necrolytic Migratory Erythema
[Glucagonoma: case report and literature review]
Neonatal Sepsis
Cerebral blood flow and serum neuron-specific enolase in early-onset neonatal sepsis.
Neoplasm Metastasis
?-enolase is highly expressed in liver cancer and promotes cancer cell invasion and metastasis.
A case of cervical metastases from temporal bone carcinoid.
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target.
Alveolar rhabdomyosarcoma of the lung in a child.
Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Carcinoid tumors--somatostatine in the diagnosis and therapy.
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
Clinical characteristics and prognostic factors of prostate cancer with liver metastases.
Clinical utility of endoscopic ultrasound-guided fine-needle aspiration in mixed adenoneuroendocrine carcinoma with signet-ring cells of the pancreas: a case report and review of the literature.
Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Dedifferentiation of neoplastic cells in medullary thyroid carcinoma: report of a case.
Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.
Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma.
Diagnostic value of NSE factor combined with ultrasound hemodynamic indexes in cervical lymph node metastasis of lung cancer.
Effective treatment of relapsed prostate small cell carcinoma with amrubicin: report of a case.
Enolase isoenzymes in human cerebral metastasis.
Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Examination of bone marrow biopsy specimens and staging of small cell lung cancer.
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
First Case Report of a Sporadic Adrenocortical Carcinoma With Gastric Metastasis and a Synchronous Gastrointestinal Stromal Tumor of the Stomach.
Glycolytic enzyme activities in breast cancer metastases.
Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: an analysis of 310 reported cases.
Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer.
Histopathological and Immunohistochemical Evaluation of Malignant Potential in Canine Aortic Body Tumours.
Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells.
Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.
Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis.
Inhibition of experimental metastasis of human fibrosarcoma cells by anti-recombinant 37-kDa laminin binding protein antibody.
Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
Iron deficiency in children at the time of initial neuroblastoma diagnosis.
Metastatic small cell tumor of bone with 'true' rosettes and glial fibrillary acidic protein positivity.
Metastatic subcutaneous sarcoma and abdominal carcinoma in a peach-faced lovebird (Agapornis roseicollis).
Multiple liver metastases of pancreatic solid pseudopapillary tumor treated with resection following chemotherapy and transcatheter arterial embolization: A case report.
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.
Neuron specific enolase promotes tumor metastasis by activating the Wnt/?-catenin pathway in small cell lung cancer.
Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
Neuron-specific enolase in mucosal endocrine cells and carcinoid tumours of the small intestine: a comparative study with neuron-specific enolase immunocytochemistry and silver stains.
Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer.
Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma.
Neurone-specific enolase and liver metastasis in small cell lung cancer.
Nomogram prediction for the survival of the patients with small cell lung cancer.
Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer.
Primary culture of cells arising from a neuroendocrine skin carcinoma.
Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Prostatic carcinoma: a multivariate analysis of prognostic factors.
Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
Pulmonary blastoma with fatal hypercalcemia.
Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative review.
Routine immunohistochemical characterization of short term in vitro explants from human intracranial tumours.
Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
The c-erbB-2 protein in primary and metastatic breast carcinomas.
The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification.
Tumor markers in patients with lung cancer.
Tumor-Specific Diagnostic Marker for Transmissible Facial Tumors of Tasmanian Devils: Immunohistochemistry Studies.
Upregulation of ? enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.
Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis]
[Glucagonoma: case report and literature review]
Neoplasms
"Polyphenotypic" tumors in the central nervous system: problems in nosology and classification.
131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
14-3-2 protein in rat primary and transplanted gliomas and neurinomas and in clonal cell lines.
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma.
45-year-old male with symptomatic mass in the frontal lobe.
68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.
A case of classical carcinoid tumor of the gallbladder: review of the Japanese published works.
A case of endocrine ductal carcinoma of the breast.
A case of malignant cystic endocrine tumor of the pancreas.
A case of mixed ductal-endocrine carcinoma of the pancreas.
A case of neck ectopic meningioma.
A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase.
A case of primary combined neuroendocrine carcinoma with squamous cell carcinoma in the upper gingiva.
A case of primary intrapulmonary neurilemoma and review of the literature.
A case of primary small cell carcinoma of the breast.
A case of small cell carcinoma in the buccal region.
A case of undifferentiated glioma in a 70-year-old woman.
A cerebral primitive neuroectodermal tumor in a squirrel monkey (Saimiri sciureus).
A clinical and immunohistochemical study of gastrointestinal stromal tumours.
A clinicopathologic study of primary hepatic carcinoid tumors.
A clinicopathologic, histologic, and immunohistochemical study of mixed germ cell-stromal tumors of the testis in 16 dogs.
A clinicopathological, immunohistochemical and neuroradiological study of eight patients with central neurocytoma.
A comparative review of melanocytic neoplasms.
A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.
A comparative study on etoposide combined with lobaplatin or cisplatin in the first-line treatment of extensive-stage small cell lung cancer.
A comprehensive screen for chicken proteins that interact with proteins unique to virulent strains of Marek's disease virus.
A cross-sectional study to assess the association between major depression and inflammatory markers in patients with acute ischemic stroke.
A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen.
A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
A Highly Selective Poly(thiophene)-graft-Poly(methacrylamide) Polymer Modified ITO Electrode for Neuron Specific Enolase Detection in Human Serum.
A histomorphologic and immunohistochemical study of chordoma in twenty ferrets (Mustela putorius furo).
A knock-down cell-based study for the functional analysis of chloride intracellular channel 1 (CLIC1): Integrated proteomics and microarray study.
A malignant astrocytoma containing simian virus 40 DNA in a macaque infected with simian immunodeficiency virus.
A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum.
A neuroendocrine (Merkel) cell carcinoma with coexisting intraepidermal squamous cell carcinoma of the skin. Its growth accelerated by an extrinsic factor.
A nevocellular nevus consisting mostly of nevic corpuscles.
A new human malignant peripheral nerve sheath tumour-cell line, HS-sch-2, harbouring p53 point mutation.
A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients.
A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma.
A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells.
A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis.
A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.
A rapidly growing benign intrathoracic neurofibroma after lung lobectomy.
A rare case of a pulmonary granular cell tumor presenting as a coin lesion.
A rare case report of mixed olfactory neuroblastoma: Carcinoma with review of literature.
A rare case report of pituicytoma with biphasic pattern and admixed with scattered Herring bodies.
A Rare Cause of Abdominal Pain and Mass in an 18-Year-Old Patient: A Diagnostic Dilemma.
A rare soft tissue tumor located in the trunk: Ossifying fibromyxoid tumor.
A rare tumor in the adrenal region: neuron-specific enolase (NSE)-producing leiomyosarcoma in an elderly hypertensive patient.
A reassessment of histologic classification and an immunohistochemical study of 88 retinoblastomas. A special reference to the advent of bipolar-like cells.
A retrospective immunohistochemical and clinicopathological study of small cell carcinomas of the urinary tract.
A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2?.
A study of the histopathogenesis of carcinoid tumors of the small intestine and appendix.
A word of caution in the use of neuron-specific enolase expression in tumor diagnosis.
Aberrant insulinoma of the duodenal bulb.
Abrikosoff's tumor: A clinicopathologic study of nine cases.
Acetonitrile-assisted enzymatic digestion can facilitate the bottom-up identification of proteins of cancer origin.
Acinar Cell Carcinoma of Exocrine Pancreas in Two Horses.
Acinar-islet cell carcinoma presenting as insulinoma.
Acquired renal cystic disease and tumor markers in chronic hemodialysis patients.
ACTH-secreting islet cell tumor of the pancreas presenting as bilateral ovarian tumors and Cushing's syndrome.
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in lipoblastic and neurogenic proliferations.
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation.
Acute pancreatitis combined with acute Budd-Chiari syndrome as the initial manifestation of small cell lung cancer.
Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Adenocarcinoid of the liver arising within an area of hamartoma with predominant bile duct component.
Adenoendocrine cell carcinoma of the gallbladder: report of a case.
Adenoma of the retinal pigment epithelium: a report of 3 cases.
Adenomatous lesions of the temporal bone immunohistochemical analysis and theories of histogenesis.
Administrations of Preoperative Shenmai Injection and Postoperative Shenfu Injection, Two Ginseng Containing TCM Formulas, Improve Cognitive Dysfunction in Aged Rats.
Adrenal cortical tumors clinically mimicking pheochromocytoma.
Adult-onset neuroblastoma: Report of seven cases with molecular genetic characterization.
Advanced composite of large cell neuroendocrine carcinoma and squamous cell carcinoma: a case report of uterine cervical cancer in a virgin woman.
Advanced pneumonic type of lung adenocarcinoma: survival predictors and treatment efficacy of the tumor.
Advanced primary adenosquamous carcinoma of the liver with a small cell carcinoma component: an autopsy case report.
Advancements in Hydrogel-Functionalized Immunosensing Platforms.
Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Age-related profile of neuroblastoma: a comparison of tumors detected by mass-screening with those detected clinically.
Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex.
Aldolase C in neuroendocrine tumors: an immunohistochemical study.
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ?133p53? mimic.
Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target.
Alpha-fetoprotein-producing urachal adenocarcinoma.
Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Alveolar soft part sarcoma, granular cell tumor, and paraganglioma. An immunohistochemical comparative study.
Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study of 12 cases.
Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study.
Alveolar soft part sarcoma. An immunohistochemical, cytologic and electron-microscopic study and a quantitative DNA analysis.
Alveolar soft part sarcoma. An ultrastructural and immunocytochemical investigation of its histogenesis.
Alveolar soft-part sarcoma of the cheek: report of a case with a review of the literature.
Amelanotic malignant melanoma of the esophagus: case report and review of the literature.
Amphicrine tumor.
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine.
An atypical endocrine tumor of the lung responsive to radiation therapy and 5-fluorouracil-streptozotocin.
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
An immunocytochemical demonstration of calcineurin in human nerve cell tumors. A comparison with neuron-specific enolase and glial fibrillary acidic protein.
An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.
An immunohistochemical study of intracranial germ cell tumours.
An immunohistochemical study of pheochromocytomas.
An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers.
An immunohistochemical study of spontaneous histiocytic tumours in the rat.
An investigation of beta enolase as a histological marker of rhabdomyosarcoma.
An ultrastructural and immunohistochemical study of olfactory neuroepithelioma with rhabdomyoblasts.
An ultrastructural and immunohistochemical study of pigmented dermatofibrosarcoma protuberans (Bednar tumor).
An unclassified cerebral small cell tumor in a patient with human T-cell lymphotropic virus type 1-induced primary extranodal lymphoma.
An unusual case of bronchial carcinoid predominantly consisting of large cells.
An unusual cerebellar primitive neuroectodermal tumor with t(11;22) translocation: pathological and molecular analysis.
Analysis of clinical features of RPE adenoma.
Anaplastic small cell (oat cell) carcinoma of the tonsils: report of two cases.
Anaplastic variant of spermatocytic seminoma.
Angiomyoma of the upper lip: report of a case with electron microscopic and immunohistochemical observation.
Angiosarcoma of the Oral Cavity.
Animal model of human medulloblastoma: clinical, magnetic resonance imaging, and histopathological findings after intra-cisternal injection of MHH-MED-1 cells into nude rats.
Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.
Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1.
Antibodies to neuron-specific enolase for the delineation of the entire diffuse neuroendocrine system in health and disease.
Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis.
Antiproliferative and antioxidant potential of beta-ionone against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice.
Antiproliferative effects of the Ca2+/calmodulin antagonist B859-35 and the Ca(2+)-channel blocker verapamil on human lung cancer cell lines.
Aphidius ervi teratocytes release an extracellular enolase.
Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study.
Application of electron microscopic analysis and fluorescent in situ hybridization technique for the successful diagnosis of extraskeletal Ewing's sarcoma.
Are laboratory investigations recommended in current medical practice guidelines supported by available evidence?
Argyrophilic carcinoma "carcinoid tumor" of the breast: case report with electron microscopic and immunohistochemical investigations.
Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models.
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.
Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement.
Assessment of serum CYFRA 21-1 in lung cancer.
Association of folate deficiency and selected tumor marker concentrations in long-term hexavalent chromium exposed population.
Astroblastoma presenting with intracerebral hemorrhage misdiagnosed as dural arteriovenous fistula: review of a rare entity.
Astroblastoma: a case report.
Astroblastoma: electron microscopy and immunohistochemical findings: case report.
Atypical carcinoid (neuroendocrine carcinoma) of the gingiva: Counterpart of a laryngeal tumor.
Atypical carcinoid tumor of the lung with amyloid stroma.
Atypical carcinoid tumor of the lung, associated with giant-cell transformation in bone metastasis.
Atypical carcinoid tumour of the lung: a study of 33 cases with prognostic features.
Atypical primitive neuroectodermal tumors. Comparative light and electron microscopic and immunohistochemical studies on peripheral neuroepitheliomas and Ewing's sarcomas.
Atypical teratoid/rhabdoid tumor arising from the spinal cord--case report and review of the literature.
Atypical teratoid/rhabdoid tumor of lumbar spine in a toddler child.
Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma.
Auerbach's myenteric plexus. A possible site of origin for gastrointestinal stromal tumors in von Recklinghausen's neurofibromatosis.
Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide.
Autophagy sensitivity of neuroendocrine lung tumor cells.
Balloon cell melanoma in three dogs: a histopathological, immunohistochemical and ultrastructural study.
Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases.
Basic fibroblast growth factor alleviates brain injury following global ischemia reperfusion in rabbits.
Bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.
Beneficial effects of dexmedetomidine on early postoperative cognitive dysfunction in pediatric patients with tonsillectomy.
Benign clear (sugar) cell tumor of the lung with CD1a expression.
Benign oncocytic endocrine tumor of the pancreas in a patient with polyarteritis nodosa.
Benign Tumors of the Esophagus: A Histopathologic Study of 49 Cases among 931 Consecutive Esophageal Biopsies.
Bilateral cerebellar epithelioid hemangioblastoma with possible ependymal differentiation in a patient with von Hippel-Lindau disease.
Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers.
Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome.
Biological microchip for a simultaneous quantitative immunoassay of tumor markers in human serum.
Biological variation of serum neuron-specific enolase and carbohydrate antigen 724 tumor markers.
Biological variations of seven tumor markers.
Biology of small cell lung cancer: an overview.
Biomarkers along the continuum of care in lung cancer.
Biomarkers in the lung cancer diagnosis: a clinical perspective.
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study.
Black phosphorus based fiber optic biosensor for ultrasensitive cancer diagnosis.
Bombesin in human neuroendocrine (NE) neoplasms.
Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis.
Botryoid-type embryonal rhabdomyosarcoma of liver in a young cat.
Brain metastasis from small-cell neuroendocrine carcinoma of the urinary bladder: a case report.
Brain-specific proteins: solid-phase immunobioluminescence assay for neuron-specific enolase in human plasma.
Breast tumors with a solid and uniform carcinoid pattern. Ultrastructural and immunohistochemical study of two cases.
Bronchial carcinoid with paranuclear fibrillary inclusions related to cytokeratins and vimentin.
Bronchial carcinoids and phaeochromocytomas. A comparative study with special emphasis on S-100 protein, serotonin and neuron-specific enolase (NSE) immunoreactivity.
Bronchial granular cell tumor with osteopontin and osteonectin expression: a case report.
C cell adenoma of the thyroid: a rare but distinct clinical entity.
C cell hyperplasia and carcinoma developing in sheep with experimentally-induced lymphosarcoma.
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.
Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Calcium Carbonate-Gold Nanoclusters Hybrid Spheres: Synthesis and Versatile Application in Immunoassays.
Cancer-associated retinopathy 4 years after surgery for ovarian cancer.
Canine adrenocorticotropic hormone-producing sinusoidal neuroendocrine tumor associated with Cushing's disease.
Canine cutaneous spindle cell tumours with features of peripheral nerve sheath tumours: a histopathological and immunohistochemical study.
Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study.
Canine mammary minute oncocytomas with neuroendocrine differentiation associated with multifocal acinar cell oncocytic metaplasia.
Canine peripheral nerve sheath tumor with eosinophilic cytoplasmic globules.
Caprine peripheral neuroblastomas: structural and ultrastructural features, intermediate filaments profile and neuro-endocrine characterization.
Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
Carcinoid tumor in the female urethral orifice: rare case report and a review of the literature.
Carcinoid tumor of the jugulo-tympanic region.
Carcinoid tumor of the lung and type-1 multiple endocrine neoplasia associated with persistent hypercalcemia: a case report.
Carcinoid tumor of the lung: clinicopathological and immunohistochemical studies.
Carcinoid tumor of the middle ear containing serotonin and multiple peptide hormones. A case report and review of the pathology literature.
Carcinoid tumor of the middle ear. An immunohistochemical and electron microscopic study. Report of a case.
Carcinoid tumor of the Vater's papilla presenting with chronic pancreatitis--a case report--.
Carcinoid Tumors of Digestive Organs: a Clinicopathologic Study of 13 Cases.
Carcinoid tumors of the thymus. An immunohistochemical study.
Carcinoid tumour arising in a recurrent intradural spinal teratoma.
Carcinoid tumour complicating inflammatory bowel disease. A study of two cases with review of the literature.
Carcinoid tumour of the middle ear. A morphological and immunohistochemical study with comments on histogenesis and differential diagnosis.
Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors.
Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates.
Carcinoma of the nasopharynx. Histopathological examination with supplementary immunohistochemistry.
Cardiac paragangliomas. A clinicopathologic and immunohistochemical study of four cases.
Cardiac sarcoma showing bone formation and neurogenic markers: report of a case.
Case report of neuroendocrine carcinoma of the skin, histochemical and electron microscopic study.
CD34-reactive myxoid dermal dendrocytoma.
CEA producing primary hepatic carcinoid.
Cell culture of small round cell tumor originating in the thoracopulmonary region. Evidence for derivation from a primitive pluripotent cell.
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer.
Cellular neurothekeoma: detailed characterization in a series of 133 cases.
Central Nervous System Neuroblastoma in a Wild Deer (Capreolus capreolus).
Central neurocytoma--case report.
Central neurocytoma: clinico-pathological study of 5 cases and review of the literature.
Central neurocytoma: immunohistochemical and ultrastructural study.
Central neuronal tumors in childhood: relationship to dysplasia.
Central primitive neuroectodermal tumour with ependymal differentiation in a dog.
Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component.
Cerebellar metastasis from clear cell sarcoma of the kidney. A case report with immunohistochemistry.
Cerebral metastasis from an epithelioid malignant schwannoma: case report.
Cerebral neuroblastoma and pituitary adenocarcinoma in two budgerigars (Melopsittacus undulatus).
Cerebral neurocytoma without ganglion cell differentiation.
Cerebral primitive neuroectodermal tumor in an adult male. A case report.
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?
Characterization and uptake of radiolabelled meta-iodobenzylguanidine (MIBG) in a human neuroblastoma heterotransplant model in athymic rats.
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
Characterization of uterine granular cell tumors in B6C3F1 mice: a histomorphologic, immunohistochemical, and ultrastructural study.
Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.
Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
Chondrocytic differentiation of peripheral neuroectodermal tumor cell line in nude mouse xenograft.
Chordoid glioma of the third ventricle: Report of a case with cytologic features and utility during intraoperative consultation.
Chordoid glioma: clinicopathologic profile and differential diagnosis of an uncommon tumor.
Chordoma: cytologic and immunocytochemical study of four cases.
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus.
CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1.
Circulating arginine-vasopressin, calcitonin, carcinoembryonic antigen, neuron-specific enolase, and beta-2 microglobulin fluctuations during combined modality induction therapy for small-cell bronchogenic carcinoma. Association of postchemotherapy AVP surge with high tumor response rate and durable remission.
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Classification of primary hepatic tumours in the dog.
Clear cell "sugar" tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells.
Clear cell adenocarcinoma of the uterine cervix in a young pregnant woman: a case report with immunohistochemical study.
Clear cell carcinoma of the breast with immunohistochemical evidence of divergent differentiation.
Clear cell sarcoma of kidney. Two cases in adults.
Clear cell sarcoma of the esophagus: report of a case.
Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Clinical and Pathologic Study of Feline Merkel Cell Carcinoma With Immunohistochemical Characterization of Normal and Neoplastic Merkel Cells.
Clinical characteristics and prognosis of primary pancreatic carcinoid tumors: A report of 13 cases from a single institution.
Clinical Characteristics of Anti-GABA-B Receptor Encephalitis.
Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in China.
Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy.
Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
Clinical Research on Systemic Chemotherapy Combined With Bronchoscopic Seed Implantation in the Treatment of Advanced Lung Cancer.
Clinical research on the combined use of systemic chemotherapy and CT-guided radiofrequency ablation in treatment of lung cancer.
Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Clinical significance of dynamic measurements of seric TNF-?, HMGBl, and NSE levels and aEEG monitoring in neonatal asphyxia.
Clinical significance of gene amplification studied in human neuroblastoma xenografts: relationship with tumor growth rate, chemotherapeutic sensitivities and levels of neuron-specific enolase.
Clinical significance of MYCN amplification in patients with high-risk neuroblastoma.
Clinical Significance of Pretreatment FDG PET/CT in MIBG-Avid Pediatric Neuroblastoma.
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population.
Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma.
Clinical significance of serum S100 in metastatic malignant melanoma.
Clinical significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay.
Clinical use of tumor markers in childhood malignancies.
Clinical use of tumor markers in oncology.
Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.
Clinicopathologic and radiologic features of extraskeletal myxoid chondrosarcoma: a retrospective study of 40 Chinese cases with literature review.
Clinicopathological features from long-term observation of a papillary tumor of the pineal region (PTPR): a case report.
Clinicopathological studies on solid and cystic tumors of the pancreas.
Coexistence of granular cell tumor with squamous cell carcinoma on the tongue: a case report.
Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
Combined production of mucus, amines and peptides by goblet-cell carcinoids of the appendix and ileum.
Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy.
Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.
Comparative proteomic analysis of esophageal squamous cell carcinoma.
Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer.
Comparison of beta enolase and myoglobin as histological markers of rhabdomyosarcoma.
Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Comparison of the usefulness of histochemistry and ultrastructural cytochemistry in the identification of neuroendocrine neoplasms.
Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
Comparison of tumor markers using different detection devices.
Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment.
Composite carcinoid and small cell carcinoma of the duodenum.
Composite glandular-endocrine cell carcinoma of the extrahepatic bile duct: immunohistochemical study.
Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer.
Congenital epulis.
Congenital mediastinal bronchogenic cyst with malignant transformation: an autopsy report.
Consensus Diagnoses and Mode of Action for the Formation of Gastric Tumors in Rats Treated with the Chloroacetanilide Herbicides Alachlor and Butachlor.
Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements.
Control pathways of the 67 kDa laminin binding protein: surface expression and activity of a new ligand binding domain.
Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.
Correction of serum NSE reference intervals includes the unidentified hemolysis sample: 1-year data analysis from healthcare individuals.
Correction: Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.
Correlation between inflammatory response and markers of neuronal damage in coronary revascularization with and without cardiopulmonary bypass.
Correlation of changes in serum S100?, NSE and inflammatory factor levels with MMSE and MoCA in intracranial tumor patients with cognitive impairment.
Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.
Cortical versus medullary thymomas: a useful morphologic distinction?
Creatine kinase B subunit as a biomarker for small cell carcinoma of the lung: comparison with gamma-enolase.
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases.
CS5931, A Novel Marine Polypeptide, Inhibits Migration and Invasion of Cancer Cells Via Interacting with Enolase 1.
CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology.
Cushing's syndrome produced by a bronchial carcinoid tumor.
Cushing's syndrome secondary to olfactory neuroblastoma.
Cut-off levels of NSE to differentiate SCLC from NSCLC.
Cutaneous adrenal cortical carcinoma metastasis in a 6 year-old boy.
Cutaneous clear-cell granular cell tumors: the histologic description of an unusual variant.
Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma.
Cutaneous plasmacytomas in dogs: a morphologic and immunohistochemical study.
Cutaneous undifferentiated small (Merkel) cell carcinoma, that developed synchronously with multiple actinic keratoses, squamous cell carcinomas and basal cell carcinoma.
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma.
Cystic endocrine tumor of the pancreas.
Cytogenetic and molecular evaluation of clinically aggressive esthesioneuroblastoma.
Cytokeratin and laminin immunostaining in the diagnosis of cutaneous neuro-endocrine (Merkel cell) tumours.
Cytokeratin-negative desmoplastic small round cell tumor: a report of two cases emphasizing the utility of reverse transcriptase-polymerase chain reaction.
Cytologic feature by squash preparation of pineal parenchyma tumor of intermediate differentiation.
Cytological aspiration of intraocular retinoblastoma in an 11-year-old boy.
Cytomorphology and immunohistochemistry of extrarenal rhabdoid tumor: a case report with review of literature.
Cytomorphology and marker expression of malignant neuroendocrine cells in pleural effusions.
Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements.
Dbl expression driven by the neuron specific enolase promoter induces tumor formation in transgenic mice with a p53(+/-) genetic background.
Decline of serum CYFRA21-1 during chemoradiotherapy of NSCLC: a probable predictive factor for tumor response.
Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer.
Dedifferentiated leiomyosarcoma of the intestinal tract: histological, ultrastructural and immunohistochemical examinations.
Definitive chemoradiotherapy of limited-disease small cell lung cancer: Retrospective analysis of new predictive factors affecting treatment results.
Deletion of chromosome arm 1p in a Merkel cell carcinoma (MCC).
Delirium in patients with acute ischemic stroke admitted to the non-intensive stroke unit: Incidence and association between clinical features and inflammatory markers.
Demonstration of neuron-specific enolase in nonneuronal tumors using a specific monoclonal antibody.
Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas.
Dermal intravascular leiomyosarcoma in a cat.
Dermal malignant melanoma in a horse with multifocal pancytokeratin expression.
Dermatofibroma-like granular cell tumor.
Desmoplastic cerebral astrocytoma of infancy: a case report.
Desmoplastic malignant melanoma of the gingiva: case report and review of the literature.
Desmoplastic small cell tumor in the pancreas.
Desmoplastic small round cell tumors of the abdomen.
Desmoplastic small round cell tumors of the paratesticular region. A report of six cases.
Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis.
Detection of metastatic neuroblastoma in bone marrow biopsy specimens with an antibody to neuron-specific enolase.
Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
Determination of enolase isozymes in various adrenal gland tumours.
Determination of neuron-specific enolase in patients with midgut-type tumour treated with somatostatin analogues.
Determination of serum neuron-specific enolase by differential immunocapture.
Determination of three enolase isozymes and S-100 protein in various tumors in children.
Development of a radioimmunoassay for neurone specific enolase (NSE) and its application in the study of patients receiving intra hepatic arterial streptozotocin and floxuridine.
Development of prognostic models for patients with traumatic brain injury: a systematic review.
Diagnosis and management of esthesioneuroblastoma.
Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients.
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.
Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers.
Diagnostic immunohistochemistry of canine round cell tumors.
Diagnostic immunohistochemistry of neuroblastic tumors.
Diagnostic Immunostaining and Tumor Markers Predict the Prognosis of Esophageal Neuroendocrine Cell Carcinoma Patients.
Diagnostic potential of extracellular vesicle-associated microRNA-10b and tumor markers for lung adenocarcinoma.
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions.
Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions
Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis.
Diagnostic value of tumor markers Cyfra 21-1 and neuron-specific enolase in analysis of pleural fluid.
Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.
Diagnostic value of tumour markers in pleural effusions.
Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis.
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases.
Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.
Differential immunohistochemical reactions of carcinoid tumors.
Differential protein expression in honeybee (Apis mellifera L.) larvae: underlying caste differentiation.
Differential protein expression in primary breast cancer and matched axillary node metastasis.
Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
Differential proteomic profiling of chordomas and analysis of prognostic factors.
Differentiated cerebral neuroblastoma: a tumor in need of discovery.
Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Differentiation in the medulloblastoma. A histological and immunohistochemical study.
Diffuse intracranial oligodendroglioma in a cow.
Diffuse type of giant-cell tumor of tendon sheath: an ultrastructural study of two cases with cytogenetic support.
Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells.
Discovering robust protein biomarkers for disease from relative expression reversals in 2-D DIGE data.
Discovery of stage-related proteins in esophageal squamous cell carcinoma using proteomic analysis.
Disseminated liposarcoma in a dog.
Distribution of beta-enolase in normal and tumor rat cells.
Distribution of neurofilament protein and neuron-specific enolase in peripheral neuronal tumours.
Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.
DNA sequences encoding enolase are remarkably conserved from yeast to mammals.
Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
Do neuron-specific enolase levels discriminate between small-cell lung cancer and mediastinal tumors?
Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis.
Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.
Duct-islet cell tumor of the pancreas. A case report with immunohistochemical and electron microscopic findings.
Duodenal gangliocytic paraganglioma as a radiological moving defect.
Duodenal stromal tumor with neural differentiation.
Duodeno-pancreatic neuroendocrine tumours.
Dysbiosis in chronic periodontitis: Key microbial players and interactions with the human host.
Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.
Dystrophic axonal formation (spheroid body) in central neurocytoma--case report.
Early Biomarkers of Clinical-Diffusion Mismatch in Acute Ischemic Stroke.
Early clinical diagnosis of synchronous multiple primary lung cancer.
Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.
Ectopic ACTH syndrome.
Ectopic ACTH-syndrome due to ovarian carcinoma.
Ectopic thyroid tumor in a dog: thyroglobulin, calcitonin, and neuron-specific enolase immunocytochemical studies.
Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-? levels, and IL-10 mRNA, TNF-? mRNA expression levels, cerebral TGF-?1 positive expression level and its neuroprotective mechanisms in CIR rats.
Effect of diesel exhaust inhalation on blood markers of inflammation and neurotoxicity: a controlled, blinded crossover study.
Effect of electroacupuncture preconditioning on serum S100beta and NSE in patients undergoing craniocerebral tumor resection.
Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.
Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction.
Effect of Whole-Brain and Intensity-Modulated Radiotherapy on Serum Levels of miR-21 and Prognosis for Lung Cancer Metastatic to the Brain.
Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs).
Effects of acute hypercapnia on cognitive function in patients undergoing bronchoscope intervention.
Effects of dexmedetomidine on the expression of inflammatory factors in children with congenital heart disease undergoing intraoperative cardiopulmonary bypass: a randomized controlled trial.
Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice.
Effects of Three Months of Honey Supplementation on Quality of Life and Neuropathy in Type 2 Diabetic Patients.
Electrochemical Immunosensors for Sensitive Detection of Neuron-Specific Enolase Based on Small-Size Trimetallic Au@Pd^Pt Nanocubes Functionalized on Ultrathin MnO2 Nanosheets as Signal Labels.
Electron microscopic and immunohistochemical findings in a case of olfactory neuroblastoma.
Electron-immunocytochemical localization of neuron-specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells.
Electrophoretic determination of aqueous and serum neuron-specific enolase in the diagnosis of retinoblastoma.
Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon.
Elevated concentrations of gamma-enolase in renal cell tumors in rats: similarity to renal cell carcinoma in man.
Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy.
Encapsulated cystic papillary variant of medullary carcinoma of thyroid gland.
Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina.
Endocrine cell hyperplasia of the uterine cervix. A precursor of neuroendocrine carcinoma of the cervix?
Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Endocrine mucin-producing sweat gland carcinoma of the eyelid: A clinical and histological conundrum.
Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks.
Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Endolymphatic sac papillary tumor: a case report and review.
Endolymphatic sac tumor associated with a von Hippel-Lindau disease patient: an immunohistochemical study.
Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL).
ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas.
Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis.
Enolase activity and isoenzyme distribution in human brain regions and tumors.
Enolase isoenzyme distribution in the human brain and its tumours.
Enolase isoenzymes as tumour markers.
Enolase isoenzymes in benign and malignant melanocytic lesions.
Enolase isoenzymes in human cerebral metastasis.
Enolase isoenzymes in human gliomas.
Enolase isoenzymes in uveal melanomas--a possible parameter of malignancy.
Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Enolase isozymes in differentiated and undifferentiated medullary thyroid carcinomas.
Enolase isozymes in renal tubules and renal cell carcinoma.
Enolase isozymes in seminoma.
Enolase subunits in patients with neuroendocrine tumors.
Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients.
Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.
Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio.
Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Epithelial marker-negative desmoplastic small round cell tumor with atypical morphology: definitive classification by fluorescence in situ hybridization.
Epithelial Phenotype in Ewing's Sarcoma/Primitive Neuroectodermal Tumor.
Epithelioid malignant peripheral nerve sheath tumor of the uterine corpus.
Epithelioid malignant schwannoma. A study of 14 cases.
Epulis-like gingival angiosarcoma of the mandible: a case report.
Esophageal granular cell tumor: Clinical, endoscopic and histological features of 19 cases.
Esophageal pleomorphic giant cell carcinoma combined with small cell carcinoma.
Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor.
Establishment and characterization of a clonal human extraskeletal Ewing's sarcoma cell line, EES1.
Establishment and characterization of a prostatic small-cell carcinoma cell line (PSK-1) derived from a patient with Klinefelter syndrome.
Establishment and characterization of pheochromocytoma tumor models expressing different levels of trkA receptors.
Establishment and evaluation of a radioimmunoassay for neuron-specific enolase. A marker for small cell lung cancer.
Establishment and immunohistochemical characterization of an experimentally induced transplantable malignant schwannoma in the rat and two derived cell lines.
Establishment of a cell line from a neuroendocrine carcinoma of the endometrium and an invasion model.
Establishment of a human medulloblastoma cell line (BO-101) demonstrating skeletal muscle differentiation.
Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens.
Estimation of diagnostic value of chosen markers of neural differentiation in neuroblastoma group of tumors and pPNETs.
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis.
Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.
Evaluation of gamma-enolase as a tumor marker for lung cancer.
Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Evaluation of laboratory data by conventional statistics and by three types of neural networks.
Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: a preliminary report.
Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor").
Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone.
EWSR1(22q12) Translocation Positive Pediatric Adrenal Tumor with Loss of 1p, 11q, and Unbalanced Gain of 17q: Neuroblastoma or Ewing Sarcoma?
Ex vivo-expanded donor CD4(+) lymphocyte infusion against relapsing neuroblastoma: A transient graft-versus-tumor effect.
Exercise-induced changes in neurotrophic factors and markers of blood-brain barrier permeability are moderated by weight status in multiple sclerosis.
Exosome-derived ENO1 regulates integrin ?6?4 expression and promotes hepatocellular carcinoma growth and metastasis.
Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.
Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.
Exploration and analysis of the value of tumor-marker joint detection in the pathological type of lung cancer.
Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells.
Expression of a new set of glycolytic isozymes in activated human peripheral lymphocytes.
Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Expression of brain-derived neurotrophic factor and tropomyosin-related kinase-B in a bovine jejunal nodular ganglioneuroblastoma.
Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma.
Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in Mucinous Bronchioloalveolar Adenocarcinoma After Hodgkin Lymphoma.
Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines.
Expression of hydroxyindole-O-methyltransferase enzyme in the human central nervous system and in pineal parenchymal cell tumors.
Expression of N-myc downstream regulated gene 1 (NDRG1) in central neurocytoma.
Expression of Neuroectodermal Markers in Atypical Fibromas in Two Dwarf Hamsters (Phodopus spp.).
Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Expression of neurofilament and neuron-specific enolase in small cell tumors of skin using immunohistochemistry.
Expression of neuron-specific enolase in multiple myeloma and implications for clinical diagnosis and treatment.
Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis.
Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.
Extragastrointestinal stromal tumor of the retroperitoneum mimicking kidney tumor.
Extrapleural solitary fibrous tumor: a report of seven cases.
Extrapulmonary small cell carcinoma of the liver: clinicopathological and immunohistochemical findings.
Extrarenal rhabdoid sarcoma.
Extraskeletal Ewing's sarcoma with cutaneous involvement.
Extraskeletal myxoid chondrosarcoma with systemic metastasis in a five-month-old irish setter dog.
Extraventricular neurocytoma of the spinal cord in a dog.
Eyelid basal cell carcinoma with neuroendocrine differentiation: a case report and literature review.
Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis.
FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.
Feline cutaneous neuroendocrine carcinoma (Merkel cell tumour): clinical and pathological findings.
Fine needle aspiration biopsy of pediatric orbital tumors. An immunocytochemical study.
Fine needle aspiration cytology of neuroblastoma, including peripheral neuroectodermal tumor, with immunocytochemical and ultrastructural confirmation.
Fine-needle aspiration cytology of pulmonary adenocarcinoma of fetal type: report of a case with immunohistochemical and ultrastructural studies.
First Case Report of a Sporadic Adrenocortical Carcinoma With Gastric Metastasis and a Synchronous Gastrointestinal Stromal Tumor of the Stomach.
Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.
Footpad peripheral ganglioneuroblastoma in a dog.
For which cancer types can neuron-specific enolase be clinically helpful in Turkish patients?
Four-year clinical and neuroradiological follow-up of a papillary tumor of the pineal region.
Frequency-dependent alterations in enolase activity in Escherichia coli caused by exposure to electric and magnetic fields.
Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
Fulminant Buddchiari syndrome caused by renal primitive neuroectodermal tumor with inferior vena cava thrombus extending to atrium.
Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer.
Gamma-enolase activity in choroidal melanoma.
Gamma-enolase and glial fibrillary acidic protein in nervous system tumors. An immunohistochemical study using specific monoclonal antibodies.
Gamma-enolase: a well-known tumour marker, with a less-known role in cancer.
Gangliocytoma with immature neuronal cell elements in the pituitary of a rat.
Ganglioglioma of the brain stem: neurological dysfunction of 16-year duration.
Ganglion cells in Ewing's sarcoma following chemotherapy: a case report.
Gastric carcinoid tumour. A clinicopathologic and immunohistochemical study of four cases.
Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?
Gastric small cell carcinoma with squamous and neuroendocrine differentiation.
Gastric submucosal tumours of neurogenic origin with neuroaxonal and Schwann cell elements.
Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.
Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Gastrointestinal autonomic nerve tumor (plexosarcoma): report of a case with fine needle aspiration biopsy and histologic, immunocytochemical and ultrastructural study.
Gastrointestinal autonomic nerve tumor of the esophagus. A clinicopathologic, immunohistochemical, ultrastructural study of a case and review of the literature.
Gastrointestinal autonomic nerve tumor of the jejunum. Case report and review of the literature.
Gastrointestinal autonomic nerve tumor presenting as high-grade sarcoma. Case report and review of the literature.
Gastrointestinal autonomic nerve tumor with giant abscess. A case report and literature review.
Gastrointestinal autonomic nerve tumor.
Gastrointestinal autonomic nerve tumor: a case report with electron microscopic and immunohistochemical analysis and review of the literature.
Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'.
Gastrointestinal autonomic nerve tumours: a case report with ultrastructural and immunohistochemical studies.
Gastrointestinal stromal tumors in equids.
Gastrointestinal stromal tumors of the equine cecum.
Gastrointestinal stromal tumour of the rectum.
Gastrointestinal stromal tumours: evaluation of biological and clinical current opinions.
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes.
Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials.
Giant cell tumor of tendon sheath. An immunohistochemical study of 28 cases.
Giant cell tumor of the pancreas of mixed osteoclastic and pleomorphic cell type: evidence for a histogenetic relationship and mesenchymal differentiation.
Giant pigmented tumour of the scalp--a diffuse neurofibroma or a congenital naevus showing neurofibromatous changes? Immunohistochemical and electron microscopic studies.
Gingival granular cell myoblastoma in newborns. Report of two cases.
Glucagonoma in a jaguar (Panthera onca).
Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.
Glycolytic enzyme activities in breast cancer metastases.
Goblet cell carcinoid arising in a mature teratoma of the mediastinum.
Goblet cell carcinoid of the appendix: Investigation of the expression of beta-catenin and E-cadherin.
Granular cell tumor expressing myogenic markers in the prostate.
Granular cell tumor occurring in the sigmoid colon treated by endoscopic mucosal resection using a transparent cap (EMR-C).
Granular cell tumor of colon: report of a case and review of literature.
Granular cell tumor of the cecum with extensive hyalinization and calcification: a case report.
Granular cell tumor of the pancreas: A case report and review of literature.
Granular cell tumor of the rectum: a case report and review of the literature.
Granular cell tumor of the urethra.
Granular cell tumor of the urinary bladder.
Granular cell tumor: an immunohistochemical study.
Granular cell tumors: evidence for heterogeneous tumor cell differentiation. An immunocytochemical study.
Granular cell tumours of the lower respiratory tract.
Gross, histologic, cytochemical, and immunocytochemical study of medullary thyroid carcinoma in sixteen dogs.
Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: an analysis of 310 reported cases.
Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function.
Hepatoblastoma in a dog.
Hepatocellular carcinoma with an unusual neuroendocrine component.
Herbal formula FBD extracts prevented brain injury and inflammation induced by cerebral ischemia-reperfusion.
Heterogeneity and multiple expression of intermediate filament proteins, S-100 protein and neuron specific enolase in skin mixed tumor.
Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer.
Heterogeneity of so-called neuroendocrine lung tumors.
Heterotransplantation of argyrophil small cell carcinoma of the uterine cervix integrating HPV16 DNA into nude mice.
hGH and GHR Expression in Large Cell Neuroendocrine Carcinoma of the Colon and Rectum.
HIF-1alpha Modulates Energy Metabolism in Cancer Cells by Inducing Over-expression of Specific Glycolytic Isoforms.
HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays.
Histochemical and ultrastructural characterization of primary cardiac chondrosarcoma.
Histochemical studies of dense-core granulated tumors of the lung. Neuron-specific enolase as a marker for granulated cells.
Histogenesis and cell lineage analysis of medulloblastomas.
Histogenesis and differentiation potential of central neurocytomas.
Histogenesis and possible mechanism of chondroid changes in mixed tumour of the skin: immunohistochemical evaluation of bone morphogenetic protein, glycosaminoglycans, keratin, vimentin and neuronal markers.
Histogenesis of alveolar soft part sarcoma. An immunohistochemical and biochemical study.
Histogenesis of haemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome.
Histologic and immunohistochemical investigation of neuroblastomas and correlation with prognosis.
Histologic and immunohistochemical studies of granular cell tumors in seven dogs, three cats, one horse, and one bird.
Histological and immunohistochemical study of 30 cases of canine meningioma.
Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report.
Histological, immunohistochemical, and ultrastructural features of a rat medullary thyroid carcinoma transfected with a corticotropin-releasing hormone cDNA expression vector.
Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution.
Histopathologic study of the rectum in 1,464 consecutive rectal specimens in a single Japanese hospital: II. malignant lesions.
Histopathological and immuno-histochemical characteristics of primary renal primitive neuroectodermal tumor.
Histopathological and Immunohistochemical Evaluation of Malignant Potential in Canine Aortic Body Tumours.
Histopathological features and clinical course of the gastrointestinal stromal tumors.
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
How to express tumor markers in bronchoalveolar lavage.
Huge endocrine tumor of the pancreas.
Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.
Human gamma enolase: isolation of a cDNA clone and expression in normal and tumor tissues of human origin.
Hyalinizing spindle cell tumor with giant rosettes: a report of three cases with ultrastructural analysis.
Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies.
Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland.
Hydrogen water reduces NSE, IL-6, and TNF-? levels in hypoxic-ischemic encephalopathy.
Hyperthermia in a pediatric patient with neuroblastoma during anesthesia: a case report.
Hypoglycemia and seizures associated with canine primary hepatic neuroendocrine carcinoma.
Hypoxia induces differential translation of enolase/MBP-1.
Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside binding lectin.
Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics.
Identification of hypoxia-responsive messengers expressed in human microvascular endothelial cells using differential display RT-PCR.
Identity and pathogenesis of stomach tumors in Sprague-Dawley rats associated with the dietary administration of butachlor.
Imaging features of granular cell tumor in the breast: Case report.
Immature Chondroid Choristoma: Clinicopathologic, Immunohistochemical, and Molecular Study of an Unusual Benign Skin Tumor.
Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small cell lung cancer: clinical evaluation and biological hypothesis.
Immunoassay of three enolase isozymes in human serum and in blood cells.
Immunochemical and ultrastructural studies of an ovarian strumal carcinoid.
Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Immunocytochemical demonstration of neuron-specific enolase for differential diagnosis of retroperitoneal tumours in children.
Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.
Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas.
Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor.
Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
Immunocytochemical reactivity of breast cancer tissue with antibodies to neuron-specific enolase and an adenocarcinoma-associated glycolipid antigen.
Immunocytochemical study of 18 tumours causing ectopic Cushing's syndrome.
Immunocytochemistry of canine thyroid tumors.
Immunocytochemistry of neuronal and glial markers in retinoblastoma.
Immunohistochemical analysis of a primary ovarian leiomyosarcoma. Case report.
Immunohistochemical analysis of diethylstilbestrol-induced renal tumors in adult male Syrian hamsters: evidence for relationship to peripheral nerve sheath tumors.
Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Immunohistochemical and cytogenetic findings in malignant rhabdoid tumor.
Immunohistochemical and electron microscopy studies of a case of hyalinizing trabecular tumor of the thyroid gland, with special consideration of the hyalinizing mass associated with it.
Immunohistochemical and flow cytometric study of neuroendocrine carcinoma of the skin.
Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Immunohistochemical and ultrastructural investigation of granular cell tumours in dog, cat, and horse.
Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma.
Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas.
Immunohistochemical characterisation of a case of insular thyroid carcinoma.
Immunohistochemical characteristics of canine aortic and carotid body tumours.
Immunohistochemical characterization of endocrine cells in experimental exocrine pancreatic cancer in the Syrian golden hamster.
Immunohistochemical Characterization of Nonhuman Primate Ovarian sex Cord-Stromal Tumors.
Immunohistochemical demonstration of neuron-specific enolase in gynecologic malignant tumors.
Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.
Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms.
Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
Immunohistochemical distinction of classic and chondroid chordomas.
Immunohistochemical evaluation of a malignant intestinal carcinoid in a dog.
Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
Immunohistochemical expression patterns of S100, synaptophysin, chromogranin A and neuron specific enolase in predicting malignant behaviour in paragangliomas.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Immunohistochemical localization of gamma-enolase in early human embryos.
Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.
Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
Immunohistochemical markers in (ganglio)neuroblastomas.
Immunohistochemical observation of S-100 protein and neuron specific enolase in the tumour cells of granular cell tumour.
Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomas.
Immunohistochemical Profile of Urothelial and Small Cell Carcinomas of the Bladder.
Immunohistochemical staining of granular cell tumour for neurone specific enolase: evidence in support of a neural origin.
Immunohistochemical staining patterns of canine meningiomas and correlation with published immunophenotypes.
Immunohistochemical staining techniques of intraocular tumors.
Immunohistochemical studies of Merkel cell carcinoma of the eyelid.
Immunohistochemical studies of retinoblastoma.
Immunohistochemical study of a case of malignant müllerian mixed tumor in comparison with the activity of normal uterine tissue.
Immunohistochemical study of a non-invasive canine thymoma: a case report.
Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody.
Immunohistochemical study of granular cell tumors of the neurohypophysis.
Immunohistochemical study of granular cell tumours. Demonstration of neurone specific enolase, S 100 protein, laminin and alpha-1-antichymotrypsin.
Immunohistochemical study of neuron specific enolase expression in salivary-gland tumors.
Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Immunohistochemistry of ultimobranchial thyroid carcinomas in seven slaughtered cows and one bull.
Immunohistological studies on neoplasms of female and male Onchocerca volvulus: filarial origin and absence of Wolbachia from tumor cells.
Immunopathological study of neuropeptide expression in human salivary gland neoplasms.
Immunophenotype of the canine transmissible venereal tumour.
Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response.
Immunoradiometric and immunohistochemical demonstration of neuron-specific enolase in experimental rat gliomas.
Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma-in-situ.
Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Immunoreactivity of bovine schwannomas.
Immunostaining of neuron-specific enolase as a diagnostic tool for Merkel cell tumors.
Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
Impact of chronic kidney disease on serum tumor markers concentrations.
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma.
Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells.
Improved screen-printed carbon electrode for multiplexed label-free amperometric immuniosensor: Addressing its conductivity and reproducibility challenges.
Improvement of enzyme-linked immunosorbent assay for the multicolor detection of biomarkers.
Incidental cystic endocrine tumor of the pancreas: A case report with immunohistochemical study.
Increased expression of alpha-enolase in c-jun transformed rat fibroblasts without increased activation of plasminogen.
Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Increased neuron specific enolase expression by urothelial cells exposed to or malignantly transformed by exposure to Cd²? or As³?.
Increased plasma concentrations of tumour markers in the absence of neoplasia.
Increases in tumor markers are associated with primary Sjögren's syndrome-associated interstitial lung disease.
Inhibiting enolase eradicates tumours.
Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.
Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1.
Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells.
Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
Intestinal clear cell sarcoma with melanocytic differentiation and EWS [corrected] rearrangement: report of a case.
Intra-abdominal mass aspirate from an alopecic dog.
Intra-abdominal polyphenotypic tumor.
Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma.
Intra-epithelial neuroendocrine carcinoma of the nasal cavity.
Intracranial Ewing sarcoma/'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation.
Intracranial meningeal melanocytoma: case report.
Intradural, extramedullary spinal cord granular cell tumor: A case report and clinicopathologic review of the literature.
Intraosseous malignant peripheral nerve sheath tumor. Report of a case and review of the literature.
Intraosseous schwannoma of rib.
Intrapulmonary neurofibroma independent of neurofibromatosis type 1.
Intrathoracic extraskeletal Ewing's sarcoma: a case report and review of literature.
Intratubular spermatocytic seminomas in 2 sprague-dawley rats.
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Invasive giant cell astrocytoma of the retina in a patient with tuberous sclerosis.
Inverse expression of two laminin binding proteins, 67LR and galectin-3, correlates with the invasive phenotype of trophoblastic tissue.
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Invisible hemolysis in serum samples interferes in NSE measurement.
Iron deficiency in children at the time of initial neuroblastoma diagnosis.
Is esthesioneuroblastoma a peripheral neuroectodermal tumor?
Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Is Ovarian Tissue Transplantation Safe in Patients with Central Nervous System Primitive Neuroectodermal Tumors?
Is there an Additional Value of Somatostatin Receptor Subtype 2A Immunohistochemistry over Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
Isoenzyme pattern of enolase in human lung tumor xenografts in nude mice.
Isoenzyme pattern of enolase in the diagnosis of neuroendocrine bronchopulmonary tumors.
Isolated carcinoid tumor metastatic to the thyroid gland: report of a case initially diagnosed by fine needle aspiration cytology.
Isozyme pattern of enolase of childhood tumors.
Laminin receptor in lymph node negative breast carcinoma.
Laparoscopic resection of urinary bladder paraganglioma: a case report.
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Large Cell Calcifying Sertoli Cell Tumour of Testis-A Rare Case Report.
Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
Large cell neuroendocrine carcinoma of the thymus.
Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity.
Large-cell neuroendocrine carcinoma of the ampulla of Vater.
Leiomyoma exhibiting a marked granular change: granular cell leiomyoma versus granular cell schwannoma.
Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients.
Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity.
Lipomatous differentiation in a medulloblastoma.
Lipomatous differentiation in ependymomas: a report of three cases and comparison with similar changes reported in other central nervous system neoplasms of neuroectodermal origin.
lncRNA RNCR2 facilitates cell proliferation and epithelial-mesenchymal transition in melanoma through HK2-mediated Warburg effect via targeting miR-495-3p.
LOC285629 regulates cell proliferation and motility in colorectal cancer cells.
Localized malignant mesothelioma of the pleura.
Low PSA metastatic androgen- independent prostate cancer.
Low-grade cribriform ductal carcinoma in situ of the breast. Fine needle aspiration cytology in three cases.
Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: a histological, immunohistochemical and ultrastructural study.
Low?dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats.
Lymphoepithelioma-like carcinoma originating on the eyelid.
Malignant aortic body tumor in a Holstein cow.
Malignant cauda equina paraganglioma in a cat.
Malignant chondroid syringoma with bone invasion: a case report and review of the literature.
Malignant female adnexal tumor of Wolffian origin (FATWO) positive for CD56: a possible diagnostic role for the biomarker.
Malignant fibrous histiocytoma masquerading as germ cell tumor by producing beta-human chorionic gonadotropin and neuron-specific enolase.
Malignant glomus tumor of the foot with obvious neuroendocrine differentiation: a case report with immunohistochemical studies.
Malignant granular cell tumor: a case report and review of the recent literature.
Malignant granular cell tumor: report of a case and review of the literature.
Malignant granular cell tumour of the cervical sympathetic nerve trunk.
Malignant intestinal schwannoma: a case report and a review of the literature in Japan.
Malignant intraductal oncocytic papillary neoplasm of the common bile duct.
Malignant melanoma and adenocarcinoma of a Barrett oesophagus.
Malignant melanotic neuroectodermal tumor arising from the pineal body.
Malignant Merkel cell neoplasm of the eyelid.
Malignant mixed sex cord-stromal tumour in a stallion.
Malignant non-teratoid medulloepithelioma of ciliary body with retinoblastic differentiation: a case report and review of literature.
Malignant pancreatic oncocytoma. An unusual cause of organic hypoglycemia.
Malignant paraganglioma of the organ of Zuckerkandl. Initially diagnosed as renal cell carcinoma by biopsy of a right humeral fracture lesion.
Malignant peripheral nerve sheath tumor as a cause of chronic cardiac insufficiency in cattle.
Malignant peripheral nerve sheath tumor in a hamster.
Malignant peripheral nerve sheath tumor of the breast: case report.
Malignant peripheral nerve sheath tumor of the lower labial mucosa: case report and literature review.
Malignant peripheral neuroectodermal tumors in urology.
Malignant retroperitoneal paraganglial tumour in a cow.
Malignant rhabdoid skin tumor: an uncommon primary skin neoplasm. Ultrastructural and immunohistochemical analysis.
Malignant Round Cell Neoplasia in Llamas and Alpacas.
Malignant round cell neoplasia in llamas and alpacas.
Malignant schwannoma of the esophagus with lymph node metastasis: literature review of schwannoma of the esophagus.
Malignant sertoli cell tumor in a goose (Anser cygnoides domesticus).
Malignant Sertoli cell tumor of the ovary metastatic to the lung mimicking neuroendocrine carcinoma: report of a case.
Malignant somatostatinoma presenting with diabetic ketoacidosis.
MaMi, a human endometrial stromal sarcoma cell line that constitutively produces interleukin-6, interleukin-8, and monocyte chemoattractant protein-1.
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.
Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseases.
Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
Mediastinal malignant carcinoid with Cushing's syndrome: immunohistochemical and ultrastructural study.
Medullary carcinoma of the thyroid gland: an immunocytochemical study.
Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
Medulloepithelioma of the uterus in an infant with clonal +del (2)(q11.2),-13: A possible role of increased gene dosage on 2pter-2q11.2 in the tumorigenesis.
Melanin-producing medullary thyroid carcinoma with glandular differentiation.
Melanocytic neuroendocrine carcinoma of the thymus.
Melanotic Neuroectodermal Tumor of Infancy Arising in the Temporal Bone.
Melanotic neuroectodermal tumor of infancy occurring in the left thigh of a 6-month-old female infant.
Melanotic neuroectodermal tumor of infancy. Clinicopathological, immunohistochemical, and flow cytometric study.
Melanotic paraganglioma of the posterior mediastinum.
Meningeal melanocytoma extruded from the skull of a neonate--case report.
Meningothelial meningioma in a Malayan sun bear (Helarctos malayanus).
Merkel Cell Carcinoma in a Steer.
Merkel cell carcinoma with an unusual immunohistochemical profile.
Merkel cell carcinoma within follicular cysts: report of two cases.
Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning.
Merkel cell carcinoma.
Merkel cell carcinoma: a distinct lesion of the eyelid.
Merkel cell tumor in a trichilemmal cyst: collision or association?
Merkel cell tumor.
Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene.
Merkel's cell (neuroendocrine) carcinoma of the vulva.
Mesenchymal Chondrosarcoma: A Small Cell Neoplasm with Polyphenotypic Differentiation.
Metastasizing neuroendocrine carcinoma of the larynx with calcitonin and somatostatin secretion and CEA production, resembling medullary thyroid carcinoma.
Metastatic Extra-Adrenal Sympathetic Paraganglioma in a Horse.
Metastatic Hepatocellular Carcinoma of Skin Diagnosed With Hepatocyte Paraffin 1 and a-Fetoprotein Immunostainings.
Metastatic iridociliary adenocarcinoma in a labrador retriever.
Metastatic Melanomas in Young Broiler Chickens (Gallus gallus domesticus).
Metastatic subcutaneous sarcoma and abdominal carcinoma in a peach-faced lovebird (Agapornis roseicollis).
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells.
Middle ear adenoma. A tumor displaying mucinous and neuroendocrine differentiation.
Middle ear adenoma/carcinoid tumour: a case report and review of the literature.
Mixed acinar-endocrine carcinoma of the pancreas--a case report.
Mixed apocrine sweat gland tumor of the tail in a cow.
Mixed neuronal-glial tumor of the digestive tract: distinctive entity from gastrointestinal stromal tumor?
Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
Molecular and immunohistochemical profile of a basaloid (cloacogenic) carcinoma of the sigmoid colon: possible predictive value for clinical outcomes.
Molecular genetic, cytogenetic, and immunohistochemical characterization of alveolar soft-part sarcoma. Implications for cell of origin.
Molecular mechanisms of therapeutic hypothermia on neurological function in a swine model of cardiopulmonary resuscitation.
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases.
Morphological and immunohistochemical characterization of granular cells in non-hypophyseal tumours of the central nervous system.
Motilin-producing liver and bone metastases evidenced 14 years after resection of a rectal polyp.
Mouth metastasis of peripheral primitive neuroectodermal tumor.
Mucinous adenocarcinoma of the prostate.
Mucinous adenocarcinoma with neuroendocrine differentiation of the mandibular ramus: report of a case.
Mucinous tubular and spindle cell carcinoma of the kidney with neuroendocrine differentiation: report of two cases.
Mucoepidermoid carcinoma of the thyroid gland.
Multi-Biomarker Detection Following Traumatic Brain Injury.
Multicentric epithelioid angiosarcoma of bone.
Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates.
Multidisciplinary approach in diagnosis of lung carcinoma.
Multiple cutaneous granular cell tumors in childhood.
Multiple forms of enolase (E.C. 4.2.1.11): their distribution in human tissues.
Multiple Glucagon-Producing Pancreatic Neuroendocrine Tumors in a Horse (Equus caballus).
Multiple isolated cutaneous plexiform schwannomas.
Multiple liver metastases of pancreatic solid pseudopapillary tumor treated with resection following chemotherapy and transcatheter arterial embolization: A case report.
Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
Multiple osseous metastases of a carotid body tumor in a dog.
Multiple peptide production and presence of general neuroendocrine markers detected in 12 cases of human phaeochromocytoma and in mammalian adrenal glands.
Multiple small intestinal stromal tumors with skeinoid fibers in association with neurofibromatosis 1 (von Recklinghausen's disease).
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
N-myc amplification and neuron-specific enolase production of a neuroblastoma cell line and germ cell tumor cell lines.
N-myc gene amplification and neuron specific enolase production in immature teratomas.
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
N-myc oncogene expression in histopathologically unrelated bilateral pediatric renal tumors.
Nasal myoepithelioma removed through endonasal endoscopic surgery: a case report.
Nasal oncocytoma in a domestic shorthair cat.
Nasal Polyp - An Incidental Paraganglioma.
Nasopharyngeal neuroendocrine carcinoma: a case report.
Negative neuron-specific enolase immunostain in intracranial germinomas: a finding against the existence of a tumor of pineal parenchymal-cell origin with histological features of germinoma?
Nephroblastoma with neuroendocrine differentiation.
Nerve contact with muscle component in neuromuscular hamartoma.
Nerve sheath myxoma of the tongue in a child.
Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases.
Neural granular cell tumor. A case report.
Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
Neuroblastoma in adults. Pathologic findings and clinical outcome.
Neuroblastoma of parotid gland: report of a case and immunohistochemical characteristics.
Neuroblastoma presenting as acute lymphoblastic leukemia but correctly diagnosed after orbital fine-needle aspiration biopsy.
Neurocytoma of spinal cord.
Neurocytoma of the pituitary gland: A case report and literature review.
Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior.
Neuroectodermal tumor of bone. Evidence for neural differentiation in a cultured cell line.
Neuroendocrine (Merkel cell) carcinoma of the skin: a clinico-morphological study of 13 cases.
Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component.
Neuroendocrine (Merkel cell) tumor of the skin: fine-needle aspiration cytology, histology, electron microscopy and immunohistochemistry of 12 cases.
Neuroendocrine apendicopathy in morphologically normal appendices of patients with diagnosis of acute appendicitis: Diagnostic study.
Neuroendocrine breast cancer.
Neuroendocrine carcinoma of skin with simultaneous cytokeratin expression.
Neuroendocrine carcinoma of the breast with Merkel cell carcinoma-like features.
Neuroendocrine carcinoma of the breast: a case report of pure type.
Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases.
Neuroendocrine carcinoma of the esophagus: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
Neuroendocrine carcinoma of the extrahepatic biliary tract with positive immunostaining for gastrin-releasing peptide: report of a case.
Neuroendocrine carcinoma of the larynx.
Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature.
Neuroendocrine carcinoma of the liver: an autopsy case.
Neuroendocrine Carcinoma of the Mammary Gland in a Dog.
Neuroendocrine carcinoma of the oral cavity.
Neuroendocrine carcinoma of the pancreas diagnosed by aspiration cytology. A case report.
Neuroendocrine carcinoma of the pancreas with soft tissue metastasis.
Neuroendocrine carcinoma of the posterior mediastinum: a possible primary lesion.
Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature.
Neuroendocrine carcinomas of the breast.
Neuroendocrine carcinomas of the colon and rectum.
Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation.
Neuroendocrine cells in tumour growth of the prostate.
Neuroendocrine characteristics of human Leydig cell tumours.
Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
Neuroendocrine differentiation in colorectal carcinomas.
Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Neuroendocrine differentiation in human gastric carcinoma.
Neuroendocrine differentiation in prostatic carcinoma.
Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
Neuroendocrine differentiation is a common feature of thymic carcinoma.
Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours.
Neuroendocrine marker expression in cervical carcinomas of non-small cell type.
Neuroendocrine markers in paragangliomas of the head and neck.
Neuroendocrine markers; chromogranin, pancreastatin and serotonin in the management of patients with advanced renal cell carcinoma.
Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants.
Neuroendocrine neoplasms of the larynx.
Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes.
Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples.
Neuroendocrine tumor markers.
Neuroendocrine tumours metastatic to the uvea: diagnosis by fine needle aspiration biopsy.
Neurofilament immunoreactivity in Merkel-cell tumors: a differentiating feature from small-cell carcinoma.
Neuron specific enolase demonstration in the diagnosis of a solid-cystic (papillary cystic) tumour of the pancreas.
Neuron specific enolase expression in carcinoma of the lung.
Neuron specific enolase promotes tumor metastasis by activating the Wnt/?-catenin pathway in small cell lung cancer.
Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.
Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.
Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
Neuron-specific enolase (NSE) serum level in non small cell lung cancer--can it be an indicator of tumour chemosensitivity?
Neuron-specific enolase and its mRNA are highly expressed in large congenital nevi: a study using immunocytochemistry, biochemical assay, and in situ hybridization.
Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's sarcoma in bone and soft tissue.
Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.
Neuron-specific enolase as a differential marker in a case of retroperitoneal tumour.
Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma.
Neuron-specific enolase as a tumor marker in metastatic melanoma.
Neuron-specific enolase concentrations in serum in benign liver diseases.
Neuron-specific enolase correlates to laboratory markers of haemolysis in patients on long-term circulatory support†
Neuron-specific enolase expression and neuroendocrine differentiation in carcinomas of the breast.
Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker.
Neuron-specific enolase in neuroblastoma and other pediatric tumors: a comparative nude mouse and clinical investigation.
Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
Neuron-specific enolase in retinoblastoma. An immunohistochemical study.
Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
Neuron-specific enolase in the diagnosis and therapy monitoring of lung cancer: a comparison with CEA, TPA, ferritin and calcitonin.
Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children.
Neuron-specific enolase in the pituitary gland.
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients.
Neuron-specific enolase reactivity in hyperplasias and neoplasms of the thyroid.
Neuron-specific enolase reflects metabolic activity in mesencephalic neurons of the rat.
Neuron-specific enolase--a serum tumour marker in seminoma?
Neuron-specific enolase-producing epithelioid leiomyosarcoma with gross vascular invasion and intracardiac involvement.
Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung.
Neuron-specific enolase: a serum tumor marker in malignant germ-cell tumors?
Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
Neuron-specific enolase: how useful as a cancer marker?
Neuron-specific gamma-enolase derived from human glioma.
Neuronal and glial markers in tumours of neuroblastic origin.
Neuronal and glial properties of a murine transgenic retinoblastoma model.
Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Neurotropic melanoma of the face invading the maxillary nerve.
Newly established uterine cervical carcinoma cell line with co-amplification of human papillomavirus DNA and c-myc gene.
No Evidence of Antibodies against GAD65 and Other Specific Antigens in Children with Autism.
Non-functional C-cell adenoma in aged horses.
Non-functional malignant paraganglioma of the stomach.
Non-functioning Well Differentiated Endocrine Carcinoma of the Pancreas.
Non-neural granular cell tumor of the uterine corpus mimicking uterine leiomyoma: A case report.
Nonfunctioning malignant neuroendocrine tumors of the pancreas.
Nonpulmonary small cell carcinomas of extragenital origin metastatic to the ovary.
Noradrenalin-secreting retroperitoneal schwannoma resected by hand-assisted laparoscopic surgery: report of a case.
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Novel Germ Line Mutation p53-P177R in Adult Adrenocortical Carcinoma Producing Neuron-specific Enolase as a Possible Marker.
NSE can predict the sensitivity to definitive chemoradiotherapy of small cell carcinoma of esophagus.
Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.
Oat cell carcinoma of the gallbladder. A rare and highly lethal neoplasm.
Oat cell carcinoma of the urinary tract. An immunohistochemical and electron microscopic study.
Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
Occurrence of Pineal Gland Tumors in Combined Chronic Toxicity/Carcinogenicity Studies in Wistar Rats.
Olfactory neuroblastoma. Additional immunohistochemical characterization.
Olfactory neuroblastoma: clinical and pathological aspects.
Olfactory neuroepithelioma arising from the olfactory placode.
Oligodendroglioma arising in an immature ovarian teratoma: case report.
Oligodendroglioma with Neuronal Differentiation in Two Boxer Dogs.
Omental leiomyoma in a male adult horse.
Oncocytic Adrenocortical Carcinoma in a Putty-nosed Monkey (Cercopithecus nictitans) with Hyperadrenocorticism.
Oncocytic adrenocortical carcinoma.
Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature.
Oncocytic carcinoid of the nasal cavity and carcinoid of the lung in a child.
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Oral granular cell tumours: a histological and immunocytochemical study.
Oral nerve sheath myxoma. Report of a case with findings of ultrastructural and immunohistochemical studies.
Ossifying fibromyxoid tumor of soft parts. Report of a rare tumor in Kuwait.
Ossifying fibromyxoid tumor of soft parts: clinicopathologic, immunohistochemical and ultrastructural study of four cases.
Ossifying fibromyxoid tumor of soft parts: report of a case with novel cytogenetic findings.
Ossifying fibromyxoid tumor of the retroperitoneum.
Ossifying fibromyxoid tumour (of soft parts) of the head and neck: a clinicopathological and immunohistochemical study of nine cases.
Ossifying gastric carcinoid tumor containing bone morphogenetic protein, osteopontin and osteonectin.
Ossifying subcutaneous tumor with myofibroblastic differentiation: a variant of ossifying fibromyxoid tumor of soft parts?
Osteosarcomatous changes in malignant melanoma. Immunohistochemical and ultrastructural studies of a case.
Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study.
Ovarian female adnexal tumor of probable Wolffian origin?-?Case report.
Ovarian myxoma: clinicopathologic and immunocytologic analysis of five cases and a review of the literature.
Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Ovarian strumal carcinoid in association with multiple endocrine neoplasia, type IIA.
Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis.
Oxyphil and squamous variants of medullary thyroid carcinoma.
p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.
Paget's disease of the esophagus.
Palliative treatment efficacy of glucose inhibition combined with chemotherapy for non-small cell lung cancer with widespread bone and brain metastases: A case report.
Pancreatic analogue solid pseudopapillary neoplasm arising in the paratesticular location. The first case report.
Pancreatic endocrine tumor admixed with a diffuse microcystic adenoma--a case report.
Pancreatic endocrine tumor with signet ring cell features: a case report with novel ultrastructural observations.
Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature.
Pancreatic exocrine carcinoma producing adrenocorticotropic hormone.
Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
Pancreatic polypeptide-immunoreactive gallbladder carcinoid tumor.
Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
Pancreatoblastoma: a histochemical and immunohistochemical analysis.
Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
Papillary cystadenocarcinoma of salivary-glands - an immunohistochemical study.
Papillary cystic tumor of the pancreas. An analysis of cellular differentiation by electron microscopy and immunohistochemistry.
Papillary cystic tumor of the pancreas: an immunohistochemical and ultrastructural study of 14 patients.
Papillary tumor of pineal region presenting with leptomeningeal seeding.
Papillary tumor of the pineal region.
Paraganglioma of the cauda equina region. Clinicopathologic study of 31 cases with special reference to immunocytology and ultrastructure.
Paraganglioma of the cauda equina. A case report and review of the literature.
Paraganglioma of the cauda equina: a histological, ultrastructural and immunocytochemical study of two cases with a review of the literature.
Paraganglioma of the mesenterium: a case report.
Paraganglioma of the palatine tonsil.
Paraganglioma of the prostatic urethra. A report of three cases and a review of the literature.
Paraganglioma of the urinary bladder.
Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
Paraganglioma-Like Adenomas of the Thyroid (PLAT): Incidental Lesions with Unusual Features in a Patient with Nodular Goiter.
Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuro-endocrine carcinomas.
Paranuclear blue inclusions of small cell carcinoma of the stomach: report of a case with cytologic presentation in peritoneal washings.
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Pathologic and immunohistochemical findings in a feline aortic body tumor.
Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies.
Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study.
Pathologic, cytologic and immunohistochemical findings of an intra-abdominal desmoplastic small round cell tumor in a 15-year-old male.
Pathology of midline brain tumors. Immunocytochemical tumor markers and classificatory aspects.
PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.
PD-L1 and c-MET expression and survival in patients with small cell lung cancer.
Peanut lectin: a histochemical marker for phaeochromocytomas.
Pediatric Granular Cell Tumor of the Breast: A Case Report and Review of the Literature.
Pediatric sex cord-stromal tumor with composite morphology: a case report.
Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.
Peripheral hemangioblastoma: clinicopathologic characterization in a series of 22 cases.
Peripheral neuroectodermal tumor of the chest (Askin tumor) as secondary neoplasm after Hodgkin's disease: a case report.
Peripheral neuroectodermal tumor presenting pleural effusion.
Peripheral neuroepithelioma (peripheral primitive neuroectodermal tumor) of the uterine cervix.
Peripheral primitive neuroectodermal tumor after radiotherapy.
Peripheral primitive neuroectodermal tumor of the small bowel mesentery: a case showing perforation at onset.
Peripheral primitive neuroectodermal tumor of the urinary bladder in an Arab woman with history of squamous cell carcinoma: a case report.
Peripheral primitive neuroectodermal tumor with osseous component of the small bowel mesentery: a case study.
Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study.
Peripheral primitive neuroectodermal tumour in a lumbar vertebra and the liver of a dromedary camel (Camelus dromedarius).
Peripheral Primitive Neuroectodermal Tumour in a Dog.
Peripheral primitive neuroectodermal tumour with ganglioneuroma-like areas arising in the cauda equina.
Perivascular epithelioid cell tumour of the vagina in an 8 year old girl.
Perivascular epithelioid clear cell tumor of the common bile duct.
Periventricular neurocytoma: a pathological entity.
PGP 9.5, a new marker for human neuroendocrine tumours.
Phakomatous choristoma of the eyelid: immunohistochemical observation.
Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma.
Pharyngeal pituitary non-functioning adenoma with normal intra-sellar gland: massive tumor shrinkage on octreotide therapy.
Phenotypic change of human cultured meningioma cells.
Phenotypic variations and dynamic topography of transformed cells in an experimental model of diethylstilbestrol-induced renal tumour in male Syrian hamster.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.
Pigmented adenoid cystic carcinoma of the ear skin arising from the epidermis: a case report with immunohistochemical studies.
Pigmented intraosseous odontogenic carcinoma of the maxilla: a pediatric case report and differential diagnosis.
Pigmented solid-pseudopapillary neoplasm of the pancreas.
Pilomatricoma-like endometrioid adenosquamous carcinoma of the ovary with neuroendocrine differentiation.
Pineal parenchymal tumor of intermediate differentiation showing malignant progression at relapse.
Pineocytoma with neuronal differentiation--case report.
Pineocytoma. Observation of an autopsy case by electron microscopy and cell markers.
Pituicytomas, a mis-diagnosed benign tumor of the neurohypophysis: report of three cases.
Placental metastasis from maternal primitive neuroectodermal tumor.
Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors?
Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma.
Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma.
Plasma Tumor Necrosis Factor Alpha Is a Predictor of Persisting Symptoms Post-Concussion in Children.
Pleomorphic (giant cell) carcinoma of the intestine. An immunohistochemical and electron microscopic study.
Pleomorphic nonfunctioning islet cell tumor of the pancreas.
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.
Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Plexiform Atypical Spitz Tumor With Rosette-Like Giant Cells. A Histologic and Immunohistochemical Study on a Case Suggesting Ganglioneuroblastic Differentiation. Review of the Literature and Considerations on Histogenesis.
Plexiform schwannoma of the small intestine: report of a case.
Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats.
Polar spongioblastoma of the spinal cord: a case report.
Polar spongioblastoma with cerebrospinal fluid metastases.
Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations.
Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story.
Poorly differentiated rectal carcinoid in a cow.
Poorly differentiated, neuron-specific enolase positive round cell tumor with two translocations t(11;22) and t(21;22).
Positron emission tomography utilizing C-11 5-hydroxytryptophan, plasma biochemistry and neuroendocrine immunohistochemistry of metastatic renal-cell carcinoma.
Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.
Postmenopausal intra-abdominal desmoplastic small cell tumor.
Potential lung carcinogenicity induced by chronic exposure to PM2.5 in the rat.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Predictive factors in radiotherapy for non-small cell lung cancer: present status.
Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer.
Presence of nerve growth factor-like immunoreactivity in carcinoid tumour cells and induction of a neuronal phenotype in long-term culture.
Pretreatment Levels of Chromogranin A and Neuron-specific Enolase in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia.
Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection.
Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors.
Prevalence of antitumor antibodies in laying hen model of human ovarian cancer.
Primary Atypical Carcinoid of the Parietal Pleura Expressing KIT.
Primary bronchial and ovarian carcinoid tumors in the same patient: a case report and histopathologic analysis.
Primary carcinoid of the kidney.
Primary carcinoid of the kidney. Immunohistochemical and ultrastructural studies of five patients.
Primary carcinoid tumor in a polycystic kidney.
Primary carcinoid tumor of the kidney with special reference to its histogenesis.
Primary carcinoid tumor of the testis: case report.
Primary cerebral radiotherapy-induced rhabdomyosarcoma: treatment with intraoperative carmustine implants.
Primary congenital sacrococcygeal neuroblastoma: A case report with immunohistochemical study and review of literature.
Primary cutaneous epidermotropic alveolar rhabdomyosarcoma with t(2;13) in an elderly woman: case report and review of the literature.
Primary cutaneous neuroendocrine tumor (atypical carcinoid) expressing KIT and PDGFRA with myoepithelial differentiation: a case report with immunohistochemical and molecular genetic studies.
Primary cutaneous neuroendocrine tumors. Diagnostic use of cytogenetic and MIC2 analysis.
Primary duodenal small-cell neuroendocrine carcinoma with production of vasoactive intestinal polypeptide.
Primary endocardial malignant spindle-cell sarcoma in the right atrium of a dog resembling a malignant peripheral nerve sheath tumour.
Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations.
Primary extraskeletal mesenchymal chondrosarcoma in fossa poplitea of a 93-year-old woman.
Primary gastric small cell carcinoma: report of a case and review of the literature.
Primary glioblastoma of the cerebellopontine angle in adults.
Primary glomangioma of the esophagus mimicking esophageal papilloma.
Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases.
Primary hepatic carcinoid tumor (a case report).
Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up.
Primary hepatic carcinoid tumor.
Primary hepatic neuroendocrine carcinoma in a child. Morphologic, immunocytochemical, and molecular biologic studies.
Primary intraosseous melanotic schwannoma of the fibula associated with the Carney complex.
Primary Intraparotid Peripheral Nerve Sheath Tumour with Characteristics of Benign Schwannoma in a Horse.
Primary Large-Cell Neuroendocrine Carcinoma of the Breast Occurring in a Pre-Menopausal Woman.
Primary malignant peripheral nerve sheath tumor with eosinophilic cytoplasmic globules arising from the greater omentum in a dog.
Primary neuroendocrine (Merkel cell?) carcinoma of the skin. II. An immunocytochemical study of 21 cases.
Primary neuroendocrine carcinoma coexisting with hemangioma in the liver: report of a case.
Primary neuroendocrine carcinoma of breast: a rare case report.
Primary neuroendocrine carcinoma of the eyelid, immunohistochemical and ultrastructural study.
Primary Neuroendocrine Carcinoma of the Vagina With Merkel Cell Carcinoma Phenotype.
Primary omental gastrointestinal stromal tumor (GIST).
Primary paraganglioma of thyroid gland: a clinicopathologic and immunohistochemical study with review of the literature.
Primary primitive neuroectodermal tumor (PNET) of the kidney with venous thrombus.
Primary primitive neuroectodermal tumor of the breast: a rare case presentation.
Primary primitive neuroectodermal tumor of the cauda equina.
Primary primitive neuroectodermal tumor of the cervix.
Primary primitive neuroectodermal tumor of the lung: report of two cases.
Primary primitive peripheral neuroectodermal tumor of the prostate. Immunophenotypic and molecular study of a case.
Primary Pulmonary Primitive Neuroectodermal Tumor (PNET): A Clinicopathological and Immunohistochemical Study of Six Cases.
Primary pulmonary primitive neuroectodermal tumor metastasis to the pancreas: a rare case with seven-year follow-up.
Primary signet-ring stromal tumour of the testis: case report with literature review.
Primary small cell anaplastic carcinoma of the breast diagnosed by fine needle aspiration cytology: a case report.
Primary Small Cell Carcinoma of Liver: A Rare Tumor.
Primary small cell carcinoma of prostate without immunoreactive neuroendocrine proteins but with expressions of KIT and platelet-derived growth factor-?.
Primary small cell carcinoma of the esophagus with ectopic gastrin production. Report of a case and review of the literature.
Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes.
Primary small cell neuroendocrine carcinoma of the breast.
Primary small cell neuroendocrine carcinoma of the kidney.
Primary small cell neuroendocrine carcinoma of the oral cavity: A case report and review of the literature.
Primary small cell neuroendocrine carcinoma of the vagina. Marked effect of combination chemotherapy: a case report.
Primary small cell neuroendocrine carcinoma of vagina: a rare case report.
Primary Supratentorial Atypical Teratoid/Rhabdoid Tumor in Children: A Report of Two Cases.
Primary thymic carcinoid with Cushing's syndrome.
Primary thyroid paraganglioma presenting with double thyroid nodule: a case report.
Primary typical carcinoid tumour in the retromolar region with prominent squamous differentiation: a case report.
Primary ureteral giant cell sarcoma in a Pomeranian.
Primitive neuroectodermal tumor (PNET) of the urinary bladder.
Primitive neuroectodermal tumor arising in the pancreas.
Primitive neuroectodermal tumor as a differential diagnosis of CD56-positive tumors in adults.
Primitive neuroectodermal tumor in the skin with features of neuroblastoma in an adult patient.
Primitive neuroectodermal tumor of the breast: immunohistochemistry and fluorescence in situ hybridization.
Primitive neuroectodermal tumor of the kidney associated with Budd-Chiari syndrome in a 17-year-old girl.
Primitive neuroectodermal tumor of the kidney--another enigma: a pathologic, immunohistochemical, and molecular diagnostic study.
Primitive neuroectodermal tumor of the kidney. Report of a case initially diagnosed by fine needle aspiration cytology.
Primitive neuroectodermal tumor of the lung.
Primitive Neuroectodermal Tumor of the Meninges: An Histological, Immunohistochemical, Ultrastructural, and Cytogenetic Study.
Primitive neuroectodermal tumor of the myocardium: a case report, review of the literature, immunohistochemical, and ultrastructural study.
Primitive neuroectodermal tumor of the orbit in an adult. A case report and literature review.
Primitive neuroectodermal tumor of the retroperitoneal cavity.
Primitive neuroectodermal tumor of the stomach.
Primitive neuroectodermal tumor of the transverse colonic mesentery defined by the presence of EWS-FLI1 chimeric mRNA in a Japanese woman.
Primitive neuroectodermal tumor originating in the vulva: A case report.
Primitive neuroectodermal tumors of the cerebrum: a histological and immunohistochemical study of 10 cases.
Primitive neuroepithelial tumors with vermiform processes (filiform neuroepithelial tumors). Immunocytochemical and ultrastructural study of 2 cases.
Primitive neuroepithelial tumours of soft tissues and of bone: further ultrastructural and immunocytochemical clarification of 'Ewing's sarcoma', including freeze-fracture analysis.
Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.
Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.
Pro-invasive stimuli and the interacting protein Hsp70 favour the route of alpha-enolase to the cell surface.
Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade.
Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases.
Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.
Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.
Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.
Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.
Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.
Prognostic value of serum tumor markers in patients with lung cancer.
Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease.
Progressive systemic sclerosis associated with primary small cell carcinoma of the stomach.
Prostatic carcinoma with endocrine features. A report of a neoplasm containing multiple immunoreactive hormonal substances.
Protective effect of vanillic acid against benzo(a)pyrene induced lung cancer in Swiss albino mice.
Protective effects of dexmedetomidine on brain function of glioma patients undergoing craniotomy resection and its underlying mechanism.
Protective effects of nicorandil against cerebral injury in a swine cardiac arrest model.
Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry.
Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells.
Protein Expression Profile using Two-Dimensional Gel Analysis in Squamous Cervical Cancer Patients.
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2.
Proteome serological determination of tumor-associated antigens in melanoma.
Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies.
Proteomic Analysis of Hippocampus and Cortex in Streptozotocin-Induced Diabetic Model Mice Showing Dementia.
Proteomic Determination of Metabolic Protein Expression in Ten Different Tumor Cell Lines.
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response.
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases.
Pseudopapillary neurocytoma of temporal lobe with glial differentiation.
Pulmonary benign metastasizing leiomyoma: a case report and literature review.
Pulmonary blastoma with fatal hypercalcemia.
Pulmonary carcinoid tumor--tumorlet type: a case report.
Pulmonary clear cell carcinoid tumor: another entity in the differential diagnosis of pulmonary clear cell neoplasia.
Pulmonary large cell carcinoma with rhabdoid phenotype.
Pulmonary large cell neuroendocrine carcinoma diagnosed in a brain metastasis.
Pulmonary meningioma. Immunohistochemical and ultrastructural features.
Pulmonary neuroendocrine carcinoma in a four-month-old dog.
Pulmonary non-Hodgkin's lymphoma (NHL) of diffuse large B-cell type with simultaneous humeral involvement in a young lady: An uncommon presentation with cytologic implications.
Pulmonary sarcomas in a young chicken.
Pure small cell carcinoma of the prostate: A rare tumor.
Purely epithelioid malignant peripheral nerve sheath tumor of the vulva.
Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer.
Quantitative distribution of cluster 1 small cell lung cancer antigen in cancerous and non-cancerous tissues, cultured cells and sera.
Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures.
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Rapid and sensitive detection of neuron specific enolase with a polydopamine coated plasmonic chip utilizing a rear-side coupling method.
Rapid growth of an optic nerve ganglioglioma in a patient with neurofibromatosis 1.
Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.
Rapidly fatal Askin's tumor: a case report and literature review.
Rare orbitocranial tumour in an adult.
Rare paraneoplastic erythroderma associated with ectopic neuron-specific enolase deposition in basal cells.
Rat endomyocardial disease: a neural origin?
Reactivity of lung tumors with lung-derived and non-lung-derived monoclonal antibodies.
Recovery from Marie-Bamberger's syndrome and diabetes insipidus after removal of a lung adenocarcinoma with neuroendocrine features.
Rectal and colonic carcinoids. A clinicopathologic study of 84 cases.
Recurrence of primary hepatic carcinoid tumor in the remnant liver 13 yr after resection.
Recurrent medulloepithelioma of the ciliary body. Immunohistochemical characteristics.
Recurrent ossifying fibromyxoid tumour of soft parts. Immunohistochemical profile and ultrastructure.
Recurrent Syncope Associated with Lung Cancer.
Regulatory peptides and neuron-specific enolase in the respiratory tract of man and other mammals.
Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
Renal primitive neuroectodermal tumor: an immunohistochemical and cytogenetic analysis.
Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative review.
Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
Retinoblastoma--a histologic and immunohistologic study.
Retinoblastoma. A clinical, immunohistochemical, and electron microscopic case report.
Retinoblastoma. Immunohistochemistry and cell differentiation.
Retroperitoneal Ganglioneuroma in an Adult Patient: A Case Report and Literature Review of the Last Decade.
Retroperitoneal malignant fibrous histiocytoma mimicking pheochromocytoma.
Retroperitoneal peripheral hemangioblastoma: a case report and review of the literature.
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
Rhabdomyosarcoma of the prostate--report of a case with an immunohistochemical study of the neoplastic rhabdomyoblast.
Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies.
Risk factors for nicotine dependence in Chinese patients with lung cancer.
Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
Role of enolase-1 in response to hypoxia in breast cancer: Exploring the mechanisms of action.
Role of Rifampin in Reducing Inflammation and Neuronal Damage in Childhood Bacterial Meningitis: A Pilot Randomized Controlled Trial.
Role of the ratio of NSE serum concentration in evaluating the therapeutic effect on metastatic neuroendocrine neoplasms of the liver.
Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.
Routine immunohistochemical characterization of short term in vitro explants from human intracranial tumours.
S-100 protein in human lung neuroendocrine neoplasms. Immunohistochemical study of 14 cases and review of the literature.
S-100-negative atypical granular cell tumor: report of a case.
Sarcoma of possible nerve sheath origin in a captive muskrat.
Schwannoma in the sigmoid colon: report of a case.
Sclerosing paraganglioma: report of 19 cases of an unusual variant of neuroendocrine tumor that may be mistaken for an aggressive malignant neoplasm.
Sclerosing Sertoli cell tumor without expression of typical sex cord stromal tumor markers: case report and literature review.
Sclerotic fibromas of the skin.
Secretagogin is a novel marker for neuroendocrine differentiation.
Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
Secretion of neuron-specific enolase, prolactin, growth hormone, luteinising hormone and follicle stimulating hormone by "functionless" and endocrine-active pituitary tumours in vitro.
Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts.
Serous cystic neoplasm in an intrapancreatic accessory spleen.
Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers.
Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases.
Sertoli cell tumour in an Amur tiger.
Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
Serum chromogranin-A in advanced prostate cancer.
Serum depletion induces changes in protein expression in the trophoblast-derived cell line HTR-8/SVneo.
Serum ferritin in stage IV neuroblastoma.
Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
Serum neuron-specific enolase (NSE) as a tumour marker for the Ewing's sarcoma family of tumours.
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
Serum neuron-specific enolase in children's cancer.
Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
Serum neuron-specific enolase in metastatic Merkel cell tumors.
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Serum neuron-specific enolase levels in patients with small cell carcinoma of the uterine cervix.
Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1-3 Months of Age.
Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours.
Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer.
Serum ST2 as a potential prognostic biomarker for traumatic brain injury.
Serum tumor marker levels at the development of intracranial metastasis in patients with lung or breast cancer.
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening.
Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
SF2312 is a natural phosphonate inhibitor of enolase.
Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities.
Significance of cytologic criteria in distinguishing small cell from non-small cell carcinoma of the lung.
Significance of tumor markers in lung cancer.
Simultaneous exposure to nicotine and hyperoxia causes tumors in hamsters.
Simultaneous occurrence of medullary carcinoma and papillary carcinoma of the thyroid.
Simultaneous presentation of a small-cell carcinoma involving the ovary and the uterine endometrium.
Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma.
Sinonasal small cell neoplasm developing after radiation therapy for retinoblastoma: an immunohistologic, ultrastructural, and cytogenetic study.
Sinonasal undifferentiated carcinoma with orbital invasion: report of three cases.
Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma.
Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association.
Small cell (endocrine cell) carcinoma of the gallbladder with squamous and adenocarcinomatous components.
Small cell (oat cell) carcinoma of the breast.
Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients.
Small cell carcinoma arising from the outer urethral orifice: a case report examined by histologic, ultrastructural and immunohistochemical methods.
Small cell carcinoma of the brain without extracranial involvement by serial CT, MRI and PET.
Small cell carcinoma of the gall-bladder with intestinal metaplastic epithelium.
Small cell carcinoma of the gallbladder combined with adenocarcinoma.
Small cell carcinoma of the kidney. A clinicopathologic, immunohistochemical, and ultrastructural study.
Small cell carcinoma of the major salivary glands. An immunohistochemical study.
Small cell carcinoma of the ovary: a case report of large cell variant.
Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases.
Small cell carcinoma of the urinary bladder.
Small Cell Carcinoma of the Urinary Bladder: KIT and PDGFRA Gene Mutations.
Small cell carcinoma of the urinary tract.
Small cell carcinoma of the uterine cervix with syndrome of inappropriate antidiuretic hormone secretion.
Small cell carcinomas of the large intestine.
Small cell extraskeletal osteosarcoma.
Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma.
Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging: a clinicopathologic study of a case and a brief review of the literature.
Small cell neuroendocrine carcinoma of the endometrium.
Small cell neuroendocrine carcinoma of the prostate: Incidence and a report of four cases with an examination of KIT and PDGFRA.
Small cell neuroendocrine carcinoma of the rectum.
Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature.
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Small cell undifferentiated carcinoma of the pancreas. Report of a patient with tumor marker studies.
Small cell undifferentiated carcinoma of the parotid gland. Cytologic, histologic, immunohistochemical and ultrastructural features of a neuroendocrine variant.
Small cell undifferentiated carcinoma of the submandibular gland with neuroendocrine features.
Small Cell Variant of Metastatic Melanoma: A Mimicker of Lymphoblastic Leukemia/Lymphoma.
Small non-functioning endocrine tumor of pancreas: comparison with solid cystic tumor.
Small round and spindle cell sarcoma with neuronal differentiation and oncocyte-like features of the thoracic wall: a case report with histological, immunohistochemical and ultrastructural examinations.
Small round cell neoplasms: can electron microscopy and immunohistochemical studies accurately classify them?
Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.
Small-cell carcinoma of the endometrium: an immunohistochemical and ultrastructural analysis.
Small-cell carcinoma of the extrahepatic bile duct: a case report and review of the literature.
Small-cell carcinoma of the gallbladder - a clinicopathological, immunohistochemical and flow cytometric study of 15 cases.
Small-cell neuroendocrine carcinoma of the ampulla of Vater.
So-called "papillary and cystic neoplasm of the pancreas." An immunohistochemical and ultrastructural study.
Soft tissue sarcomas in the African hedgehog (Atelerix albiventris): microscopic and immunohistologic study of three cases.
Soft-tissue Hemangioblastoma of the Retroperitoneum: A Case Study and Review of the Literature.
Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms?
Solid and cystic pancreatic tumors. Clinical, histochemical, and electron microscopic features in ten cases.
Solid and cystic papillary neoplasms of the pancreas: Report of four cases.
Solid and cystic tumor (SCT) of the pancreas in an adult man.
Solid and cystic tumor of the pancreas: clinicopathologic and genetic studies of four cases.
Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure.
Solid and papillary neoplasm of the pancreas.
Solid Pseudopapillary Tumor of the Pancreas in a 50-Year-Old Man: A Case Report and Review of the Literature.
Solid pseudopapillary tumor of the pancreas in children: report of a case and review of the literature.
Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma?
Solid-cystic tumour of the pancreas. An endocrine neoplasm?
Solid-pseudopapillary neoplasm of the pancreas: Three cases with a literature review.
Solitary cutaneous malignant schwannoma. Immunohistochemical and ultrastructural studies.
Solitary fibrous tumor of the nasal cavity and orbit.
Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex.
Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients.
Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen's disease.
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer.
Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Spinal nerve sheath myxoma (neurothekeoma).
Spindle cell carcinoma of the nasal cavity.
Spontaneous olfactory neuroepithelioma in a domestic medaka (Oryzias latipes).
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization.
Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme.
Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein.
Subcutaneous continuous injection of octreotide decreased the tumor marker levels and induced cystic necrosis of the tumors in a case of pancreatic neuroendocrine tumor with multiple hepatic metastases.
Subcutaneous malignant epithelioid schwannoma with cartilaginous differentiation.
Subependymal giant cell astrocytoma: clinical, histologic and immunohistochemical characteristic of 3 cases.
Subungual melanoma with osteocartilaginous differentiation.
Successful Radical Pneumonectomy for a Primitive Neuroendodermal Tumor in the Lung: A Case Report and Review of the Literature.
Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.
Surgical Control of a Primary Hepatic Carcinoid Tumor: A Case Report.
Suspected hydatid cyst of liver harbouring an aggressive desmoplastic small round cell tumour.
Symptomatic granular cell tumor involving the pituitary gland in a dog: a case report and review of the literature.
Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex.
Synaptophysin. A new marker for pancreatic neuroendocrine tumors.
Synchronous gastric adenocarcinoma and carcinoid.
Synovial sarcoma arising in the vulva cytogenetically confirmed by SYT break-apart rearrangement fluorescence in situ hybridization: A case report and discussion of diagnostic methods.
Synovial sarcoma of the prostate with t(X;18)(p11.2;q11.2).
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy.
t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors?
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.
Teratoma in the cerebrum of a fantail pigeon.
Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.
The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis.
The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review.
The clinical efficacy of argon-helium knife cryoablation combined with nivolumab in the treatment of advanced non-small cell lung cancer.
The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage.
The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer.
The concentrations of five tumor markers in both BAL fractions in lung cancer patients in relation to cigarette smoking.
The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.
The determination of copeptin levels helps management decisions among transient ischaemic attack patients.
The diagnostic value of SYT-SSX detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH) for synovial sarcoma: a review and prospective study of 255 cases.
The dual anti-inflammatory and antioxidant activities of natural honey promote cell proliferation and neural regeneration in a rat model of colitis.
The effect of simvastatin on the proteome of detergent-resistant membrane domains: Decreases of specific proteins previously related to cytoskeleton regulation, calcium homeostasis and cell fate.
The effects of selective head cooling versus whole-body cooling on some neural and inflammatory biomarkers: a randomized controlled pilot study.
The epithelial-mesenchymal transition induces aggressivity of mucinous cystic neoplasm of the pancreas with neuroendocrine component: An immunohistochemistry study.
The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation.
The expression of keratins, vimentin, neurofilament proteins, smooth muscle actin, neuron-specific enolase, and synaptophysin in tumors of the specific glands in the canine anal region.
The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
The human allicin-proteome: S-thioallylation of proteins by the garlic defence substance allicin and its biological effects.
The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin.
The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma.
The levels of three enolase subunits in human tumors; a low ?-/?-subunit ratio as indicator of tumors of neuronal and neuroendocrine nature.
The morphology and neuroendocrine profile of pancreatic epithelial VIPomas and extrapancreatic, VIP-producing, neurogenic tumors.
The neuroectodermal tumor of bone.
The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy.
The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
The role of immunohistochemistry, electron microscopy, and ultrastructural cytochemistry in the diagnosis of mixed carcinoma-neuroendocrine neoplasms.
The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
The spectrum of olfactory neural tumors. A light-microscopic immunohistochemical and ultrastructural analysis.
The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma.
The Value of Extracellular Cold-Inducible RNA-Binding Protein (eCIRP) in Predicting the Severity and Prognosis of Patients After Cardiac Arrest: A Preliminary Observational Study.
The value of tumour markers in lung cancer.
Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Therapy for small cell and non-small cell lung cancer.
Three are better than one: plasminogen receptors as cancer theranostic targets.
Three cases of carcinoid in the equine nasal cavity and maxillary sinuses: histologic and immunohistochemical features.
Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids.
Thymic carcinoid tumor with Cushing's syndrome. Report of a case with electron microscopic and immunoperoxidase studies for neuron-specific enolase and corticotropin.
Thymic carcinoid with prominent mucinous stroma. Report of a distinctive morphologic variant of thymic neuroendocrine neoplasm.
Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases.
Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare Tumor.
Thyroid-like follicular carcinoma of the kidney: A report of two cases and literature review.
TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung.
Transcription factor e3 protein-positive perivascular epithelioid cell tumor of the appendix presenting as acute appendicitis: a case report and review of the literature.
Transfection with CXCR4 potentiates homing of mesenchymal stem cells in vitro and therapy of diabetic retinopathy in vivo.
Transformation to small cell lung cancer after first-line afatinib treatment.
Traumatic neuroma of the lower lip with intraepithelial nerve fibers.
Treatment of a local recurrence of a carcinoid tumor of the middle ear by extended subtotal petrosectomy.
TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY ?-ADRENERGIC STIMULATION.
True carcinosarcoma of the larynx.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in human renal cell carcinoma.
Tumor markers in neuroendocrine tumors.
Tumor markers in patients with chronic renal failure.
Tumor markers in pleural effusions.
Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
Tumor shedding of laminin binding protein modulates angiostatin production in vitro and interferes with plasmin-derived inhibition of angiogenesis in aortic ring cultures.
Tumor-Specific Diagnostic Marker for Transmissible Facial Tumors of Tasmanian Devils: Immunohistochemistry Studies.
Tumors of the endocrine/neuroendocrine system: an overview.
Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?
Tumour markers with clinically controlled cut-offs for suspected cancer.
Two canine Merkel cell tumours: immunoexpression of c-KIT, E-cadherin, beta-catenin and S100 protein.
Two case reports of brain metastases in patients with pancreatobiliary neuroendocrine carcinoma.
Two cases of duodenal gangliocytic paraganglioma: immunocytochemical characteristics.
Two cases of uveal amelanotic melanoma in transgenic Tyr-HRAS+ Ink4a/Arf heterozygous mice.
Two malignant peripheral primitive neuroepithelial tumor cell lines established from consecutive samples of one patient: characterization and cytogenetic analysis.
Two synchronous solid and cystic tumors of the pancreas.
Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
Type C retroviral expression in spontaneous feline olfactory neuroblastomas.
Tyrosine hydroxylase indicates cell differentiation of catecholamine biosynthesis in neuroendocrine tumors.
Ultrastructural study of a black insulinoma.
Ultrastructural study of a mucinous carcinoid of the skin.
Ultrastructural, immunohistochemical, and cytogenetic study of a malignant peripheral neuroectodermal tumor in a patient seropositive for human immunodeficiency virus.
Ultrastructural, lectin histochemical and immunohistological observations on Merkel cell tumors.
Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases.
Undifferentiated carcinoma of the liver: a case report with immunohistochemical analysis.
Unilateral retinoblastoma in an adult: report of a case and review of the literature.
Unusual features of metastatic atypical carcinoid of the larynx.
Unusual prostatic adenocarcinoma with endocrine basophilic FSH-immunoreactive cells.
Unusual renal sarcoma in a young adult: its similarities to clear cell sarcoma of the kidney.
Unusual sinonasal small-cell neoplasms following radiotherapy for bilateral retinoblastomas.
Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating ?-catenin.
Up-Regulation of ENO1 by HIF-1? in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells.
Upregulation of ? enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.
Upregulation of Inflammatory Mediators in End-Stage Renal Disease as Measured Using Biochip Array Technology.
Use of neuron-specific enolase as a serum marker for neuroendocrine neoplasms.
Use of s-100 and chromogranin a antibodies as immunohistochemical markers on detection of malignancy in aortic body tumors in dog.
Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
Usefulness of chromogranin A, neuron-specific enolase and 5-hydroxyindolacetic acid measurements in patients with malignant carcinoids.
Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury.
Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Utility of tumour markers in the diagnosis of neoplastic pleural effusion.
Uveal malignant melanoma and von Recklinghausen's neurofibromatosis.
V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.
Vaginal clear cell carcinoma in a Japanese Black cow.
Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Value of tumour and inflammatory markers in lung cancer.
Well-differentiated endocrine tumor of the distal common bile duct: a case study and literature review.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma.
Zollinger-Ellison syndrome in a cat.
Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.
[123I-MIBG scintigraphy in patients with neuroblastoma]
[A benign neuroendocrine tumor of the lung: study on the origin of the so-called sclerosing hemangioma of the lung]
[A case of adult neuroblastoma arising in the retroperitoneal space]
[A CASE OF ADVANCED BLADDER NEUROENDOCRINE CARCINOMA (SMALL CELL CARCINOMA) SIGNIFICANTLY IMPROVED BY LOW DOSE OF ORAL TEGAFUR-URACIL].
[A case of carcinoid tumor arising from a horseshoe kidney]
[A case of Merkel cell carcinoma of the eyelid]
[A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
[A case of primary hepatic carcinoid. A report of its surgical resolution]
[A clinical study of advanced large cell neuroendocrine carcinoma]
[A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer]
[A preliminary study of retinoblastoma-related serum tumor markers].
[Alveolar soft part sarcoma--case report]
[Amphicrine adenoma of the middle ear. Histological, immunohistochemical and ultrastructural study of a case]
[An immunohistochemical study of retinoblastoma]
[An immunohistochemical study on neuron specific enolase in testicular germ cell tumors]
[Anorectal neuroendocrine carcinoma and small cell carcinoma. Report of two cases]
[Application of serum tumor markers and support vector machine in the diagnosis of oral squamous cell carcinoma]
[Benign and malignant granular cell tumors. An immunohistochemical classification of tumor cells]
[Biochemical parameters in the comprehensive diagnosis of lung cancer]
[Carcinoid tumor of the liver]
[Central neurocytoma--report of a case]
[Central neurocytoma: analysis of three cases and review of the literature]
[Central neurocytomas of the lateral ventricle. A series of 35 cases with review of the literature].
[Cerebellar hemangioblastoma with marked pleomorphism: a case report].
[Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer]
[Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer]
[Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer]
[Clinical evaluation of serum NSE and CEA in primary lung cancer patients]
[Clinical significance of detection of serum values of neuron specific enolase before and after treatment for small cell lung cancer].
[Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer]
[Clinicopathologic features and surgical treatment of nonfunctioning islet cell tumors (78 case report)]
[Clinicopathologic study of four cases of vagal paraganglioma]
[Clinicopathological study of Ewing's sarcoma and primitive neuroectodermal tumor]
[Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases]
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]
[Contribution of immunohistochemical methods to the study of central nervous system tumors]
[Cutaneous apudoma. Apropos of a case and review of the literature]
[Detection of neuroendocrine feature about salivary adenoid cystic carcinoma]
[Determination of carcinoembryonic antigen in lung cancer using an immunoenzyme assay]
[Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin]
[Determination of tumor markers NSE and CEA in patients with various lung diseases, especially carcinomas]
[Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]
[Determining the level of the tumor marker--neuron-specific enolase in patients with neoplastic and non-neoplastic diseases]
[Development of barcode and proteome profiling of glioblastoma].
[Diagnositic values of combined determination of carbohydrate antigen and tissue polypeptide antigen and neuron-specific enolase and carcinoembryonic antigen in the malignant pleural effusion.]
[Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)]
[Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer]
[Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis]
[Diagnostic value of ProGRP and NSE for small cell lung cancer: a meta-analysis].
[Digestive carcinoid tumors: often undiagnosed endocrine tumors (a case report)]
[Ectopic meningioma of the tonsil]
[Electrophoretic determination of aqueous and serum neuron-specific enolase (NSE) in the diagnosis of retinoblastoma]
[Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases]
[Endocrine mucin-producing sweat gland carcinoma. three case reports with a brief review of the literature].
[Endocrine tumors of the hepatobiliary system. Case report and review of the literature]
[ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
[Epithelioid angiomyolipoma of kidney: clinicopathologic study of two cases and review of literature]
[Establishment of reference intervals of tumor markers in Korean adults]
[Evaluation of gamma-enolase as a tumor marker for lung cancer]
[Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung]
[Evaluation of tumor markers in the management of small cell lung cancer]
[Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation]
[Extrathoracal pulmonary sequestration in the differential diagnosis of paravertebral tumors in the neonate]
[Gamma-enolase (gamma-eno)]
[Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase]
[Gastrointestinal autonomic nerve tumor (GANT)--a rate tumor of the ileum]
[Glucagonoma: case report and literature review]
[Granular cell tumor of the eyelid]
[Granular cell tumor--a rare, benign respiratory tract neoplasm in the material of the Institute of Tuberculosis and Lung Diseases]
[Granular cell tumors. Rare tumors of the neurohypophysis]
[Hippel-Lindau syndrome: morphology and immunohistochemistry of tumors related to this syndrome]
[Hippocampal neuronal ferroptosis involved in cognitive dysfunction in rats with sepsis-related encephalopathy through the Nrf2/GPX4 signaling pathway].
[Histologic and immunohistochemical profiles of benign granular cell tumors. Report of 41 cases]
[Immunoassay of nine serological tumor markers on hydrogel-based microchip].
[Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy]
[Immunohistochemical investigation of S100 protein and neuron specific enolase in skin tumors]
[Immunohistochemical studies of paraffin-embedded material of solitary cutaneous neurofibromas]
[Immunohistochemical study of subependymal giant cell tumor associated with tuberous sclerosis]
[Immunohistochemistry and ultrastructure of a granular cell tumor]
[Immunohistochemistry characterization of neurocytoma of the cerebral hemispheres]
[In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?]
[Increased neuron-specific enolase levels in patients with long-standing pyothorax-associated lymphoma]
[Intracranial primitive neuroectodermal tumor in an infant: a case report]
[Laboratory markers of melanoma progression]
[Liver apudoma simulating cystic liver]
[Localization of enolase in the cancer nest of digestive organs]
[Melanotic neuroectodermal tumor in a newborn]
[MEN I (multiple endocrine neoplasia): patient screening and new tumor markers]
[Merkel cell carcinoma--immunohistochemical study in a group of 11 patients]
[Merkel cell carcinoma: diagnostic and treatment]
[Merkel cell carcinoma: report of three cases]
[Merkel cell carcinoma]
[Merkeloma (Merkel cell carcinoma) from the clinical viewpoint based on 4 cases]
[Mesenchymal chondrosarcoma of the lung]
[Morphological characteristics of stromal gastrointestinal tumors]
[Morphology and clinical picture of thymus carcinoid]
[N-myc gene copies in children with neuroblastoma and its clinical significance].
[Nasal glial heterotopia: Clinical and morphological characteristics].
[Neuroendocrine (Merkel cell?) carcinoma of the skin]
[Neuroendocrine carcinoma of the esophagus. Case report with immunohistochemical study]
[Neuroendocrine differentiation as a survival prognostic factor in advanced non-small cell lung cancer]
[Neuroendocrine larynx cancer of the small cell (oat cell) type. Morphologic and immunohistochemical findings and their significance for therapy]
[Neuroendocrine tumor of the nasal cavity (esthesioneuroblastoma). Apropos of a case with paraneoplastic Cushing's syndrome]
[Neuroendocrine tumors of the kidney: report of 3 cases and review of the literature.]
[Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].
[Neurofilaments in Abrikosov's tumor (an immunohistochemical study)]
[Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model]
[Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?]
[Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma]
[Neuron-specific enolase as a new tumor marker]
[Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma]
[Neuron-specific enolase as a tumor marker]
[Neuron-specific enolase in bronchial anaplastic small-cell cancer: a clinical case and review of the literature]
[Neurospecific proteins: potentials and prospects for their use in morphological research on tumors]
[New histopathologic data of prognostic value in extra-adrenal paragangliomas. Study of 9 cases]
[Olfactory esthesioneuroma. Clinical, histological and therapeutic aspects; apropos of 6 cases]
[Oligodendroglioma with neuronal differentiation in an 8-month-old African hedgehog (Atelerix albiventris)].
[Oncocytic adrenocortical neoplasms]
[Peripheral neuroepithelioma]
[Peripheral primitive neuroectodermal tumor in parietal pleura]
[Pheochromocytomas as adrenal gland incidentalomas]
[Pleuropulmonary metastases of female cancers]
[Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study]
[Primary carcinoid of the testis]
[Primary rhabdomyosarcoma of the cerebellum. Histopathological and immunohistochemical study of an autopsy case]
[Primary small cell carcinoma of the kidney: report of a case]
[Primitive neuroectodermal tumor with peritoneal metastasis through a ventriculoperitoneal shunt. Case report]
[Prognostic significance of neuroendocrine differentiation in non-small cell lung cancer patients' survival.]
[Prostatic carcinoma that arose with hearing loss: a case report]
[Protective effect of jasminoidin on cascade of damage of cerebral ischemia in rats]
[Pseudo-oligodendrogliomatous meningioma. Report of 2 cases and review of the literature]
[Radioimmunometric assay of neuron specific enolase in aqueous humor and serum in patients with retinoblastoma]
[Rectal endocrine intermediate-cell carcinoma]
[Renal carcinoid tumor presenting as bladder tamponade: a case report and review of the Japanese cases]
[Retroperitoneal non-secreting paraganglioma]
[Risk of endocrine activation in interventions of paragangliomas in the head-neck area]
[Role of ?7 nicotinic acetylcholine receptor in attenuation of endotoxin induced delirium with dexmedetomidine in mice].
[Serum level of neuron-specific enolase: value as tumor marker of microcellular bronchial cancer]
[Serum neuron-specific enolase as a marker of lung cancers]
[Serum neuron-specific enolase in patients with non-pulmonary neoplasms]
[Serum neuron-specific enolase in small cell bronchial cancers]
[Significance of immunohistologic methods in the differential diagnosis of solid tumors in childhood]
[Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
[Small cell neuroendocrine carcinoma of the urinary bladder: a case report]
[Solid and cystic tumor of the pancreas with prominent calcification]
[Solid pseudopapillary neoplasms. Enigmatic entity with female preponderance]
[Solid pseudopapillary tumor of the pancreas]
[Solitary fibrous tumor (fibrous mesothelioma). Report of 2 cases in an extraserous location]
[Somatostatinoma in the pancreas]
[Study of 2 markers, keratin and neuron-specific enolase, in bronchial cancers]
[Subependymal giant cell astrocytoma associated with tuberous sclerosis exhibiting rapid regrowth after 17 years: a case report]
[Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study]
[The association of neuro-endocrine carcinoma of the skin and Bowen's disease. Review of the literature apropos of 4 cases]
[The ectopic ACTH syndrome]
[The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma]
[The melanotic neuroectodermal tumor of childhood. Tumor identification with immunohistochemical methods. A case report]
[The morphological and immunohistochemical features and malignancy potential of a hyalinizing trabecular tumor of the thyroid]
[The neuroendocrine Merkel cell carcinoma of the skin]
[The role of tumour markers in diagnosis and management of testicular germ cell tumours.]
[Tumor markers in lung cancer]
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
[Tumor markers in the diagnosis of lung cancer]
[Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma]
[Tumors of the peripheral sympathetic nervous system in childhood. Immunohistochemical study]
[Tumors of the thyroid gland in dogs--a local characteristic in the area of Leipzig]
[Two cases of paragangliomas of the cauda equina--case reports and review of the literature]
[Unusual intra-abdominal tumor]
[Usefulness of neuron specific enolase in patients with head and neck malignant tumors]
[Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma].
[Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma]
Neoplasms, Germ Cell and Embryonal
An immunohistochemical study of intracranial germ cell tumours.
Clinical use of tumor markers in childhood malignancies.
Malignant fibrous histiocytoma masquerading as germ cell tumor by producing beta-human chorionic gonadotropin and neuron-specific enolase.
N-myc amplification and neuron-specific enolase production of a neuroblastoma cell line and germ cell tumor cell lines.
Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma.
Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
[An immunohistochemical study on neuron specific enolase in testicular germ cell tumors]
Neoplasms, Glandular and Epithelial
Occult medullary thyroid carcinoma. Unusual histologic variant presenting with metastatic disease.
Neoplasms, Muscle Tissue
Gingival granular cell myoblastoma in newborns. Report of two cases.
Granular-cell tumours: an immunohistochemical study.
Neoplasms, Neuroepithelial
Recurrent medulloepithelioma of the ciliary body. Immunohistochemical characteristics.
Neoplasms, Squamous Cell
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
Neoplastic Cells, Circulating
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
The clinical efficacy of argon-helium knife cryoablation combined with nivolumab in the treatment of advanced non-small cell lung cancer.
Nervous System Diseases
Biological Variation and Reference Change Value Data for Serum Neuron-Specific Enolase in a Turkish Population.
Cerebrospinal fluid and serum neuron-specific enolase levels after febrile seizures.
Cerebrospinal fluid levels of alpha-synuclein, amyloid ?, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders.
Detection of neuron specific enolase concentrations in cerebrospinal fluid from patients with neurological disorders by means of a sensitive enzyme immunoassay.
Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus.
Immunoreactive nervous system of specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid.
Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Neuron-specific enolase as a marker of neuronal lesions during various comas in man.
Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder.
Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.
Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy.
Serum and CSF biomarkers in acute pediatric neurological disorders.
Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis.
Serum neurone-specific enolase concentrations in patients with neurological disorders.
Signs of neuroaxonal injury in preeclampsia-A case control study.
Studies on neuronal death in the mouse model of Niemann-Pick C disease.
The Relationship Between Serum Neuron-Specific Enolase Levels and Severity of Bleeding and Functional Outcomes in Patients With Nontraumatic Subarachnoid Hemorrhage.
Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders.
[Autoimmune thyroid disease and brain]
[Cerebrospinal fluid level of aldolase C in patients with various neurological disorders: comparison with neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme]
[Gamma-enolase (gamma-eno)]
[Level of S-100 and neuron-specific enolase in cerebrospinal fluid from subjects with neurological pathologies]
Nervous System Neoplasms
Enolase isoenzymes in human cerebral metastasis.
Gamma-enolase and glial fibrillary acidic protein in nervous system tumors. An immunohistochemical study using specific monoclonal antibodies.
Nesidioblastosis
Histological classification of nesidioblastosis: efficacy of immunohistochemical study of neuron-specific enolase.
Neural Tube Defects
Determination of neuron specific enolase in amniotic fluid and maternal serum for the prenatal diagnosis of fetal neural tube defects.
Maternal serum neurone specific enolase in the diagnosis of anencephaly and other neural tube defects.
Neuronal overmaturation in dysraphism: ontogenic expression of neuropeptides in the fetal brain and developmental anomalies in exencephaly.
S-100 protein and neuron-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus.
Neurilemmoma
14-3-2 protein in rat primary and transplanted gliomas and neurinomas and in clonal cell lines.
Determination of enolase isozymes in various adrenal gland tumours.
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Duodenal stromal tumor with neural differentiation.
Immunohistochemical profile of meningiomas and their histological subtypes.
Localization of neuron-specific (gamma gamma) enolase in proliferating (supportive and neoplastic) Schwann cells. An immunohisto- and electron-immunocyto-chemical study of ganglioneuroblastoma and schwannomas.
Oral granular cell tumours: a histological and immunocytochemical study.
Routine immunohistochemical characterization of short term in vitro explants from human intracranial tumours.
Schwannoma of the duodenum causing melena.
[Gastric schwannoma]
Neuroblastoma
A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.
A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter.
Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
An investigation of beta enolase as a histological marker of rhabdomyosarcoma.
Atypic SUMOylation of Nor1/NR4A3 regulates neural cell viability and redox sensitivity.
Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome.
Biochemical parameters in neuroblastoma.
Changes in the expression of the alpha alpha form of enolase during neuroblastoma differentiation.
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.
Clinical collection and use of peripheral blood stem cells in pediatric patients.
Clinical significance of gene amplification studied in human neuroblastoma xenografts: relationship with tumor growth rate, chemotherapeutic sensitivities and levels of neuron-specific enolase.
Clinical use of tumor markers in childhood malignancies.
Conservative treatment of massive hemothorax in a girl with neuroblastoma.
Cytogenetic and molecular evaluation of clinically aggressive esthesioneuroblastoma.
Cytomorphology and immunohistochemistry of extrarenal rhabdoid tumor: a case report with review of literature.
Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Demonstration of lymphoid antigens in decalcified bone marrow trephines.
Detection of metastatic neuroblastoma in bone marrow biopsy specimens with an antibody to neuron-specific enolase.
Detection of neuroblastoma cells in the bone marrow with immunohistochemical staining of neuron-specific enolase.
Determination of serum neuron-specific enolase by differential immunocapture.
Determination of three enolase isozymes and S-100 protein in various tumors in children.
Determination of urine neuron-specific enolase levels in neuroblastoma patients.
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.
Differential expression of neuron-specific enolase mRNA in mouse neuroblastoma cells in response to differentiation inducing agents.
Dual-signal electrochemiluminescence immunosensor for Neuron-specific enolase detection based on "dual-potential" emitter Ru(bpy)32+ functionalized zinc-based metal-organic frameworks.
Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome.
Effect of nerve growth factor on the expression of colchicine-binding activity and 14-3-2 protein in an established line of human neuroblastoma.
Effects of neurotoxins on neurone-specific enolase and lactate dehydrogenase activity and leakage in neuroblastoma cells.
Enolase activity in chicken embryo primary retina cells is not affected by exposure to a 60-Hz electric field.
Enolase isoenzyme distribution in the human brain and its tumours.
Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione.
Estimation of diagnostic value of chosen markers of neural differentiation in neuroblastoma group of tumors and pPNETs.
Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor").
Ewing's sarcoma family of tumor arising in the adrenal gland--possible diagnostic pitfall in pediatric pathology: histologic, immunohistochemical, ultrastructural, and molecular study.
EWSR1(22q12) Translocation Positive Pediatric Adrenal Tumor with Loss of 1p, 11q, and Unbalanced Gain of 17q: Neuroblastoma or Ewing Sarcoma?
Expression of a carboxy-terminal region of the beta-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity.
Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation.
Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Flow cytometric immunophenotyping and comparison with immunocytochemistry in small round cell tumors.
Gamma enolase expression as early marker of neuronal differentiation of murine neuroblastoma cells N-115.
High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.
High levels of Mn-superoxide dismutase in serum of patients with neuroblastoma and in human neuroblastoma cell lines.
Histologic and immunohistochemical investigation of neuroblastomas and correlation with prognosis.
Immunocytochemical and ultrastructural studies of the histogenesis of Ewing's sarcoma and putatively related tumors.
Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Immunohistochemical demonstration of neurone specific enolase in bone marrow infiltrated by neuroblastoma.
Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.
Immunohistochemical markers in (ganglio)neuroblastomas.
Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens.
Induction of S 100 protein by 5-bromo-2'-deoxyuridine in human neuroblastoma cell lines.
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Involvement of the YIGSR sequence of laminin in protein tyrosine phosphorylation.
Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.
Iron deficiency in children at the time of initial neuroblastoma diagnosis.
Isolation and characterization of non-neuronal enolase (NNE) from Neurospora crassa and comparison with neuron specific enolase isolated from neuroblastoma cell line NG108.
Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients.
Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role?
Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166).
N-myc amplification and neuron-specific enolase production of a neuroblastoma cell line and germ cell tumor cell lines.
Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma.
Nervous system-specific enolase in serum as a marker for neuroblastoma.
Neuroblastoma as a prominent component of a mixed germ cell tumor of testis.
Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?
Neuroblastoma in adults. Pathologic findings and clinical outcome.
Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor.
Neuron specific protein (NSP) in neuroblastoma cells: relation to differentiation.
Neuron-specific enolase as a differential marker in a case of retroperitoneal tumour.
Neuron-specific enolase as a marker for neuroblastoma and small-cell carcinoma of the lung.
Neuron-specific enolase evaluation in patients with neuroblastoma.
Neuron-specific enolase in neuroblastoma and other pediatric tumors: a comparative nude mouse and clinical investigation.
Neuron-specific enolase in relation to differentiation in human neuroblastoma.
Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children.
Neuron-specific enolase.
Neuron-specific enolase: reference values in cord blood.
Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma.
New autoantibodies in pediatric opsoclonus myoclonus syndrome.
Overexpression of tissue-nonspecific alkaline phosphatase increases the expression of neurogenic differentiation markers in the human SH-SY5Y neuroblastoma cell line.
Paravertebral Burkitt's Lymphoma in a Child: An Unusual Presentation.
Pathology of midline brain tumors. Immunocytochemical tumor markers and classificatory aspects.
Primary small cell carcinoma of the maxillary sinus: a case report with immunohistochemical and molecular genetic study involving KIT and PDGFRA.
Primitive neuroepithelial tumours of soft tissues and of bone: further ultrastructural and immunocytochemical clarification of 'Ewing's sarcoma', including freeze-fracture analysis.
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.
Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma.
Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma.
Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report.
Proteomic Analysis on Anti-Proliferative and Apoptosis Effects of Curcumin Analog, 1,5-bis(4-Hydroxy-3-Methyoxyphenyl)-1,4-Pentadiene-3-One-Treated Human Glioblastoma and Neuroblastoma Cells.
Purification and characterization of enolase from neuroblastoma cell line NG108.
Purification and characterization of neuron-specific gamma gamma enolase from human neuroblastoma: comparison with the brain enzyme.
Radioimmunoassay development for human neuron-specific enolase: with some clinical results in lung cancers and neuroblastoma.
Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Regulation of neuron-specific enolase in NG108-15 hybrid cells and C6BU-1 glioma cells.
Regulation of neuron-specific enolase isozyme levels during differentiation of murine neuroblastoma cell cultures.
Role of immunocytochemistry and DNA flow cytometry in the fine-needle aspiration diagnosis of malignant small round-cell tumors.
Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1-3 Months of Age.
Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
Small round cell neoplasms: can electron microscopy and immunohistochemical studies accurately classify them?
Spindle cell carcinoma of the nasal cavity.
The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis.
The diagnostic and prognostic value of pretreatment serum creatine kinase BB levels in patients with neuroblastoma.
Transition between isozymic forms of enolase during in vitro differentiation of neuroblastoma cells-II.
Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma.
[123I-MIBG scintigraphy in patients with neuroblastoma]
[Gamma-enolase (gamma-eno)]
[Neuroblastoma: biological markers, surgery, and clinical course]
[Pathological and immunohistochemical study of pineal parenchymal tumors]
[Radioimmunometric assay of neuron specific enolase in aqueous humor and serum in patients with retinoblastoma]
[The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients]
[Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma]
Neurocysticercosis
Neuron-specific enolase in patients with neurocysticercosis.
Neurocytoma
Central neurocytomas. Critical evaluation of a small-cell neuronal tumor.
Neurocytoma of the pituitary gland: A case report and literature review.
Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies.
Periventricular neurocytoma: a pathological entity.
Neurodegenerative Diseases
Detection of brain injury by fatty acid-binding proteins.
Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons.
Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice.
Genomic and proteomic responses to environmentally relevant exposures to dieldrin: indicators of neurodegeneration?
Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.
Proteomic analysis of rat cerebral cortex following subchronic acrolein toxicity.
Serum neuron-specific enolase is related to cerebellar connectivity - A resting-state fMRI pilot study.
Neuroectodermal Tumor, Melanotic
Melanotic Neuroectodermal Tumor of Infancy Arising in the Temporal Bone.
Neuroectodermal Tumors
Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1.
Pigmented neuroectodermal tumor of infancy. A light microscopic and immunohistochemical study.
Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Neuroectodermal Tumors, Primitive
Cerebral primitive neuroectodermal tumour in a heifer.
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Differentiation in medulloblastomas and other primitive neuroectodermal tumours.
Embryonal (botryoides) rhabdomyosarcoma of the uterus harboring a primitive neuroectodermal tumor component.
Establishment of a human cell line secreting neuron-specific enolase from a primitive neuroectodermal tumor of the retroperitoneal cavity.
EWS/FLI-1 fusion transcripts in three peripheral primitive neuroectodermal tumors of the kidney.
Immunocytochemical and ultrastructural studies of the histogenesis of Ewing's sarcoma and putatively related tumors.
Lumbar region intra-spinal primitive neuroectodermal tumour (PNET) combined with neurofibromatosis type 1.
Monoclonal antibody MB2: a potential marker for Ewing's sarcoma and primitive neuroectodermal tumor.
Mouth metastasis of peripheral primitive neuroectodermal tumor.
Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases.
Pathology of midline brain tumors. Immunocytochemical tumor markers and classificatory aspects.
Primary primitive neuroectodermal tumor of the cervix.
Primitive neuroectodermal tumor as a differential diagnosis of CD56-positive tumors in adults.
Primitive neuroectodermal tumor of lungs in adults: a rare series of three cases treated with upfront chemo-radiation.
Primitive neuroectodermal tumor of the median nerve. Case report with cytogenetic analysis.
Sinonasal small cell neoplasm developing after radiation therapy for retinoblastoma: an immunohistologic, ultrastructural, and cytogenetic study.
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Successful Radical Pneumonectomy for a Primitive Neuroendodermal Tumor in the Lung: A Case Report and Review of the Literature.
Neuroectodermal Tumors, Primitive, Peripheral
Adult extrarenal Wilms tumor of the uterus with teratoid features.
Peripheral primitive neuroectodermal tumor of the urinary bladder in an Arab woman with history of squamous cell carcinoma: a case report.
[Immunohistochemical study of neuron specific enolase in peripheral neuroectodermal tumors]
Neuroendocrine Tumors
Aace/Ace disease state clinical review: diagnosis and management of midgut carcinoids.
Aldolase C in neuroendocrine tumors: an immunohistochemical study.
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.
Canine adrenocorticotropic hormone-producing sinusoidal neuroendocrine tumor associated with Cushing's disease.
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.
Chromogranin-A as a serum marker for neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings.
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs.
Determination of three enolase isozymes and S-100 protein in various tumors in children.
Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumours.
Differentiated cerebral neuroblastoma: a tumor in need of discovery.
Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
Enolase subunits in patients with neuroendocrine tumors.
Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines.
Fine needle aspiration cytology of neuroendocrine tumors of the pancreas. A cytologic, immunocytochemical and electron microscopic study.
Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Gastrointestinal neuroendocrine tumors in 2020.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies.
Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
Localization of bombesin-like peptides in tumors.
Merkel cell carcinoma.
Neuroendocrine differentiation in stage D2 prostate cancers.
Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes.
Neuroendocrine tumours metastatic to the uvea: diagnosis by fine needle aspiration biopsy.
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
Neuron-specific enolase is produced by neuroendocrine tumours.
Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung.
Oral granular cell tumours: a histological and immunocytochemical study.
Peanut lectin: a histochemical marker for phaeochromocytomas.
Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.
Preparation and characterization of monoclonal antibodies to human neuron-specific enolase.
Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
Primary small cell carcinoma of the esophagus with ectopic gastrin production. Report of a case and review of the literature.
Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.
Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures.
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Re: Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.
Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors.
Serum neuron-specific enolase levels in patients with small cell carcinoma of the uterine cervix.
Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours.
The levels of three enolase subunits in human tumors; a low ?-/?-subunit ratio as indicator of tumors of neuronal and neuroendocrine nature.
The Role of Histopathology and Immunohistochemistry in the Diagnosis of Neuroendocrine Biliary Duct Tumor.
Tyrosine hydroxylase indicates cell differentiation of catecholamine biosynthesis in neuroendocrine tumors.
Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.
[Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin]
[Immunohistochemical study of 17 cases of rectal neuroendocrine tumors]
[Neuroendocrine prostate cancer].
[Neuroendocrine tumors of the kidneys].
[Significance of neuron-specific enolase (NSE) in the diagnosis of bronchial carcinomas and neuroendocrine tumors]
[Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study]
[The value of tumor markers in digestive oncology]
[Usefulness of chromogranin A determination in the diagnosis of neuroendocrine neoplasia]
Neurofibroma
A rapidly growing benign intrathoracic neurofibroma after lung lobectomy.
[Immunohistochemical studies of paraffin-embedded material of solitary cutaneous neurofibromas]
Neurofibromatoses
Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1.
Neurofibromatosis 1
Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1.
[Gastric schwannoma]
Neurofibrosarcoma
A new human malignant peripheral nerve sheath tumour-cell line, HS-sch-2, harbouring p53 point mutation.
Establishment and immunohistochemical characterization of an experimentally induced transplantable malignant schwannoma in the rat and two derived cell lines.
Malignant peripheral nerve sheath tumor in a hamster.
Malignant peripheral nerve sheath tumor of the breast: case report.
Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases.
Soft tissue sarcomas in the African hedgehog (Atelerix albiventris): microscopic and immunohistologic study of three cases.
Neuroinflammatory Diseases
S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation.
Neurologic Manifestations
MR and cerebrospinal fluid enzymes as sensitive indicators of subclinical cerebral injury after open-heart valve replacement surgery.
Neuroma, Acoustic
Enolase isoenzyme distribution in the human brain and its tumours.
Neuromuscular Diseases
Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
Neurothekeoma
An infiltrative variant of non-neural granular cell tumor: a case report.
Nevus
A nevocellular nevus consisting mostly of nevic corpuscles.
Congenital agminated Spitz nevi: immunoreactivity with a melanoma-associated monoclonal antibody.
Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Neuron-specific enolase and its mRNA are highly expressed in large congenital nevi: a study using immunocytochemistry, biochemical assay, and in situ hybridization.
Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study.
Nevus of Ota
Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Nevus, Blue
Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Nevus, Pigmented
Neuron-specific enolase and its mRNA are highly expressed in large congenital nevi: a study using immunocytochemistry, biochemical assay, and in situ hybridization.
Obesity
ENOblock inhibits the pathology of diet-induced obesity.
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
Proteomic profile of visceral adipose tissues between low-fat diet-fed obesity-resistant and obesity-prone C57BL/6 mice.
Obstetric Labor, Premature
Amniotic fluid neuron-specific enolase: a role in predicting neonatal neurologic injury?
Reference values of amniotic fluid neuron-specific enolase.
Oligodendroglioma
Atypical central neurocytoma: report of a case.
Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers.
Neuron-specific gamma-enolase derived from human glioma.
Oligodendroglioma with Neuronal Differentiation in Two Boxer Dogs.
Optic Atrophy, Hereditary, Leber
Neuron Specific Enolase is Elevated in Asymptomatic Carriers of Leber's Hereditary Optic Neuropathy.
Optic Nerve Diseases
Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients.
Neuron Specific Enolase is Elevated in Asymptomatic Carriers of Leber's Hereditary Optic Neuropathy.
Oral Submucous Fibrosis
Identification of ?-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
Oral Ulcer
Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Osteosarcoma
An investigation of beta enolase as a histological marker of rhabdomyosarcoma.
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Otitis Media
Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media.
Out-of-Hospital Cardiac Arrest
Arterial blood pressure during targeted temperature management after out-of-hospital cardiac arrest and association with brain injury and long-term cognitive function.
Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection.
Changes in Neuron-Specific Enolase are More Suitable Than Its Absolute Serum Levels for the Prediction of Neurologic Outcome in Hypothermia-Treated Patients with Out-of-Hospital Cardiac Arrest.
Comparison of Prognostic Performance between Neuron-Specific Enolase and S100 Calcium-Binding Protein B Obtained from the Cerebrospinal Fluid of Out-of-Hospital Cardiac Arrest Survivors Who Underwent Targeted Temperature Management.
Impact of low and high partial pressure of carbon dioxide on neuron-specific enolase derived from serum and cerebrospinal fluid in patients who underwent targeted temperature management after out-of-hospital cardiac arrest: A retrospective study.
Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making.
Near-infrared spectroscopy after out-of-hospital cardiac arrest.
Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis.
Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia-experience from the HAnnover COoling REgistry (HACORE).
Neuron specific enolase and Glasgow motor score remain useful tools for assessing neurological prognosis after out-of-hospital cardiac arrest treated with therapeutic hypothermia.
Neuron-Specific Enolase and long-term neurological outcome after OHCA - a validation study.
Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33°C and 36°C.
Neuron-specific enolase concentrations for the prediction of poor prognosis of comatose patients after out-of-hospital cardiac arrest: an observational cohort study.
Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients.
Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100.
Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after out-of-hospital ventricular fibrillation and therapeutic hypothermia.
Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study.
Serial disseminated intravascular coagulation score with neuron specific enolase predicts the mortality of cardiac arrest-a pilot study.
Serum Neuron Specific Enolase and Malondialdehyde in Patients After Out-Of-Hospital Cardiac Arrest.
Serum neuron-specific enolase measurement for neuro-prognostication post out-of-hospital cardiac arrest: Determination of the optimum testing strategy in routine clinical use.
Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest - A TTM-Trial Substudy.
The Combination of Biomarkers for Prognostication of Long-Term Outcome in Patients Treated with Mild Hypothermia After Out-of-Hospital Cardiac Arrest-A Pilot Study.
Usefulness of early plasma S-100B protein and Neuron-Specific Enolase measurements to identify cerebrovascular etiology of out-of-hospital cardiac arrest.
Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC.
Ovarian Neoplasms
Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies.
Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells.
Overweight
Association between serum neuron-specific enolase, age, overweight, and structural MRI patterns in 901 subjects.
Pancreatic Neoplasms
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
Circulating Autoantibodies to Phosphorylated alpha-Enolase are a Hallmark of Pancreatic Cancer.
Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
Laparotomy Cryoablation in Rabbit VX2 Pancreatic Carcinoma.
Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Pancreatitis
Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Pancreatitis, Chronic
Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Papilloma
Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Choroid plexus tumours--an immunohistochemical analysis with review of literature.
Colloid cyst of the third ventricle. A comparative immunohistochemical study of neuraxis cysts and choroid plexus epithelium.
Papilloma, Choroid Plexus
Choroid plexus tumours--an immunohistochemical analysis with review of literature.
Colloid cyst of the third ventricle. A comparative immunohistochemical study of neuraxis cysts and choroid plexus epithelium.
Paraganglioma
A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
A comparison of paraganglioma, carcinoid tumor, and small-cell carcinoma of the larynx.
Alveolar soft part sarcoma, granular cell tumor, and paraganglioma. An immunohistochemical comparative study.
Alveolar soft-part sarcoma. A review on its histogenesis and further studies based on electron microscopy, immunohistochemistry, and biochemistry.
Cauda equina tumor with ependymal and paraganglionic differentiation.
Combination chemotherapy for malignant paraganglioma.
Cytokeratins expression in paragangliomas of the cauda equina.
Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study.
Duodenal gangliocytic paraganglioma as a radiological moving defect.
Immunohistochemical expression patterns of S100, synaptophysin, chromogranin A and neuron specific enolase in predicting malignant behaviour in paragangliomas.
Malignant jugulotympanic paraganglioma in a dog.
Obstructive jaundice due to a rare periampullary tumor.
Paraganglioma in pituitary fossa.
Paraganglioma of the cauda equina: a histological, ultrastructural and immunocytochemical study of two cases with a review of the literature.
Paraganglioma of the thyroid gland: a case report.
Paraganglioma of the thyroid: report of a male case with ultrasonographic imagings, cytologic, histologic, and immunohistochemical features.
Primary nasopharyngeal paraganglioma: a case report.
The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma.
Thyroid Paraganglioma Diagnosed by Fine-Needle Aspiration Biopsy, Correlated With Histopathological Findings: Report of a Case.
[Pheochromocytomas as adrenal gland incidentalomas]
Paraganglioma, Extra-Adrenal
Immunohistochemical characteristics of canine aortic and carotid body tumours.
[New histopathologic data of prognostic value in extra-adrenal paragangliomas. Study of 9 cases]
Parakeratosis
Enolase-1 expression in the stratum corneum is elevated with parakeratosis of atopic dermatitis and disrupts the cellular tight junction barrier in keratinocytes.
Paraneoplastic Syndromes, Ocular
Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.
Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus.
Cancer-associated retinopathy 4 years after surgery for ovarian cancer.
Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy.
The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy.
The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.
Parasitic Diseases
Complete Molecular and Immunoprotective Characterization of Babesia microti Enolase.
[Enolase and parasitic infection].
Parasomnias
Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Parathyroid Neoplasms
S-100 protein and neuron-specific enolase in parathyroid glands and C-cells of the thyroid.
Parkinson Disease
Cerebrospinal fluid levels of alpha-synuclein, amyloid ?, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
Increased Striatal mRNA and Protein Levels of the Immunophilin FKBP-12 in Experimental Parkinson's Disease and Identification of FKBP-12-Binding Proteins.
Mass spectrometry detection and characterization of noncovalent protein complexes.
S100B and NSE serum levels in patients with Parkinson's disease.
Pericarditis
The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis.
Periodontitis
Dysbiosis in chronic periodontitis: Key microbial players and interactions with the human host.
Pathogenic potential of Tannerella forsythia enolase.
Periodontitis in RA-the citrullinated enolase connection.
Treponema denticola enolase contributes to the production of antibodies against ENO1 but not to the progression of periodontitis.
Peripheral Nervous System Diseases
Effect of photobiomodulation on serum neuron specific enolase (NSE) among patients with diabetic peripheral neuropathy - A pilot study.
The etiology of toxic peripheral neuropathies: in vitro effects of acrylamide and 2,5-hexanedione on brain enolase and other glycolytic enzymes.
Peripheral Nervous System Neoplasms
For which cancer types can neuron-specific enolase be clinically helpful in Turkish patients?
Persistent Infection
Definitive host influences the proteomic profile of excretory/secretory products of the trematode Echinostoma caproni.
Persistent Vegetative State
Optimizing neurologic prognosis after cardiac arrest.
Pheochromocytoma
A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese.
Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation.
Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Increased levels of neuron-specific enolase in PC12 pheochromocytoma cells as a result of nerve growth factor treatment.
Lipid degeneration in a pheochromocytoma histologically mimicking an adrenal cortical tumor.
Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.
Pheochromocytoma combined with malignant schwannoma: unusual neoplasm of the adrenal medulla.
Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor.
Pheochromocytoma of the urinary bladder. Report of 2 cases with ultrastructural and immunohistochemical analyses.
Rare pediatric adrenocortical carcinoma with oncocytic change: a cytologic dilemma.
[A case of malignant pheochromocytoma with high levels of serum neuron-specific enolase (NSE) and calcitonin]
[Pheochromocytomas as adrenal gland incidentalomas]
phosphopyruvate hydratase deficiency
Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis.
Chronic hemolytic anemia associated with erythrocyte enolase deficiency exacerbated by ingestion of nitrofurantoin.
Effects of the G376E and G157D mutations on the stability of yeast enolase--a model for human muscle enolase deficiency.
Enolase activates homotypic vacuole fusion and protein transport to the vacuole in yeast.
Metabolic and drug-induced muscle disorders.
Normalization of red cell enolase level following allogeneic bone marrow transplantation in a child with Diamond-Blackfan anemia.
Plasmodium falciparum enolase complements yeast enolase functions and associates with the parasite food vacuole.
The need for biochemical testing in beta-enolase deficiency in the genomic era.
Pinealoma
An immunohistopathologic study of trilateral retinoblastoma.
Expression of hydroxyindole-O-methyltransferase enzyme in the human central nervous system and in pineal parenchymal cell tumors.
Pituitary Diseases
Anti-alpha-enolase antibodies in pituitary disease.
Pituitary Neoplasms
ACTH-producing pituitary tumors in transgenic mice. An ultrastructural and immunoelectron microscopic study.
Anti-alpha-enolase antibodies in pituitary disease.
Comparative immunohistochemical study of stellate cells in normal canine and equine adenohypophyses and in pituitary tumours.
Differential expression of the neural cell adhesion molecule NCAM 140 in human pituitary tumors.
Enolase distribution in human brain tumors, retinoblastomas and pituitary adenomas.
Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
Immunohistochemistry of folliculo-stellate cells in normal human adenohypophyses and in pituitary adenomas.
Paraganglioma in pituitary fossa.
Secretion of neuron-specific enolase, prolactin, growth hormone, luteinising hormone and follicle stimulating hormone by "functionless" and endocrine-active pituitary tumours in vitro.
Serum neuron-specific enolase in patients with pituitary adenoma.
[The value of neuron-specific enolase assay in pituitary adenoma]
Pleural Effusion
Cell culture of small round cell tumor originating in the thoracopulmonary region. Evidence for derivation from a primitive pluripotent cell.
Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions
Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.
Diagnostic value of tumour markers in pleural effusions.
Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Elevated progastrin-releasing peptide(31-98) concentrations in pleural effusions due to small-cell lung carcinoma.
Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.
Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report.
Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis.
Peripheral neuroectodermal tumor presenting pleural effusion.
Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.
Tumor markers in pleural effusions.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
[Diagnostic usefulness of neurospecific enolase determination in pleural fluid]
[Neuron-specific enolase in pleural effusions of various etiologies]
[Pyothorax associated lymphoma with increased neuron-specific enolase level in serum and pleural effusion: a case report]
[Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion.]
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
Pleural Effusion, Malignant
Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis.
Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.
Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
[Diagnositic values of combined determination of carbohydrate antigen and tissue polypeptide antigen and neuron-specific enolase and carcinoembryonic antigen in the malignant pleural effusion.]
[Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]
[Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion.]
Pleurisy
Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Diagnostic value of tumor markers Cyfra 21-1 and neuron-specific enolase in analysis of pleural fluid.
Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Pneumococcal Infections
Molecular docking of alpha-enolase to elucidate the promising candidates against Streptococcus pneumoniae infection.
Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic.
Pneumoconiosis
[Changes of serum neuron-specific enolase and serum ferritin levels in patients with pneumoconiosis].
Pneumonia
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Neuron-specific enolase concentrations in serum in nonneoplastic patients with pneumonia.
Pseudomonas aeruginosa Enolase Influences Bacterial Tolerance to Oxidative Stresses and Virulence.
Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung.
Pneumothorax
Nonspecific benign pathological results on computed tomography-guided lung biopsy: A predictive model of true negatives.
Polyendocrinopathies, Autoimmune
Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus.
Pituitary autoantibodies in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Polyneuropathies
Cerebrospinal fluid levels of S-100b protein and neuron-specific enolase in chronic inflammatory demyelinating polyneuropathy.
Port-Wine Stain
Ectatic blood vessels in port-wine stains lack innervation: possible role in pathogenesis.
Post-Concussion Syndrome
One-year follow-up of mild traumatic brain injury: post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S-100B and neurone-specific enolase in acute phase.
Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review.
Prader-Willi Syndrome
Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Pre-Eclampsia
Absence of innervation of the uteroplacental arteries in normal and abnormal human pregnancies.
Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study.
Cerebral Biomarkers in Women With Preeclampsia Are Still Elevated 1 Year Postpartum.
Correlation between cerebral biomarkers and optic nerve sheath diameter in patients with severe preeclampsia.
Neonatal neuron specific enolase, a sensitive biochemical marker of neuronal damage, is increased in preeclampsia: A retrospective cohort study.
Plasma Levels of the Cerebral Biomarker, Neuron-Specific Enolase, are Elevated During Pregnancy in Women Developing Preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Childhood leukemia: cerebrospinal fluid enolase isoenzymes in central nervous system infiltration.
ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study.
Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leukemia during induction treatment.
Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis.
[NSE-positive lymphoblastic lymphoma in a boy with cutaneous involvement, giant splenomegaly, and hyper-gamma globulinemia]
Primary Ovarian Insufficiency
Alpha-enolase: a novel autoantigen in patients with premature ovarian failure.
Autoimmunity and premature ovarian failure.
Prion Diseases
Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease.
Distinct transmissibility features of TSE sources derived from ruminant prion diseases by the oral route in a transgenic mouse model (TgOvPrP4) overexpressing the ovine prion protein.
Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease.
Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.
Protein expression of human neuron-specific enolase and its antiserum preparation.
Prostatic Hyperplasia
The distribution of S-100 protein in hyperplastic and neoplastic prostatic epithelium.
Prostatic Intraepithelial Neoplasia
Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
Prostatic Neoplasms
A more objective staging of advanced prostate cancer--routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values.
An Experimental Platform for Characterizing Cancer Biomarkers with Capabilities in Noninvasive and Continuous Screening.
Anaplastic lymphoma kinase mutation (
Anterior gradient 2 (AGR2): Blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.
BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell.
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer.
Chromogranin A and neuron-specific enolase serum levels as predictors of treatment outcome in metastatic castration-resistant prostate cancer patients under abiraterone therapy.
Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer.
EGR1 target genes in prostate carcinoma cells identified by microarray analysis.
Enolase isoenzymes as tumour markers.
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
For which cancer types can neuron-specific enolase be clinically helpful in Turkish patients?
Gastrin-releasing peptide: Predictor of castration-resistant prostate cancer?
Hypercalcemia in prostate cancer with positive neuron-specific enolase stain.
Interaction of IGF-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells.
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Neuroendocrine differentiation in stage D2 prostate cancers.
Neuroendocrine serum tumour markers in hormone-resistant prostate cancer.
Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
Serum chromogranin A: early detection of hormonal resistance in prostate cancer patients.
Serum chromogranin-A in advanced prostate cancer.
The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.
The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature.
Prostatitis
Increased chromogranin A and neuron-specific enolase in rats with chronic nonbacterial prostatitis induced by 17-beta estradiol combined with castration.
Pseudotumor Cerebri
Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertension.
Pulmonary Disease, Chronic Obstructive
Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China.
The association of serum neuron-specific enolase with other disease markers in chronic obstructive pulmonary disease: A case-control study.
[Blood levels of CA-50, CA-19.9, CA-125, enolase, CA-15.3 and carcinoembryonic antigen in non-cancerous bronchopulmonary pathology]
Pulmonary Edema
Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness.
Pulmonary Heart Disease
[Study of plasma neuron-specific enolase activity of patients with chronic pulmonary heart disease complicated by pulmonary encephalopathy]
Rabies
Cholinergic system in experimental rabies in mice.
Raynaud Disease
[Anti-centriole antibodies and high neuron-specific enolase activity in a patient with Raynaud phenomenon, cerebrovascular lesions, and ischemic finger necrosis--a functional relationship?]
Renal Insufficiency
Serum levels of five tumor markers for lung cancer in patients with chronic renal failure.
Testicular germ cell loss in children with renal failure.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Renal Insufficiency, Chronic
Alpha-enolase staining patterns in the renal tissues of cats with and without chronic kidney disease.
[Tumour markers in chronic kidney disease.]
Reperfusion Injury
Biochemical markers of perinatal brain damage.
Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury.
Serum Neuron-Specific Enolase as a Marker of Brain Ischemia-Reperfusion Injury in Patients Undergoing Carotid Endarterectomy
Respiratory Distress Syndrome
Optimized Clustering Algorithm for Comparative Analysis of Different Prenatal Corticosteroid Neurological Deficits in Premature Infants through Magnetic Reasoning Imaging (MRI).
Respiratory Tract Infections
Diagnostic value of serum neutrophil gelatinase-associated lipocalin, interleukin-6 and anti-citrullinated alpha-enolase peptide 1 for lower respiratory tract infections.
Retinal Degeneration
Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.
Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome.
The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.
Retinal Detachment
Concentration of neuron-specific enolase and S100 protein in the subretinal fluid of rhegmatogenous retinal detachment.
Neuron specific enolase in retinal detachment.
Retinal Dysplasia
Glial-, neuronal- and photoreceptor-specific cell markers in rosettes of retinoblastoma and retinal dysplasia.
Retinal Dystrophies
Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report.
Retinoblastoma
A study of 39 retinoblastomas with particular reference to morphology, cellular differentiation and tumour origin.
An immunohistopathologic study of trilateral retinoblastoma.
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.
Effect of 8-bromo-cyclic AMP on neuron specific enolase, heat shock protein, nitric oxide, nitric oxide synthase and nitric oxide synthase mRNA in human retinoblastoma HXO-Rb44 cells and cell differentiation.
Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.
Electrophoretic determination of aqueous and serum neuron-specific enolase in the diagnosis of retinoblastoma.
Enolase distribution in human brain tumors, retinoblastomas and pituitary adenomas.
Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth.
Fine needle aspiration biopsy of pediatric orbital tumors. An immunocytochemical study.
Flow cytometric immunophenotyping and comparison with immunocytochemistry in small round cell tumors.
Glial-, neuronal- and photoreceptor-specific cell markers in rosettes of retinoblastoma and retinal dysplasia.
High concentrations of enolase, alpha- and gamma-subunits, in the aqueous humor in cases of retinoblastoma.
High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas.
Immunohistochemical characterization of human retinoblastomas in situ with multiple markers.
Immunohistochemical demonstration of neuronal and astrocytic markers and oncofoetal antigens in retinoblastomas.
Immunohistochemical diagnosis of a totally necrotic retinoblastoma: a clinicopathologic case.
Immunohistochemical staining techniques of intraocular tumors.
Immunohistochemistry of retinoblastomas in humans.
MiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cells.
Neuron-specific enolase and retinoblastoma. Clinicopathologic correlations.
Neuron-specific enolase in retinoblastoma. An immunohistochemical study.
Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma.
Retinoblastoma--a histologic and immunohistologic study.
Retinoblastoma--origin from a primitive neuroectodermal cell?
Studies of ocular retinoblastomas with immunoperoxidase techniques.
Unilateral retinoblastoma in an adult: report of a case and review of the literature.
[A preliminary study of retinoblastoma-related serum tumor markers].
[Electrophoretic determination of aqueous and serum neuron-specific enolase (NSE) in the diagnosis of retinoblastoma]
[Neuron-specific enolase in the aqueous humor. Its significance in the differential diagnosis of retinoblastoma]
[Radioimmunometric assay of neuron specific enolase in aqueous humor and serum in patients with retinoblastoma]
[The determination of neuron-specific enolase of serum in the diagnosis and supervision of retinoblastoma]
Reye Syndrome
Neuron-specific enolase in comatose children.
The neuron-specific enolase as a marker of brain destruction in a case of Reye's syndrome: related to the treatment of brain edema.
Rhabdoid Tumor
Malignant rhabdoid tumor of the colon: report of a case.
Rhabdomyoma
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.
Rhabdomyosarcoma
Alveolar soft part sarcoma. An immunohistochemical, cytologic and electron-microscopic study and a quantitative DNA analysis.
An investigation of beta enolase as a histological marker of rhabdomyosarcoma.
Comparison of beta enolase and myoglobin as histological markers of rhabdomyosarcoma.
Cytomorphology and immunohistochemistry of extrarenal rhabdoid tumor: a case report with review of literature.
Determination of three enolase isozymes and S-100 protein in various tumors in children.
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.
Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens.
Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.
Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases.
Rhabdomyosarcoma in a racing pigeon (Columba livia).
[Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma]
Rhabdomyosarcoma, Embryonal
Fine needle aspiration biopsy of pediatric orbital tumors. An immunocytochemical study.
[A case of embryonal rhabdomyosarcoma of the kidney]
Rubella
[Neuron-specific enolase activity in rubella encephalitis]
Salivary Gland Neoplasms
Immunopathological study of neuropeptide expression in human salivary gland neoplasms.
Sarcoma
Alveolar soft part sarcoma, granular cell tumor, and paraganglioma. An immunohistochemical comparative study.
An investigation of beta enolase as a histological marker of rhabdomyosarcoma.
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
Case of clear cell sarcoma in the left buttock in which serum neuron-specific enolase was a useful marker for monitoring disease progression.
Distribution of beta-enolase in normal and tumor rat cells.
Extrarenal rhabdoid sarcoma.
Granular cell tumors of the urinary bladder.
Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's sarcoma in bone and soft tissue.
Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies.
Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH).
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Subcutaneous sarcomas of probable neuronal origin in a transgenic mouse strain containing an albumin promoter-fused simian virus 40 large T antigen gene.
[A case of soft tissue alveolar sarcoma localized in the tongue]
[Alveolar soft part sarcoma: a clinicopathologic and immunohistochemical study of 13 cases]
Sarcoma, Alveolar Soft Part
Alveolar soft part sarcoma, granular cell tumor, and paraganglioma. An immunohistochemical comparative study.
[A case of soft tissue alveolar sarcoma localized in the tongue]
[Alveolar soft part sarcoma: a clinicopathologic and immunohistochemical study of 13 cases]
Sarcoma, Avian
Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity.
Influence of transformation by Rous sarcoma virus on the amount, phosphorylation and enzyme kinetic properties of enolase.
Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.
Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo.
The 46,000-dalton tyrosine protein kinase substrate is widespread, whereas the 36,000-dalton substrate is only expressed at high levels in certain rodent tissues.
Sarcoma, Clear Cell
Case of clear cell sarcoma in the left buttock in which serum neuron-specific enolase was a useful marker for monitoring disease progression.
Sarcoma, Ewing
A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.
Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.
Disodium Cromolyn and Anti-podoplanin Antibodies Strongly Inhibit Growth of BHK 21/C13-derived Fibrosarcoma in a Chick Embryo Chorioallantoic Membrane Model.
Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study.
EWSR1(22q12) Translocation Positive Pediatric Adrenal Tumor with Loss of 1p, 11q, and Unbalanced Gain of 17q: Neuroblastoma or Ewing Sarcoma?
Histological and cytogenetic findings in a malignant tumor of the chest wall and lung (Askin tumor).
Immunohistochemical expression of neuron-specific enolase and Leu 7 in Ewing's sarcoma of bone.
Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's sarcoma in bone and soft tissue.
Primitive neuroectodermal tumor of the myocardium: a case report, review of the literature, immunohistochemical, and ultrastructural study.
Serum neuron-specific enolase (NSE) as a tumour marker for the Ewing's sarcoma family of tumours.
[Ewing's sarcoma of bone in adults: an anatomic-clinical study of 30 cases]
Sarcoma, Myeloid
Small round cell neoplasms: can electron microscopy and immunohistochemical studies accurately classify them?
Scleroderma, Systemic
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis.
Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
UVA1-induced decrease in dermal neuron-specific enolase (NSE) in acrosclerosis.
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments.
Scrapie
Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.
Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent.
Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype.
Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59).
Seizures
Analysis of cerebrospinal fluid glial fibrillary acidic protein after seizures in children.
Antiapoptotic and neuroprotective role of Curcumin in Pentylenetetrazole (PTZ) induced kindling model in rat.
Brain injury markers in new-onset seizures in adults: A pilot study.
Cerebrospinal fluid neuron specific enolase, interleukin-1? and erythropoietin concentrations in children after seizures.
Cerebrospinal fluid neuron-specific enolase following seizures in children: role of etiology.
Effect of add-on melatonin on seizure outcome, neuronal damage, oxidative stress, and quality of life in generalized epilepsy with generalized onset motor seizures in adults: A randomized controlled trial.
Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial.
Effect of intravenous immunoglobulin treatment on brain interferon-gamma and interleukin-6 levels in a rat kindling model.
Efficacy of Citicoline as a Neuroprotector in children with post cardiac arrest: a randomized controlled clinical trial.
Electroencephalographic characteristics of status epilepticus after cardiac arrest.
Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: A video-EEG study.
Good Outcome in Cardiac Arrest Patients in Refractory Status Epilepticus: A Result of Aggressive Treatment or EEG Reclassification.
Hormonal alterations following seizures.
Immunocytochemistry of neuron specific enolase (NSE) in the rat brain after single and repeated epileptic seizures.
Kinetics of serum neuron-specific enolase and prolactin in patients after single epileptic seizures.
Lack of Variability in Cerebral Oximetry Tendency in Infants with Severe Hypoxic-Ischemic Encephalopathy Under Hypothermia.
Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation.
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment.
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment.
Neuron specific enolase as a marker of seizure related neuronal injury.
Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse.
Neuron-specific enolase is increased after nonconvulsive status epilepticus.
Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring.
Non increased neuron-specific enolase concentration in cerebrospinal fluid during first febrile seizures and a year follow-up in pediatric patients.
Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures.
Plasma fluoroacetic acid concentrations: Symptoms, hematological, and biochemical characteristics in patients with fluoroacetic acid poisoning in the emergency department.
Prediction of poor neurological outcome in comatose survivors of cardiac arrest: a systematic review.
RB and Cdc2 expression in brain: correlations with 3H-thymidine incorporation and neurogenesis.
Relationship of serum ATPase activity and the levels of neuron- specific enolase, S100B and B-cell lymphoma/leukemia-2 with cognitive function after epileptic seizure.
Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: A diagnostic validity.
Serum and CSF neuron-specific enolase in patients with West syndrome.
Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures.
Serum neuron-specific enolase in children with febrile seizures: time profile and prognostic implications.
Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope.
Serum neuron-specific enolase, prolactin, and creatine kinase after epileptic and psychogenic non-epileptic seizures.
Synaptic proteins after electroconvulsive seizures in immature rats.
Understanding and Managing the Ictal-Interictal Continuum in Neurocritical Care.
[Neuron-specific enolase activities in patients with convulsion]
Seizures, Febrile
Cerebrospinal fluid and serum neuron-specific enolase levels after febrile seizures.
Cerebrospinal fluid neuron-specific enolase following seizures in children: role of etiology.
Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures.
Non increased neuron-specific enolase concentration in cerebrospinal fluid during first febrile seizures and a year follow-up in pediatric patients.
Serum neuron-specific enolase in children with febrile seizures: time profile and prognostic implications.
Seminoma
A clinicopathologic, histologic, and immunohistochemical study of mixed germ cell-stromal tumors of the testis in 16 dogs.
Enolase isozymes in seminoma.
Neuron-specific enolase--a serum tumour marker in seminoma?
Neuron-specific enolase.
New cancer markers.
Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
Spermatocytic Seminoma With Neuroectodermal Differentiation and Sertoli Cell Tumor in a Dog.
Spermatocytic seminoma: an immunohistochemical study.
The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma.
Sepsis
Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis.
Cerebral blood flow and serum neuron-specific enolase in early-onset neonatal sepsis.
Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis.
Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
Glutamine's protection against brain damage in septic rats via increased protein oxygen-N-acetylglucosamine modification.
Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2.
Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock.
Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation.
The value of neutrophil gelatinase-associated lipocalin and citrullinated alpha enolase peptide-1 antibody in diagnosis, classification, and prognosis for patients with sepsis.
[Expression level of glial fibrillary acidic protein and its clinical significance in patients with ?sepsis-associated encephalopathy].
Sepsis-Associated Encephalopathy
Sepsis-associated encephalopathy and its differential diagnosis.
Serum S100? is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
Sex Cord-Gonadal Stromal Tumors
Immunohistochemical Characterization of Nonhuman Primate Ovarian sex Cord-Stromal Tumors.
Shock, Septic
Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock.
[Changes of serum neuron specific enolase in rats with septic shock]
Silicosis
Serum neuron-specific enolase: A promising biomarker of silicosis.
[Changes of neuron specific enolase in serum of patients with silicosis].
Sjogren's Syndrome
Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.
Sleep Deprivation
Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men.
Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system.
Sleep Initiation and Maintenance Disorders
Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist?
Sleep Wake Disorders
Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Small Cell Lung Carcinoma
A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.
A ureteral small cell carcinoma mixed with malignant mesodermal and ectodermal elements: a clinicopathological, morphological and immunohistochemical study.
A wireless point-of-care testing system for the detection of neuron-specific enolase with microfluidic paper-based analytical devices.
Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer.
An Experimental Platform for Characterizing Cancer Biomarkers with Capabilities in Noninvasive and Continuous Screening.
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide.
Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Biomarkers along the continuum of care in lung cancer.
Chemiluminescence enzyme immunoassay using magnetic nanoparticles for detection of neuron specific enolase in human serum.
Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer.
Cut-off levels of NSE to differentiate SCLC from NSCLC.
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy.
Determination of serum neuron-specific enolase by differential immunocapture.
Differences in initial NSE levels in malignant and benign diseases of the thoracic wall.
Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.
Do neuron-specific enolase levels discriminate between small-cell lung cancer and mediastinal tumors?
Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis.
Dual Immunomagnetic Nanobeads-Based Lateral Flow Test Strip for Simultaneous Quantitative Detection of Carcinoembryonic Antigen and Neuron Specific Enolase.
Dual Molecularly Imprinted Polymer-Based Plasmonic Immunosandwich Assay for the Specific and Sensitive Detection of Protein Biomarkers.
Dual-signal electrochemiluminescence immunosensor for Neuron-specific enolase detection based on "dual-potential" emitter Ru(bpy)32+ functionalized zinc-based metal-organic frameworks.
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide.
Enolase isoenzymes as tumour markers.
Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio.
Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Establishment and evaluation of a radioimmunoassay for neuron-specific enolase. A marker for small cell lung cancer.
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
Evaluation of histochemical anthracyclin binding as potential prognostic parameter in small cell lung cancer.
Facilitating serum determination of neuron specific enolase at clinically relevant levels by coupling on-line molecularly imprinted solid-phase extraction to LC-MS/MS.
High Sensitive Immunoelectrochemical Measurement of Lung Cancer Tumor Marker ProGRP Based on TiO?-Au Nanocomposite.
High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report.
Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small cell lung cancer: clinical evaluation and biological hypothesis.
Immunocapture and LC-MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum.
Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer.
Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer.
Isoenzyme pattern of enolase and creatine kinase in small cell lung cancer patients.
Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells.
Label-free electrochemical immunoassay for neuron specific enolase based on 3D macroporous reduced graphene oxide/polyaniline film.
Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer.
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Mediastinal lymph node metastasis of renal cell carcinoma: A case report.
Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS.
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.
Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.
Neuron specific enolase expression in carcinoma of the lung.
Neuron specific enolase in small cell lung cancer. Clinical and biochemical evaluation.
Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.
Neuron specific enolase promotes tumor metastasis by activating the Wnt/?-catenin pathway in small cell lung cancer.
Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer.
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Neuron-specific enolase (NSE) in bronchial washings: a better diagnostic marker for small cell lung cancer.
Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.
Neuron-specific enolase as a guide to the treatment of small cell lung cancer.
Neuron-specific enolase during chemotherapy of small cell lung cancer.
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
Neuron-specific enolase.
Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Neurone-specific enolase and liver metastasis in small cell lung cancer.
Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis.
New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1.
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
On-Chip Spyhole Nanoelectrospray Ionization Mass Spectrometry for Sensitive Biomarker Detection in Small Volumes.
On-line duplex molecularly imprinted solid-phase extraction for analysis of low-abundant biomarkers in human serum by liquid chromatography-tandem mass spectrometry.
Peripheral primitive neuroectodermal tumor of the chest wall of a 69-year-old man.
Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.
Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer.
Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer.
Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis.
Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation.
Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?
Reevaluaton of the usefulness of systematic bone scanning in initial staging and follow-up of small cell lung carcinoma, taking into account the serum levels of neuron-specific enolase.
Right Lung Consolidation Combined Elevated Serum Neuron Specific Enolase Misdiagnosed as Lung Carcinoma Ultimately Confirmed Pulmonary Cryptococcosis by CT-guided Percutaneous Lung Biopsy: a Case Report and Literature Review.
Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis.
Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
Significance of tumor markers in lung cancer.
Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma.
Systematic review and meta-analysis of the efficacy of serum neuron-specific enolase for early small cell lung cancer screening.
The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis.
The combination of pretreatment prognostic nutritional index and neuron-specific enolase enhances prognosis predicting value of small cell lung cancer.
The diagnostic value of neuron-specific enolase and carcino-embryonic antigen analyses in patients with carcinoma of the lung.
The prognostic influence of serum neuron specific enolase in small cell lung cancer.
The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
Therapy for small cell and non-small cell lung cancer.
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Ultrasensitive electrochemical detection of neuron-specific enolase based on spiny core-shell Au/CuxO@CeO2 nanocubes.
Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
[Clinical significance of detection of serum values of neuron specific enolase before and after treatment for small cell lung cancer].
[Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer]
[Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]
[Diagnostic value of ProGRP and NSE for small cell lung cancer: a meta-analysis].
[Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase]
[Level of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of small cell lung cancer patients: correlation with performance status, disease extent and prognosis]
[Neuron specific enolase in small cell lung cancer]
[Neuron-specific enolase: a new marker for small-cell pulmonary carcinoma]
[Recent progress in the biology of small cell bronchial carcinoma]
[Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer]
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]
[The changes in serum neuron-specific enolase in patients with small cell lung cancer]
[The prognostic value of serum neuron specific enolase detection in small cell lung cancer]
[The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma]
[The value of determining neuron specific enolase for diagnosis of complete remission during treatment of small cell lung cancer]
[Treatment monitoring of patients with small cell lung cancer by determining levels of serum neuron specific enolase]
[Tumor markers in bronchus cancer]
[Usefulness of monitoring levels of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of patients with small cell lung cancer for evaluating treatment outcome]
[Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma].
Solitary Fibrous Tumors
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
Solitary Pulmonary Nodule
Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage.
Spasms, Infantile
Serum and CSF neuron-specific enolase in patients with West syndrome.
Spina Bifida Cystica
Neurone specific enolase in amniotic fluid: a potential marker of anencephaly.
Spinal Cord Compression
Experimental subacute spinal cord compression: correlation of serial S100B and NSE serum measurements, histopathological changes, and outcome.
Spinal Cord Diseases
Elevated serum levels of neuron specific enolase in lymphoid leukaemia.
Spinal Cord Injuries
Adenosine triphosphate promotes locomotor recovery after spinal cord injury by activating mammalian target of rapamycin pathway in rats.
Biomarkers in spinal cord injury.
Combined Method of Neuronal Cell-Inducible Vector and Valproic Acid for Enhanced Gene Expression under Hypoxic Conditions.
Diagnostic value of Serum Level of GFAP, NF-H and NSE Compared with Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury.
Enolase and Acute Spinal Cord Injury.
Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury.
Implications of enolase in the RANKL-mediated osteoclast activity following spinal cord injury.
Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.
Serum Biomarkers for Experimental Acute Spinal Cord Injury: Rapid Elevation of Neuron-specific Enolase and S-100?.
Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta.
Serum Biomarkers for Experimental Acute Spinal Cord Injury: Rapid Elevation of Neuron-specific Enolase and S-100beta.
Structural biomarkers in the cerebrospinal fluid within 24?h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.
Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.
Temporal-spatial expression of ENOLASE after acute spinal cord injury in adult rats.
The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of Acute Spinal Cord Injury.
Spinal Cord Ischemia
Assessment of Neurone-Specific Enolase, Glial Fibrillary Acidic Protein and S100 B as Spinal Cord Ischemia Biomarkers in Patients Undergoing Open and Endovascular Complex Aortic Surgery: A Single-Center Experience.
Spinocerebellar Ataxias
Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Spirochaetales Infections
A surface enolase participates in Borrelia burgdorferi-plasminogen interaction and contributes to pathogen survival within feeding ticks.
Spondylosis
[Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with cervical spondylosis and ossification of posterior longitudinal ligaments]
Sporotrichosis
Immunization with recombinant enolase of Sporothrix spp. (rSsEno) confers effective protection against sporotrichosis in mice.
Squamous Cell Carcinoma of Head and Neck
[Application of serum tumor markers and support vector machine in the diagnosis of oral squamous cell carcinoma]
Starvation
A new nuclear function of the Entamoeba histolytica glycolytic enzyme enolase: the metabolic regulation of cytosine-5 methyltransferase 2 (Dnmt2) activity.
Enolase from the ectomycorrhizal fungus Tuber borchii Vittad.: biochemical characterization, molecular cloning, and localization.
Excess copper induced physiological and proteomic changes in germinating rice seeds.
Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barré syndrome.
Nutrition and fetal brain maturation. II. Impact of maternal starvation on changing levels of acetylcholinesterase and enolase in vitro.
Regulation of GlnK activity: modification, membrane sequestration and proteolysis as regulatory principles in the network of nitrogen control in Corynebacterium glutamicum.
Status Epilepticus
Cerebrospinal fluid neuron-specific enolase following seizures in children: role of etiology.
Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: A video-EEG study.
Expression of neuron-specific enolase in adult rat brain following status epilepticus.
Neuron-specific enolase is increased after nonconvulsive status epilepticus.
Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus.
Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Prognosis After Cardiac Arrest and Hypothermia: A New Paradigm.
Serum and CSF neuron-specific enolase in patients with West syndrome.
Serum neuron-specific enolase in human status epilepticus.
Serum neuron-specific enolase in the major subtypes of status epilepticus.
Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat.
Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier.
Understanding and Managing the Ictal-Interictal Continuum in Neurocritical Care.
[Effects of recombinant human erythropoietin on serum levels of neuron-specific enolase, S-100? protein and myelin basic protein in rats following status epilepticus].
[Predicting prognosis in post-anoxic coma]
[Prognosis for patients in a coma following cardiopulmonary resuscitation]
Stomach Diseases
Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori.
Stomach Neoplasms
Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.
Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis.
Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.
Overexpression of Neuron-Specific Enolase as a Prognostic Factor in Patients with Gastric Cancer.
Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer.
Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1/PKM2/GLUT1 expression.
The Effect of Artificial Neural Network Model Combined with Six Tumor Markers in Auxiliary Diagnosis of Lung Cancer.
Stomatitis, Aphthous
Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis.
Streptococcal Infections
Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae.
Protective efficacy of Streptococcus iniae derived enolase against Streptococcal infection in a zebrafish model.
Stroke
Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
Association of serum neuron-specific enolase and bilirubin levels with cerebral dysfunction and prognosis in large-artery atherosclerotic strokes.
Biomarkers for acute diagnosis and management of stroke in neurointensive care units.
Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring.
Cerebrospinal fluid enolase in stroke.
Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke.
CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model.
CXCR7+ and CXCR4+ stem cells and neuron specific enolase in acute ischemic stroke patients.
Detection of brain injury by fatty acid-binding proteins.
Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.
Effect of carotid artery stenting on the release of S-100B and neurone-specific enolase.
Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy.
Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study.
Immunochemical analysis of some proteins in cerebrospinal fluid and serum of patients with ischemic strokes.
Incidence and Clinical Outcome of Patients with Hypertensive Acute Ischemic Stroke: An Update from Tertiary Care Center of Central India.
Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke.
Labeless Immunosensor Assay for the Stroke Marker Protein Neuron Specific Enolase Based upon an Alternating Current Impedance Protocol.
Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability.
Neuron-specific enolase as a marker of neuronal lesions during various comas in man.
Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation.
Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage.
Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke.
Nucleosomes as a new prognostic marker in early cerebral stroke.
Prediction of delayed neuropsychiatric sequelae after carbon monoxide poisoning via serial determination of serum neuron-specific enolase levels.
Prognostic value of cerebral injury following transfemoral aortic valve implantation.
Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.
Role of Brain Biomarker in Predicting Clinical Outcome in Hypertensive Cerebrovascular Ischemic Stroke.
S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome.
Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis.
Serum neuron-specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke.
Serum neuron-specific enolase in human status epilepticus.
Serum neuron-specific enolase levels do not increase after electroconvulsive therapy.
Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. An enzymatic test for predicting outcome?
Serum neurone-specific enolase as an indicator of stroke volume.
Serum S100? is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy.
Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial.
Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients.
Site-directed introduction of disulfide groups on antibodies for highly sensitive immunosensors.
Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier.
Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.
The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
The second elevation of neuron-specific enolase peak after ischemic stroke is associated with hemorrhagic transformation.
The trends in nanomaterial-based biosensors for detecting critical biomarkers in stroke.
Treatment efficacy of arterial urokinase thrombolysis combined with mechanical thrombectomy for acute cerebral infarction and its influence on neuroprotective factors and factors for neurological injury.
[Advances in the biochemical markers of complications associated with carotid endarterectomy].
[Assessment of the levels of neuron-specific enolase and BDNF at the stages of rehabilitation in the acute and early recovery periods of ischemic stroke].
[Markers of inflammation, autoantibodies to neurospecific antigens and outcome in patients with acute ischemic stroke]
[The possibility of using neuron-specific enolase as a biomarker in the acute period of stroke].
[Usefulness of determining the level of neuron-specific enolase (NSE) in the cerebrospinal fluid as a biochemical indicator of the extent of cerebral ischemic stroke. Experimental study of the rat model of stroke]
Subarachnoid Hemorrhage
Detection of caspase-3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.
Detection of Caspase-3, Neuron Specific Enolase, and High-sensitivity C-reactive Protein Levels in Both Cerebrospinal Fluid and Serum of Patients after Aneurysmal Subarachnoid Hemorrhage.
Detection of caspase-3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.
Prognostic value of early S100B protein and Neuron-specific Enolase in patients with poor grade aneurysmal subarachnoid hemorrhage, a pilot study.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
Serum neuron-specific enolase levels after subarachnoid hemorrhage.
The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
The Relationship Between Serum Neuron-Specific Enolase Levels and Severity of Bleeding and Functional Outcomes in Patients With Nontraumatic Subarachnoid Hemorrhage.
[Measurement of serum neuron-specific enolase levels after subarachnoid hemorrhage and intracerebral hemorrhage]
Syncope
Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope.
Syphilis
Nucleotide sequence of the Treponema pallidum eno gene.
Takayasu Arteritis
Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Tauopathies
Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis.
Teratocarcinoma
Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse.
Teratoma
N-myc gene amplification and neuron specific enolase production in immature teratomas.
Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma.
[N-myc amplification and neuron-specific enolase production of ovarian immature teratoma]
Teratozoospermia
Enolase isoforms activities in spermatozoa from men with normospermia and abnormospermia.
Testicular Neoplasms
Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
Tumor markers in hydrocele fluids of patients with benign and malignant scrotal diseases.
Tetanus
A new neuronal marker identified by phosphorylcholine-binding myeloma proteins.
Epitopes common to trypanosomes (T. cruzi, T. dionisii and T. vespertilionis (Schizotrypanum]: astrocytes and neurons.
Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.
Identification of cell types in rat hippocampal slices maintained in organotypic cultures.
In search of the central respiratory neurons: I. Dissociated cell cultures of respiratory areas from the upper medulla.
In search of the central respiratory neurons: II. Electrophysiologic studies of medullary fetal cells inherently sensitive to CO2 and low pH.
In search of the real respiratory neurons: culture of medullary fetal cells sensitive to CO2 and low pH.
Neuronal development and migration in explant cultures of the adult canary forebrain.
Reciprocal age-dependent pattern of two neuronal markers, tetanus toxin and neuron-specific enolase, in postnatal rat sensory and sympathetic neurons.
Theileriasis
Cloning of Intron-Removed Enolase Gene and Expression, Purification, Kinetic Characterization of the Enzyme from Theileria annulata.
Functional analyses of dipeptide and pentapeptide insertions on Theileria annulata enolase by site-directed mutagenesis and in silico approaches.
Thrombosis
Cloning and characterization of a plasminogen-binding surface-associated enolase from Schistosoma bovis.
Enolase, a plasminogen receptor isolated from salivary gland transcriptome of the ixodid tick Haemaphysalis flava.
Thymoma
Myoid cells in the human thymus and thymoma revealed by three different immunohistochemical markers for striated muscle.
Neuroendocrine differentiation is a common feature of thymic carcinoma.
Primary tumours of the thymus in the rat.
Thyroid Dysgenesis
Ectopic thyroid tumor in a dog: thyroglobulin, calcitonin, and neuron-specific enolase immunocytochemical studies.
Thyroid Neoplasms
Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Circulating neuron-specific enolase in medullary thyroid cancer.
Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Enolase isozymes in differentiated and undifferentiated medullary thyroid carcinomas.
Gross, histologic, cytochemical, and immunocytochemical study of medullary thyroid carcinoma in sixteen dogs.
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Neuron-specific enolase in medullary thyroid carcinoma.
Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker.
Paraganglioma of the thyroid: report of a male case with ultrasonographic imagings, cytologic, histologic, and immunohistochemical features.
Secretome-Based Identification and Characterization of Potential Biomarkers in Thyroid Cancer.
The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.
Thyroid Paraganglioma Diagnosed by Fine-Needle Aspiration Biopsy, Correlated With Histopathological Findings: Report of a Case.
Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare Tumor.
Thyroiditis
Somatostatin: a paracrine contribution to hypothyroidism in Hashimoto's thyroiditis.
Thyroiditis, Autoimmune
Experimental evidence for alpha enolase as one potential autoantigen in the pathogenesis of both autoimmune thyroiditis and its related encephalopathy.
Tic Disorders
New insights into the role of neuron-specific enolase in tic disorders.
Tongue Neoplasms
Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response.
Trauma, Nervous System
Neuron-specific enolase and S-100B are associated with neurologic outcome after pediatric cardiac arrest.
Plasma Levels of the Cerebral Biomarker, Neuron-Specific Enolase, are Elevated During Pregnancy in Women Developing Preeclampsia.
[Trauma of cervical spinal cord--an immunohistochemical study]
Trophoblastic Neoplasms
Immunohistochemistry of germ cell and trophoblastic neoplasms.
Trypanosomiasis, African
Plasma neuronal specific enolase: a potential stage diagnostic marker in human African trypanosomiasis.
Tuberculosis
Enolase of Mycobacterium tuberculosis is a surface exposed plasminogen binding protein.
Exploring the interaction between Mycobacterium tuberculosisEnolase and human plasminogen using computational methods and experimental techniques.
Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis.
Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response.
[Proteome analysis of autoantibodies in sera of patients with cancer]
Tuberculosis, Meningeal
Expression level of NSE, S100B and NPY in children with acute miliary phthisis and secondary tubercular meningitis.
MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells.
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis.
Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis.
Tuberculosis, Miliary
Expression level of NSE, S100B and NPY in children with acute miliary phthisis and secondary tubercular meningitis.
MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells.
Tuberculosis, Pleural
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]
Tuberous Sclerosis
Central neuronal tumors in childhood: relationship to dysplasia.
Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis.
Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.
[Immunocytochemistry of subependymal giant cell astrocytoma associated with tuberous sclerosis]
[Immunohistochemical study of subependymal giant cell tumor associated with tuberous sclerosis]
Unconsciousness
Plasma fluoroacetic acid concentrations: Symptoms, hematological, and biochemical characteristics in patients with fluoroacetic acid poisoning in the emergency department.
Uremia
Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
Urinary Bladder Neoplasms
Krüppel-like factor 12 suppresses bladder cancer growth through transcriptionally inhibition of enolase 2.
Primary small cell carcinoma of the urinary bladder. Report of a case with immunohistochemical analyses.
Urologic Diseases
Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
Urticaria Pigmentosa
Immunohistochemical characterization of human cutaneous mast cells in urticaria pigmentosa (cutaneous mastocytosis)
Uterine Cervical Neoplasms
Identification of biomarkers for cervical cancer in peripheral blood lymphocytes using oligonucleotide microarrays.
Vascular Diseases
[Anti-centriole antibodies and high neuron-specific enolase activity in a patient with Raynaud phenomenon, cerebrovascular lesions, and ischemic finger necrosis--a functional relationship?]
Vasculitis
Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis.
Elevated anti-alpha-enolase antibody levels in Kawasaki disease.
Tubulointerstitial nephritis and vasculitis.
Venereal Tumors, Veterinary
Immunophenotype of the canine transmissible venereal tumour.
Venous Thrombosis
Serum neuron specific enolase may be a marker to predict the severity and outcome of cerebral venous thrombosis.
Ventricular Dysfunction, Right
Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase.
Ventricular Fibrillation
Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after out-of-hospital ventricular fibrillation and therapeutic hypothermia.
Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.
Vertigo
Characteristics of S100B and Neuron Specific Enolase in Differentiating Acute Vertigo Cases with Central Cause; a Diagnostic Accuracy Study.
Virus Diseases
Dynamics of the Interaction between Cotton Bollworm Helicoverpa armigera and Nucleopolyhedrovirus as Revealed by Integrated Transcriptomic and Proteomic Analyses.
Vitiligo
Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library.
Whooping Cough
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Wilms Tumor
Adult extrarenal Wilms tumor of the uterus with teratoid features.
Cytomorphology and immunohistochemistry of extrarenal rhabdoid tumor: a case report with review of literature.
Desmoplastic small round cell tumor: II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers.
Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Nephroblastoma with neuroendocrine differentiation.
Neural differentiation in Wilms' tumor.
Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor.
Neuron-specific enolase in nephroblastoma.
Neuron-specific enolase-positive rosettes in nephroblastoma: a possible diagnostic pitfall in aspiration cytology.
Primary renal neuroblastoma metastasizing into liver and lungs with tumor thrombus extension into the right atrium.
Primary Unilateral Small Cell Neuroendocrine Carcinoma of the Kidney in a Dog.
Serum neuron-specific enolase may be raised in children with Wilms' tumour.
Sister Mary Joseph nodule caused by metastatic desmoplastic small round cell tumor: A clinicopathological report.
Small round cell neoplasms: can electron microscopy and immunohistochemical studies accurately classify them?
[Immunohistochemical demonstration of neuron-specific enolase in nephroblastoma]
Xanthomatosis
Verruciform xanthoma of the oral mucosa: an immunohistochemical and ultrastructural study of two cases.